40 CFR 63.1429 - Process vent monitoring requirements.

Code of Federal Regulations, 2012 CFR

2012-07-01

... thermocouple, ultra-violet beam sensor, or infrared sensor) capable of continuously detecting the presence of a... used, a temperature monitoring device equipped with a continuous recorder is required. (i) Where an incinerator other than a catalytic incinerator is used, a temperature monitoring device shall be installed in...

40 CFR 63.1429 - Process vent monitoring requirements.

Code of Federal Regulations, 2011 CFR

2011-07-01

... thermocouple, ultra-violet beam sensor, or infrared sensor) capable of continuously detecting the presence of a... used, a temperature monitoring device equipped with a continuous recorder is required. (i) Where an incinerator other than a catalytic incinerator is used, a temperature monitoring device shall be installed in...

Remote maintenance monitoring system

NASA Technical Reports Server (NTRS)

Simpkins, Lorenz G. (Inventor); Owens, Richard C. (Inventor); Rochette, Donn A. (Inventor)

1992-01-01

A remote maintenance monitoring system retrofits to a given hardware device with a sensor implant which gathers and captures failure data from the hardware device, without interfering with its operation. Failure data is continuously obtained from predetermined critical points within the hardware device, and is analyzed with a diagnostic expert system, which isolates failure origin to a particular component within the hardware device. For example, monitoring of a computer-based device may include monitoring of parity error data therefrom, as well as monitoring power supply fluctuations therein, so that parity error and power supply anomaly data may be used to trace the failure origin to a particular plane or power supply within the computer-based device. A plurality of sensor implants may be rerofit to corresponding plural devices comprising a distributed large-scale system. Transparent interface of the sensors to the devices precludes operative interference with the distributed network. Retrofit capability of the sensors permits monitoring of even older devices having no built-in testing technology. Continuous real time monitoring of a distributed network of such devices, coupled with diagnostic expert system analysis thereof, permits capture and analysis of even intermittent failures, thereby facilitating maintenance of the monitored large-scale system.

40 CFR 65.156 - General monitoring requirements for control and recovery devices.

Code of Federal Regulations, 2010 CFR

2010-07-01

... AGENCY (CONTINUED) AIR PROGRAMS (CONTINUED) CONSOLIDATED FEDERAL AIR RULE Closed Vent Systems, Control Devices, and Routing to a Fuel Gas System or a Process § 65.156 General monitoring requirements for... systems. (1) All monitoring equipment shall be installed, calibrated, maintained, and operated according...

Design of a wearable device for ECG continuous monitoring using wireless technology.

PubMed

Led, Santiago; Fernández, Jorge; Serrano, Luis

2004-01-01

This project focuses on the design and implementation of an intelligent wearable device for ECG continuous acquisition and transmission to some remote gateway using Bluetooth technology. The acquisition device has been designed for having very low power consumption and reduced size. The Analog Devices' ADuC831 Micro-Converter for achieving the analog to digital conversion and the CSR's BlueCore2 chip for the Bluetooth transmission are the core of the device. The designed device is an important component of a complete prototype for remote ECG continuous monitoring of patients with diverse cardiac diseases.

21 CFR 884.2660 - Fetal ultrasonic monitor and accessories.

Code of Federal Regulations, 2012 CFR

2012-04-01

... 21 Food and Drugs 8 2012-04-01 2012-04-01 false Fetal ultrasonic monitor and accessories. 884.2660... (CONTINUED) MEDICAL DEVICES OBSTETRICAL AND GYNECOLOGICAL DEVICES Obstetrical and Gynecological Monitoring Devices § 884.2660 Fetal ultrasonic monitor and accessories. (a) Identification. A fetal ultrasonic...

21 CFR 884.2660 - Fetal ultrasonic monitor and accessories.

Code of Federal Regulations, 2014 CFR

2014-04-01

... 21 Food and Drugs 8 2014-04-01 2014-04-01 false Fetal ultrasonic monitor and accessories. 884.2660... (CONTINUED) MEDICAL DEVICES OBSTETRICAL AND GYNECOLOGICAL DEVICES Obstetrical and Gynecological Monitoring Devices § 884.2660 Fetal ultrasonic monitor and accessories. (a) Identification. A fetal ultrasonic...

21 CFR 884.2660 - Fetal ultrasonic monitor and accessories.

Code of Federal Regulations, 2013 CFR

2013-04-01

... 21 Food and Drugs 8 2013-04-01 2013-04-01 false Fetal ultrasonic monitor and accessories. 884.2660... (CONTINUED) MEDICAL DEVICES OBSTETRICAL AND GYNECOLOGICAL DEVICES Obstetrical and Gynecological Monitoring Devices § 884.2660 Fetal ultrasonic monitor and accessories. (a) Identification. A fetal ultrasonic...

21 CFR 868.2480 - Cutaneous carbon dioxide (PcCO2) monitor.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Cutaneous carbon dioxide (PcCO2) monitor. 868.2480... (CONTINUED) MEDICAL DEVICES ANESTHESIOLOGY DEVICES Monitoring Devices § 868.2480 Cutaneous carbon dioxide (PcCO2) monitor. (a) Identification. A cutaneous carbon dioxide (PcCO2) monitor is a noninvasive heated...

21 CFR 870.2620 - Line isolation monitor.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Line isolation monitor. 870.2620 Section 870.2620 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2620 Line isolation monitor...

21 CFR 870.2620 - Line isolation monitor.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Line isolation monitor. 870.2620 Section 870.2620 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2620 Line isolation monitor...

21 CFR 868.2375 - Breathing frequency monitor.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Breathing frequency monitor. 868.2375 Section 868.2375 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES ANESTHESIOLOGY DEVICES Monitoring Devices § 868.2375 Breathing frequency monitor. (a) Identification. A breathing (ventilatory)...

Noninvasive health condition monitoring device for workers at high altitudes conditions.

PubMed

Aqueveque, Pablo; Gutierrez, Cristopher; Saavedra, Francisco; Pino, Esteban J

2016-08-01

This work presents the design and implementation of a continuous monitoring device to control the health state of workers, for instance miners, at high altitudes. The extreme ambient conditions are harmful for peoples' health; therefore a continuous control of the workers' vital signs is necessary. The developed system includes physiological variables: electrocardiogram (ECG), respiratory activity and body temperature (BT), and ambient variables: ambient temperature (AT) and relative humidity (RH). The noninvasive sensors are incorporated in a t-shirt to deliver a functional device, and maximum comfort to the users. The device is able to continuously calculate heart rate (HR) and respiration rate (RR), and establish a wireless data transmission to a central monitoring station.

21 CFR 868.2500 - Cutaneous oxygen (PcO2) monitor.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Cutaneous oxygen (PcO2) monitor. 868.2500 Section... (CONTINUED) MEDICAL DEVICES ANESTHESIOLOGY DEVICES Monitoring Devices § 868.2500 Cutaneous oxygen (PcO2) monitor. (a) Identification. A cutaneous oxygen (PcO2) monitor is a noninvasive, heated sensor (e.g., a...

21 CFR 868.2500 - Cutaneous oxygen (PcO 2) monitor.

Code of Federal Regulations, 2014 CFR

2014-04-01

... 21 Food and Drugs 8 2014-04-01 2014-04-01 false Cutaneous oxygen (PcO 2) monitor. 868.2500 Section... (CONTINUED) MEDICAL DEVICES ANESTHESIOLOGY DEVICES Monitoring Devices § 868.2500 Cutaneous oxygen (PcO 2) monitor. (a) Identification. A cutaneous oxygen (PcO2) monitor is a noninvasive, heated sensor (e.g., a...

21 CFR 868.2500 - Cutaneous oxygen (PcO 2) monitor.

Code of Federal Regulations, 2013 CFR

2013-04-01

... 21 Food and Drugs 8 2013-04-01 2013-04-01 false Cutaneous oxygen (PcO 2) monitor. 868.2500 Section... (CONTINUED) MEDICAL DEVICES ANESTHESIOLOGY DEVICES Monitoring Devices § 868.2500 Cutaneous oxygen (PcO 2) monitor. (a) Identification. A cutaneous oxygen (PcO2) monitor is a noninvasive, heated sensor (e.g., a...

21 CFR 868.2500 - Cutaneous oxygen (PcO2) monitor.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Cutaneous oxygen (PcO2) monitor. 868.2500 Section... (CONTINUED) MEDICAL DEVICES ANESTHESIOLOGY DEVICES Monitoring Devices § 868.2500 Cutaneous oxygen (PcO2) monitor. (a) Identification. A cutaneous oxygen (PcO2) monitor is a noninvasive, heated sensor (e.g., a...

21 CFR 868.2500 - Cutaneous oxygen (PcO2) monitor.

Code of Federal Regulations, 2012 CFR

2012-04-01

... 21 Food and Drugs 8 2012-04-01 2012-04-01 false Cutaneous oxygen (PcO2) monitor. 868.2500 Section... (CONTINUED) MEDICAL DEVICES ANESTHESIOLOGY DEVICES Monitoring Devices § 868.2500 Cutaneous oxygen (PcO2) monitor. (a) Identification. A cutaneous oxygen (PcO2) monitor is a noninvasive, heated sensor (e.g., a...

21 CFR 26.45 - Monitoring continued equivalence.

Code of Federal Regulations, 2013 CFR

2013-04-01

... COMMUNITY Specific Sector Provisions for Medical Devices § 26.45 Monitoring continued equivalence. Monitoring activities will be carried out in accordance with § 26.69. ... 21 Food and Drugs 1 2013-04-01 2013-04-01 false Monitoring continued equivalence. 26.45 Section 26...

21 CFR 26.45 - Monitoring continued equivalence.

Code of Federal Regulations, 2012 CFR

2012-04-01

... COMMUNITY Specific Sector Provisions for Medical Devices § 26.45 Monitoring continued equivalence. Monitoring activities will be carried out in accordance with § 26.69. ... 21 Food and Drugs 1 2012-04-01 2012-04-01 false Monitoring continued equivalence. 26.45 Section 26...

21 CFR 26.45 - Monitoring continued equivalence.

Code of Federal Regulations, 2014 CFR

2014-04-01

... COMMUNITY Specific Sector Provisions for Medical Devices § 26.45 Monitoring continued equivalence. Monitoring activities will be carried out in accordance with § 26.69. ... 21 Food and Drugs 1 2014-04-01 2014-04-01 false Monitoring continued equivalence. 26.45 Section 26...

21 CFR 26.45 - Monitoring continued equivalence.

Code of Federal Regulations, 2011 CFR

2011-04-01

... COMMUNITY Specific Sector Provisions for Medical Devices § 26.45 Monitoring continued equivalence. Monitoring activities will be carried out in accordance with § 26.69. ... 21 Food and Drugs 1 2011-04-01 2011-04-01 false Monitoring continued equivalence. 26.45 Section 26...

A wearable device for continuous monitoring of heart mechanical function based on impedance cardiography.

PubMed

Panfili, G; Piccini, L; Maggi, L; Parini, S; Andreoni, G

2006-01-01

In this study we explored the possibility to realize a low power device for Cardiac Output continuous monitoring based on impedance cardiography technique. We assessed the possibility to develop a system able to record data allow an intra-subjective analysis based on the daily variations of this measure. The device was able to acquire and to send signals using a wireless Bluetooth transmission. The electronic circuit was designed in order to minimize power consumption, dimension and weight. The reported results were interesting for what concerns the power consumption and then noise level. In this way was obtained a wearable device that will permit to define specific clinical protocols based on continuous monitoring of the Cardiac Output signal.

21 CFR 882.1620 - Intracranial pressure monitoring device.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Intracranial pressure monitoring device. 882.1620 Section 882.1620 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES NEUROLOGICAL DEVICES Neurological Diagnostic Devices § 882.1620 Intracranial...

21 CFR 882.1620 - Intracranial pressure monitoring device.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Intracranial pressure monitoring device. 882.1620 Section 882.1620 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES NEUROLOGICAL DEVICES Neurological Diagnostic Devices § 882.1620 Intracranial...

21 CFR 882.1610 - Alpha monitor.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Alpha monitor. 882.1610 Section 882.1610 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES NEUROLOGICAL DEVICES Neurological Diagnostic Devices § 882.1610 Alpha monitor. (a) Identification. An alpha...

21 CFR 882.1610 - Alpha monitor.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Alpha monitor. 882.1610 Section 882.1610 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES NEUROLOGICAL DEVICES Neurological Diagnostic Devices § 882.1610 Alpha monitor. (a) Identification. An alpha...

40 CFR 63.1324 - Batch process vents-monitoring equipment.

Code of Federal Regulations, 2012 CFR

2012-07-01

... device (including but not limited to a thermocouple, ultra-violet beam sensor, or infrared sensor... temperature monitoring device equipped with a continuous recorder is required. (i) Where an incinerator other than a catalytic incinerator is used, the temperature monitoring device shall be installed in the...

21 CFR 884.2620 - Fetal electroencephalographic monitor.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Fetal electroencephalographic monitor. 884.2620 Section 884.2620 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES OBSTETRICAL AND GYNECOLOGICAL DEVICES Obstetrical and Gynecological Monitoring Devices § 884.2620 Fetal...

40 CFR 63.489 - Batch front-end process vents-monitoring equipment.

Code of Federal Regulations, 2013 CFR

2013-07-01

... device (including, but not limited to, a thermocouple, ultra-violet beam sensor, or infrared sensor... temperature monitoring device equipped with a continuous recorder is required. (i) Where an incinerator other than a catalytic incinerator is used, the temperature monitoring device shall be installed in the...

40 CFR 63.127 - Transfer operations provisions-monitoring requirements.

Code of Federal Regulations, 2013 CFR

2013-07-01

... device (including but not limited to a thermocouple, infrared sensor, or an ultra-violet beam sensor... temperature monitoring device equipped with a continuous recorder is required. (i) Where an incinerator other than a catalytic incinerator is used, a temperature monitoring device shall be installed in the firebox...

40 CFR 63.489 - Batch front-end process vents-monitoring equipment.

Code of Federal Regulations, 2012 CFR

2012-07-01

... device (including, but not limited to, a thermocouple, ultra-violet beam sensor, or infrared sensor... temperature monitoring device equipped with a continuous recorder is required. (i) Where an incinerator other than a catalytic incinerator is used, the temperature monitoring device shall be installed in the...

40 CFR 63.127 - Transfer operations provisions-monitoring requirements.

Code of Federal Regulations, 2014 CFR

2014-07-01

... device (including but not limited to a thermocouple, infrared sensor, or an ultra-violet beam sensor... temperature monitoring device equipped with a continuous recorder is required. (i) Where an incinerator other than a catalytic incinerator is used, a temperature monitoring device shall be installed in the firebox...

40 CFR 63.489 - Batch front-end process vents-monitoring equipment.

Code of Federal Regulations, 2014 CFR

2014-07-01

... device (including, but not limited to, a thermocouple, ultra-violet beam sensor, or infrared sensor... temperature monitoring device equipped with a continuous recorder is required. (i) Where an incinerator other than a catalytic incinerator is used, the temperature monitoring device shall be installed in the...

40 CFR 63.127 - Transfer operations provisions-monitoring requirements.

Code of Federal Regulations, 2012 CFR

2012-07-01

... device (including but not limited to a thermocouple, infrared sensor, or an ultra-violet beam sensor... temperature monitoring device equipped with a continuous recorder is required. (i) Where an incinerator other than a catalytic incinerator is used, a temperature monitoring device shall be installed in the firebox...

Women's experiences of continuous fetal monitoring - a mixed-methods systematic review.

PubMed

Crawford, Alexandra; Hayes, Dexter; Johnstone, Edward D; Heazell, Alexander E P

2017-12-01

Antepartum stillbirth is often preceded by detectable signs of fetal compromise, including changes in fetal heart rate and movement. It is hypothesized that continuous fetal monitoring could detect these signs more accurately and objectively than current forms of fetal monitoring and allow for timely intervention. This systematic review aimed to explore available evidence on women's experiences of continuous fetal monitoring to investigate its acceptability before clinical implementation and to inform clinical studies. Systematic searching of four electronic databases (Embase, PsycINFO, MEDLINE and CINAHL), using key terms defined by initial scoping searches, identified a total of 35 studies. Following title and abstract screening by two independent researchers, five studies met the inclusion criteria. Studies were not excluded based on language, methodology or quality assessment. An integrative methodology was used to synthesize qualitative and quantitative data together. Forms of continuous fetal monitoring used included Monica AN24 monitors (n = 4) and phonocardiography (n = 1). Four main themes were identified: practical limitations of the device, negative emotions, positive perceptions, and device implementation. Continuous fetal monitoring was reported to have high levels of participant satisfaction and was preferred by women to intermittent cardiotocography. This review suggests that continuous fetal monitoring is accepted by women. However, it has also highlighted both the paucity and heterogeneity of current studies and suggests that further research should be conducted into women's experiences of continuous fetal monitoring before such devices can be used clinically. © 2017 Nordic Federation of Societies of Obstetrics and Gynecology.

21 CFR 868.2480 - Cutaneous carbon dioxide (PcCO2) monitor.

Code of Federal Regulations, 2012 CFR

2012-04-01

... 21 Food and Drugs 8 2012-04-01 2012-04-01 false Cutaneous carbon dioxide (PcCO2) monitor. 868.2480 Section 868.2480 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES ANESTHESIOLOGY DEVICES Monitoring Devices § 868.2480 Cutaneous carbon dioxide (PcCO2) monitor. (a) Identification. A...

40 CFR 60.1315 - Must I meet other requirements for continuous monitoring?

Code of Federal Regulations, 2012 CFR

2012-07-01

... continuous monitoring? 60.1315 Section 60.1315 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY... Requirements § 60.1315 Must I meet other requirements for continuous monitoring? You must also monitor three... at the inlet of your particulate matter air pollution control device. (c) Carbon feed rate if...

40 CFR 60.1315 - Must I meet other requirements for continuous monitoring?

Code of Federal Regulations, 2010 CFR

2010-07-01

... continuous monitoring? 60.1315 Section 60.1315 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY... Requirements § 60.1315 Must I meet other requirements for continuous monitoring? You must also monitor three... at the inlet of your particulate matter air pollution control device. (c) Carbon feed rate if...

40 CFR 60.1315 - Must I meet other requirements for continuous monitoring?

Code of Federal Regulations, 2014 CFR

2014-07-01

... continuous monitoring? 60.1315 Section 60.1315 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY... Requirements § 60.1315 Must I meet other requirements for continuous monitoring? You must also monitor three... at the inlet of your particulate matter air pollution control device. (c) Carbon feed rate if...

40 CFR 60.1315 - Must I meet other requirements for continuous monitoring?

Code of Federal Regulations, 2013 CFR

2013-07-01

... continuous monitoring? 60.1315 Section 60.1315 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY... Requirements § 60.1315 Must I meet other requirements for continuous monitoring? You must also monitor three... at the inlet of your particulate matter air pollution control device. (c) Carbon feed rate if...

40 CFR 60.1315 - Must I meet other requirements for continuous monitoring?

Code of Federal Regulations, 2011 CFR

2011-07-01

... continuous monitoring? 60.1315 Section 60.1315 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY... Requirements § 60.1315 Must I meet other requirements for continuous monitoring? You must also monitor three... at the inlet of your particulate matter air pollution control device. (c) Carbon feed rate if...

40 CFR 63.11940 - What continuous monitoring requirements must I meet for control devices required to install CPMS...

Code of Federal Regulations, 2014 CFR

2014-07-01

... non-vacuum regeneration systems, an integrating regeneration stream flow monitoring device having an accuracy of ±10 percent, capable of recording the total regeneration stream mass for each regeneration cycle. For non-vacuum regeneration systems, an integrating regeneration stream flow monitoring device...

40 CFR 63.11940 - What continuous monitoring requirements must I meet for control devices required to install CPMS...

Code of Federal Regulations, 2013 CFR

2013-07-01

... non-vacuum regeneration systems, an integrating regeneration stream flow monitoring device having an accuracy of ±10 percent, capable of recording the total regeneration stream mass for each regeneration cycle. For non-vacuum regeneration systems, an integrating regeneration stream flow monitoring device...

21 CFR 884.2720 - External uterine contraction monitor and accessories.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false External uterine contraction monitor and accessories. 884.2720 Section 884.2720 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES OBSTETRICAL AND GYNECOLOGICAL DEVICES Obstetrical and Gynecological Monitoring Devices § 884.2720 External...

Real-Time Deposition Monitor for Ultrathin Conductive Films

NASA Technical Reports Server (NTRS)

Hines, Jacqueline

2011-01-01

A device has been developed that can be used for the real-time monitoring of ultrathin (2 or more) conductive films. The device responds in less than two microseconds, and can be used to monitor film depositions up to about 60 thick. Actual thickness monitoring capability will vary based on properties of the film being deposited. This is a single-use device, which, due to the very low device cost, can be disposable. Conventional quartz/crystal microbalance devices have proven inadequate to monitor the thickness of Pd films during deposition of ultrathin films for hydrogen sensor devices. When the deposited film is less than 100 , the QCM measurements are inadequate to allow monitoring of the ultrathin films being developed. Thus, an improved, high-sensitivity, real-time deposition monitor was needed to continue Pd film deposition development. The new deposition monitor utilizes a surface acoustic wave (SAW) device in a differential delay-line configuration to produce both a reference response and a response for the portion of the device on which the film is being deposited. Both responses are monitored simultaneously during deposition. The reference response remains unchanged, while the attenuation of the sensing path (where the film is being deposited) varies as the film thickness increases. This device utilizes the fact that on high-coupling piezoelectric substrates, the attenuation of an SAW undergoes a transition from low to very high, and back to low as the conductivity of a film on the device surface goes from nonconductive to highly conductive. Thus, the sensing path response starts with a low insertion loss, and as a conductive film is deposited, the film conductivity increases, causing the device insertion loss to increase dramatically (by up to 80 dB or more), and then with continued film thickness increases (and the corresponding conductivity increases), the device insertion loss goes back down to the low level at which it started. This provides a continuous, real-time monitoring of film deposition. For use with different films, the device would need to be calibrated to provide an understanding of how film thickness is related to film conductivity, as the device is responding primarily to conductivity effects (and not to mass loading effects) in this ultrathin film regime.

76 FR 34999 - Draft Guidance for Industry and Food and Drug Administration Staff; Establishing the Performance...

Federal Register 2010, 2011, 2012, 2013, 2014

2011-06-15

... human specimens or bacterial growth detected by continuous monitoring blood culture systems. This draft... versus SA in either human specimens or bacterial growth detected by continuous monitoring blood culture... devices that detect MRSA by growth in culture media or those devices that test for the protein, penicillin...

Vital signs monitoring on general wards: clinical staff perceptions of current practices and the planned introduction of continuous monitoring technology.

PubMed

Prgomet, Mirela; Cardona-Morrell, Magnolia; Nicholson, Margaret; Lake, Rebecca; Long, Janet; Westbrook, Johanna; Braithwaite, Jeffrey; Hillman, Ken

2016-09-01

Early detection of patient deterioration and prevention of adverse events are key challenges to patient safety. This study investigated clinical staff perceptions of current monitoring practices and the planned introduction of continuous monitoring devices on general wards. Multi-method study comprising structured surveys, in-depth interviews and device trial with log book feedback. Two general wards in a large urban teaching hospital in Sydney, Australia. Respiratory and neurosurgery nursing staff and two doctors. Nurses were confident about their abilities to identify patients at risk of deterioration, using a combination of vital signs and visual assessment. There were concerns about the accuracy of current vital signs monitoring equipment and frequency of intermittent observation. Both the nurses and the doctors were enthusiastic about the prospect of continuous monitoring and perceived it would allow earlier identification of patient deterioration; provide reassurance to patients; and support interdisciplinary communication. There were also reservations about continuous monitoring, including potential decrease in bedside nurse-patient interactions; increase in inappropriate escalations of patient care; and discomfort to patients. While continuous monitoring devices were seen as a potentially positive tool to support the identification of patient deterioration, drawbacks, such as the potential for reduced patient contact, revealed key areas that will require close surveillance following the implementation of devices. Training and improved interdisciplinary communication were identified as key requisites for successful implementation. © The Author 2016. Published by Oxford University Press in association with the International Society for Quality in Health Care. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Long-Term Continuous Ambulatory ECG Monitors and External Cardiac Loop Recorders for Cardiac Arrhythmia: A Health Technology Assessment

PubMed Central

Kabali, Conrad; Xie, Xuanqian; Higgins, Caroline

2017-01-01

Background Ambulatory electrocardiography (ECG) monitors are often used to detect cardiac arrhythmia. For patients with symptoms, an external cardiac loop recorder will often be recommended. The improved recording capacity of newer Holter monitors and similar devices, collectively known as longterm continuous ambulatory ECG monitors, suggests that they will perform just as well as, or better than, external loop recorders. This health technology assessment aimed to evaluate the effectiveness, cost-effectiveness, and budget impact of longterm continuous ECG monitors compared with external loop recorders in detecting symptoms of cardiac arrhythmia. Methods Based on our systematic search for studies published up to January 15, 2016, we did not identify any studies directly comparing the clinical effectiveness of longterm continuous ECG monitors and external loop recorders. Therefore, we conducted an indirect comparison, using a 24-hour Holter monitor as a common comparator. We used a meta-regression model to control for bias due to variation in device-wearing time and baseline syncope rate across studies. We conducted a similar systematic search for cost-utility and cost-effectiveness studies comparing the two types of devices; none were found. Finally, we used historical claims data (2006–2014) to estimate the future 5-year budget impact in Ontario, Canada, of continued public funding for both types of longterm ambulatory ECG monitors. Results Our clinical literature search yielded 7,815 non-duplicate citations, of which 12 cohort studies were eligible for indirect comparison. Seven studies assessed the effectiveness of longterm continuous monitors and five assessed external loop recorders. Both types of devices were more effective than a 24-hour Holter monitor, and we found no substantial difference between them in their ability to detect symptoms (risk difference 0.01; 95% confidence interval −0.18, 0.20). Using GRADE for network meta-analysis, we evaluated the quality of the evidence as low. Our budget impact analysis showed that use of the longterm continuous monitors has grown steadily in Ontario since they became publicly funded in 2006, particularly since 2011 when monitors that can record for 14 days or longer became funded, and the use of external cardiac loop recorders has correspondingly declined. The analysis suggests that, with these trends, continued public funding of both types of longterm ambulatory ECG testing will result in additional costs ranging from $130,000 to $370,000 per year over the next 5 years. Conclusions Although both longterm continuous ambulatory ECG monitors and external cardiac loop recorders were more effective than a 24-hour Holter monitor in detecting symptoms of cardiac arrhythmia, we found no evidence to suggest that these two devices differ in effectiveness. Assuming that the use of longterm continuous monitors will continue to increase in the next 5 years, the public health care system in Ontario can expect to see added costs of $130,000 to $370,000 per year. PMID:28194254

21 CFR 880.2460 - Electrically powered spinal fluid pressure monitor.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Electrically powered spinal fluid pressure monitor. 880.2460 Section 880.2460 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES GENERAL HOSPITAL AND PERSONAL USE DEVICES General Hospital and Personal Use Monitoring Devices § 880.2460...

40 CFR 63.497 - Back-end process provisions-monitoring provisions for control and recovery devices used to comply...

Code of Federal Regulations, 2013 CFR

2013-07-01

... thermocouple, ultra-violet beam sensor, or infrared sensor) capable of continuously detecting the presence of a..., as appropriate. (1) Where an incinerator is used, a temperature monitoring device equipped with a... temperature monitoring device shall be installed in the firebox or in the ductwork immediately downstream of...

40 CFR 63.497 - Back-end process provisions-monitoring provisions for control and recovery devices used to comply...

Code of Federal Regulations, 2014 CFR

2014-07-01

... thermocouple, ultra-violet beam sensor, or infrared sensor) capable of continuously detecting the presence of a..., as appropriate. (1) Where an incinerator is used, a temperature monitoring device equipped with a... temperature monitoring device shall be installed in the firebox or in the ductwork immediately downstream of...

40 CFR 63.497 - Back-end process provisions-monitoring provisions for control and recovery devices used to comply...

Code of Federal Regulations, 2012 CFR

2012-07-01

... thermocouple, ultra-violet beam sensor, or infrared sensor) capable of continuously detecting the presence of a..., as appropriate. (1) Where an incinerator is used, a temperature monitoring device equipped with a... temperature monitoring device shall be installed in the firebox or in the ductwork immediately downstream of...

40 CFR 60.663 - Monitoring of emissions and operations.

Code of Federal Regulations, 2011 CFR

2011-07-01

... the following equipment: (1) A temperature monitoring device equipped with a continuous recorder and having an accuracy of ±1 percent of the temperature being monitored expressed in degrees Celsius or ±0.5... temperature monitoring device shall be installed in the firebox. (ii) Where a catalytic incinerator is used...

40 CFR 60.663 - Monitoring of emissions and operations.

Code of Federal Regulations, 2010 CFR

2010-07-01

... the following equipment: (1) A temperature monitoring device equipped with a continuous recorder and having an accuracy of ±1 percent of the temperature being monitored expressed in degrees Celsius or ±0.5... temperature monitoring device shall be installed in the firebox. (ii) Where a catalytic incinerator is used...

21 CFR 868.2775 - Electrical peripheral nerve stimulator.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Electrical peripheral nerve stimulator. 868.2775... (CONTINUED) MEDICAL DEVICES ANESTHESIOLOGY DEVICES Monitoring Devices § 868.2775 Electrical peripheral nerve stimulator. (a) Identification. An electrical peripheral nerve stimulator (neuromuscular blockade monitor) is...

21 CFR 868.2775 - Electrical peripheral nerve stimulator.

Code of Federal Regulations, 2014 CFR

2014-04-01

... 21 Food and Drugs 8 2014-04-01 2014-04-01 false Electrical peripheral nerve stimulator. 868.2775... (CONTINUED) MEDICAL DEVICES ANESTHESIOLOGY DEVICES Monitoring Devices § 868.2775 Electrical peripheral nerve stimulator. (a) Identification. An electrical peripheral nerve stimulator (neuromuscular blockade monitor) is...

21 CFR 868.2775 - Electrical peripheral nerve stimulator.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Electrical peripheral nerve stimulator. 868.2775... (CONTINUED) MEDICAL DEVICES ANESTHESIOLOGY DEVICES Monitoring Devices § 868.2775 Electrical peripheral nerve stimulator. (a) Identification. An electrical peripheral nerve stimulator (neuromuscular blockade monitor) is...

A multi-functional, portable device with wireless transmission for home monitoring of children with a learning disability.

PubMed

Tura, A; Badanai, M; Longo, D; Quareni, L

2004-01-01

A portable monitoring device was developed to assist in the management of children with a learning disability. The device was designed for continuous home monitoring of blood oxygen saturation, heart and respiration rates, and patient activity. It could be worn on a belt, while the patient continued normal activities. Data were stored on a multimedia card and automatically transmitted to a PC at prescribed intervals via a Bluetooth wireless link. From the PC the data were transmitted to a Web server, where the information was made available to the staff involved in the patient's care. Preliminary clinical studies were performed with nine patients (four with Down's syndrome, three with cerebral palsy and two with mental retardation). Patients and families considered the device easy to use and to wear. The monitoring device identified events of possible clinical interest. Although it was designed for monitoring children with a learning disability, it may also be useful with other groups, such as elderly people.

Microfabricated fuel heating value monitoring device

DOEpatents

Robinson, Alex L [Albuquerque, NM; Manginell, Ronald P [Albuquerque, NM; Moorman, Matthew W [Albuquerque, NM

2010-05-04

A microfabricated fuel heating value monitoring device comprises a microfabricated gas chromatography column in combination with a catalytic microcalorimeter. The microcalorimeter can comprise a reference thermal conductivity sensor to provide diagnostics and surety. Using microfabrication techniques, the device can be manufactured in production quantities at a low per-unit cost. The microfabricated fuel heating value monitoring device enables continuous calorimetric determination of the heating value of natural gas with a 1 minute analysis time and 1.5 minute cycle time using air as a carrier gas. This device has applications in remote natural gas mining stations, pipeline switching and metering stations, turbine generators, and other industrial user sites. For gas pipelines, the device can improve gas quality during transfer and blending, and provide accurate financial accounting. For industrial end users, the device can provide continuous feedback of physical gas properties to improve combustion efficiency during use.

40 CFR 63.993 - Absorbers, condensers, carbon adsorbers and other recovery devices used as final recovery devices.

Code of Federal Regulations, 2014 CFR

2014-07-01

... providing a continuous record or an integrating regeneration stream flow monitoring device having an accuracy of ±10 percent or better, capable of recording the total regeneration stream mass or volumetric flow for each regeneration cycle; and a carbon-bed temperature monitoring device, capable of recording...

40 CFR 65.153 - Absorbers, condensers, carbon adsorbers, and other recovery devices used as final recovery devices.

Code of Federal Regulations, 2014 CFR

2014-07-01

..., an organic monitoring device capable of providing a continuous record, or an integrating regeneration... regeneration stream mass or volumetric flow for each regeneration cycle, and a carbon-bed temperature monitoring device capable of recording the carbon-bed temperature after each regeneration and within 15...

40 CFR 63.993 - Absorbers, condensers, carbon adsorbers and other recovery devices used as final recovery devices.

Code of Federal Regulations, 2010 CFR

2010-07-01

... providing a continuous record or an integrating regeneration stream flow monitoring device having an accuracy of ±10 percent or better, capable of recording the total regeneration stream mass or volumetric flow for each regeneration cycle; and a carbon-bed temperature monitoring device, capable of recording...

40 CFR 65.153 - Absorbers, condensers, carbon adsorbers, and other recovery devices used as final recovery devices.

Code of Federal Regulations, 2012 CFR

2012-07-01

..., an organic monitoring device capable of providing a continuous record, or an integrating regeneration... regeneration stream mass or volumetric flow for each regeneration cycle, and a carbon-bed temperature monitoring device capable of recording the carbon-bed temperature after each regeneration and within 15...

40 CFR 63.993 - Absorbers, condensers, carbon adsorbers and other recovery devices used as final recovery devices.

Code of Federal Regulations, 2011 CFR

2011-07-01

... providing a continuous record or an integrating regeneration stream flow monitoring device having an accuracy of ±10 percent or better, capable of recording the total regeneration stream mass or volumetric flow for each regeneration cycle; and a carbon-bed temperature monitoring device, capable of recording...

40 CFR 63.993 - Absorbers, condensers, carbon adsorbers and other recovery devices used as final recovery devices.

Code of Federal Regulations, 2012 CFR

2012-07-01

... providing a continuous record or an integrating regeneration stream flow monitoring device having an accuracy of ±10 percent or better, capable of recording the total regeneration stream mass or volumetric flow for each regeneration cycle; and a carbon-bed temperature monitoring device, capable of recording...

40 CFR 63.993 - Absorbers, condensers, carbon adsorbers and other recovery devices used as final recovery devices.

Code of Federal Regulations, 2013 CFR

2013-07-01

... providing a continuous record or an integrating regeneration stream flow monitoring device having an accuracy of ±10 percent or better, capable of recording the total regeneration stream mass or volumetric flow for each regeneration cycle; and a carbon-bed temperature monitoring device, capable of recording...

40 CFR 65.153 - Absorbers, condensers, carbon adsorbers, and other recovery devices used as final recovery devices.

Code of Federal Regulations, 2011 CFR

2011-07-01

..., an organic monitoring device capable of providing a continuous record, or an integrating regeneration... regeneration stream mass or volumetric flow for each regeneration cycle, and a carbon-bed temperature monitoring device capable of recording the carbon-bed temperature after each regeneration and within 15...

40 CFR 65.153 - Absorbers, condensers, carbon adsorbers, and other recovery devices used as final recovery devices.

Code of Federal Regulations, 2010 CFR

2010-07-01

..., an organic monitoring device capable of providing a continuous record, or an integrating regeneration... regeneration stream mass or volumetric flow for each regeneration cycle, and a carbon-bed temperature monitoring device capable of recording the carbon-bed temperature after each regeneration and within 15...

40 CFR 65.153 - Absorbers, condensers, carbon adsorbers, and other recovery devices used as final recovery devices.

Code of Federal Regulations, 2013 CFR

2013-07-01

..., an organic monitoring device capable of providing a continuous record, or an integrating regeneration... regeneration stream mass or volumetric flow for each regeneration cycle, and a carbon-bed temperature monitoring device capable of recording the carbon-bed temperature after each regeneration and within 15...

An intelligent stand-alone ultrasonic device for monitoring local structural damage: implementation and preliminary experiments

NASA Astrophysics Data System (ADS)

Pertsch, Alexander; Kim, Jin-Yeon; Wang, Yang; Jacobs, Laurence J.

2011-01-01

Continuous structural health monitoring has the potential to significantly improve the safety management of aged, in-service civil structures. In particular, monitoring of local damage growth at hot-spot areas can help to prevent disastrous structural failures. Although ultrasonic nondestructive evaluation (NDE) has proved to be effective in monitoring local damage growth, conventional equipment and devices are usually bulky and only suitable for scheduled human inspections. The objective of this research is to harness the latest developments in embedded hardware and wireless communication for developing a stand-alone, compact ultrasonic device. The device is directed at the continuous structural health monitoring of civil structures. Relying on battery power, the device possesses the functionalities of high-speed actuation, sensing, signal processing, and wireless communication. Integrated with contact ultrasonic transducers, the device can generate 1 MHz Rayleigh surface waves in a steel specimen and measure response waves. An envelope detection algorithm based on the Hilbert transform is presented for efficiently determining the peak values of the response signals, from which small surface cracks are successfully identified.

21 CFR 882.5500 - Lesion temperature monitor.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Lesion temperature monitor. 882.5500 Section 882.5500 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES NEUROLOGICAL DEVICES Neurological Therapeutic Devices § 882.5500 Lesion temperature...

40 CFR 60.1805 - Must I meet other requirements for continuous monitoring?

Code of Federal Regulations, 2010 CFR

2010-07-01

... continuous monitoring? 60.1805 Section 60.1805 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY..., 1999 Model Rule-Other Monitoring Requirements § 60.1805 Must I meet other requirements for continuous... device. (c) Carbon feed rate if activated carbon is used to control dioxins/furans or mercury emissions. ...

40 CFR 60.1805 - Must I meet other requirements for continuous monitoring?

Code of Federal Regulations, 2014 CFR

2014-07-01

... continuous monitoring? 60.1805 Section 60.1805 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY..., 1999 Model Rule-Other Monitoring Requirements § 60.1805 Must I meet other requirements for continuous... device. (c) Carbon feed rate if activated carbon is used to control dioxins/furans or mercury emissions. ...

40 CFR 60.1805 - Must I meet other requirements for continuous monitoring?

Code of Federal Regulations, 2012 CFR

2012-07-01

... continuous monitoring? 60.1805 Section 60.1805 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY..., 1999 Model Rule-Other Monitoring Requirements § 60.1805 Must I meet other requirements for continuous... device. (c) Carbon feed rate if activated carbon is used to control dioxins/furans or mercury emissions. ...

40 CFR 60.1805 - Must I meet other requirements for continuous monitoring?

Code of Federal Regulations, 2013 CFR

2013-07-01

... continuous monitoring? 60.1805 Section 60.1805 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY..., 1999 Model Rule-Other Monitoring Requirements § 60.1805 Must I meet other requirements for continuous... device. (c) Carbon feed rate if activated carbon is used to control dioxins/furans or mercury emissions. ...

40 CFR 60.1805 - Must I meet other requirements for continuous monitoring?

Code of Federal Regulations, 2011 CFR

2011-07-01

... continuous monitoring? 60.1805 Section 60.1805 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY..., 1999 Model Rule-Other Monitoring Requirements § 60.1805 Must I meet other requirements for continuous... device. (c) Carbon feed rate if activated carbon is used to control dioxins/furans or mercury emissions. ...

Integration of continuous-flow sampling with microchip electrophoresis using poly(dimethylsiloxane)-based valves in a reversibly sealed device.

PubMed

Li, Michelle W; Martin, R Scott

2007-07-01

Here we describe a reversibly sealed microchip device that incorporates poly(dimethylsiloxane) (PDMS)-based valves for the rapid injection of analytes from a continuously flowing stream into a channel network for analysis with microchip electrophoresis. The microchip was reversibly sealed to a PDMS-coated glass substrate and microbore tubing was used for the introduction of gas and fluids to the microchip device. Two pneumatic valves were incorporated into the design and actuated on the order of hundreds of milliseconds, allowing analyte from a continuously flowing sampling stream to be injected into an electrophoresis separation channel. The device was characterized in terms of the valve actuation time and pushback voltage. It was also found that the addition of sodium dodecyl sulfate (SDS) to the buffer system greatly increased the reproducibility of the injection scheme and enabled the analysis of amino acids derivatized with naphthalene-2,3-dicarboxaldehyde/cyanide. Results from continuous injections of a 0.39 nL fluorescein plug into the optimized system showed that the injection process was reproducible (RSD of 0.7%, n = 10). Studies also showed that the device was capable of monitoring off-chip changes in concentration with a device lag time of 90 s. Finally, the ability of the device to rapidly monitor on-chip concentration changes was demonstrated by continually sampling from an analyte plug that was derivatized upstream from the electrophoresis/continuous flow interface. A reversibly sealed device of this type will be useful for the continuous monitoring and analysis of processes that occur either off-chip (such as microdialysis sampling) or on-chip from other integrated functions.

21 CFR 866.2560 - Microbial growth monitor.

Code of Federal Regulations, 2014 CFR

2014-04-01

... 21 Food and Drugs 8 2014-04-01 2014-04-01 false Microbial growth monitor. 866.2560 Section 866.2560 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES IMMUNOLOGY AND MICROBIOLOGY DEVICES Microbiology Devices § 866.2560 Microbial growth...

21 CFR 866.2560 - Microbial growth monitor.

Code of Federal Regulations, 2012 CFR

2012-04-01

... 21 Food and Drugs 8 2012-04-01 2012-04-01 false Microbial growth monitor. 866.2560 Section 866.2560 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES IMMUNOLOGY AND MICROBIOLOGY DEVICES Microbiology Devices § 866.2560 Microbial growth...

21 CFR 866.2560 - Microbial growth monitor.

Code of Federal Regulations, 2013 CFR

2013-04-01

... 21 Food and Drugs 8 2013-04-01 2013-04-01 false Microbial growth monitor. 866.2560 Section 866.2560 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES IMMUNOLOGY AND MICROBIOLOGY DEVICES Microbiology Devices § 866.2560 Microbial growth...

Analysis: Continuous Glucose Monitoring in the Intensive Care Unit

PubMed Central

Kenneth Ward, W.

2012-01-01

Control of glycemia in hospitalized patients is important; hypoglycemia is associated with increased mortality, and hyperglycemia is associated with adverse outcomes. For these reasons, though no such device is currently available, continuous glucose monitoring (CGM) is an attractive option, especially in the critical care setting. Schierenbeck and coauthors, in this issue of Journal of Diabetes Science and Technology, report on the use of a specialized central catheter designed to monitor glucose continuously in post cardiac surgery patients. This catheter, which was indwelled within the great veins, was specially designed with a separate lumen and membrane that allowed continuous glucose microdialysis. Accuracy was quite good, better than has been reported with the use of commercially-available CGM devices. Ideally, further development of this quite promising catheter-based device would allow it to be used also to deliver fluids and drugs, thus avoiding the need for a second catheter elsewhere. PMID:23294782

Remote monitoring of cardiovascular implanted electronic devices: a paradigm shift for the 21st century.

PubMed

Cronin, Edmond M; Varma, Niraj

2012-07-01

Traditional follow-up of cardiac implantable electronic devices involves the intermittent download of largely nonactionable data. Remote monitoring represents a paradigm shift from episodic office-based follow-up to continuous monitoring of device performance and patient and disease state. This lessens device clinical burden and may also lead to cost savings, although data on economic impact are only beginning to emerge. Remote monitoring technology has the potential to improve the outcomes through earlier detection of arrhythmias and compromised device integrity, and possibly predict heart failure hospitalizations through integration of heart failure diagnostics and hemodynamic monitors. Remote monitoring platforms are also huge databases of patients and devices, offering unprecedented opportunities to investigate real-world outcomes. Here, the current status of the field is described and future directions are predicted.

30 CFR 74.11 - Tests of the continuous personal dust monitor.

Code of Federal Regulations, 2010 CFR

2010-07-01

... 30 Mineral Resources 1 2010-07-01 2010-07-01 false Tests of the continuous personal dust monitor. 74.11 Section 74.11 Mineral Resources MINE SAFETY AND HEALTH ADMINISTRATION, DEPARTMENT OF LABOR COAL MINE SAFETY AND HEALTH COAL MINE DUST SAMPLING DEVICES Requirements for Continuous Personal Dust Monitors § 74.11 Tests of the continuous personal...

30 CFR 74.11 - Tests of the continuous personal dust monitor.

Code of Federal Regulations, 2011 CFR

2011-07-01

... 30 Mineral Resources 1 2011-07-01 2011-07-01 false Tests of the continuous personal dust monitor. 74.11 Section 74.11 Mineral Resources MINE SAFETY AND HEALTH ADMINISTRATION, DEPARTMENT OF LABOR COAL MINE SAFETY AND HEALTH COAL MINE DUST SAMPLING DEVICES Requirements for Continuous Personal Dust Monitors § 74.11 Tests of the continuous personal...

Professionals' views of fetal-monitoring support the development of devices to provide objective longer-term assessment of fetal wellbeing.

PubMed

Brown, Rebecca; Johnstone, Edward D; Heazell, Alexander E P

2016-01-01

Continuous longer-term fetal monitoring has been proposed to address limitations of current technologies in the detection of fetal compromise. We aimed to assess professionals' views regarding current fetal-monitoring techniques and proposed longer-term continuous fetal monitoring. A questionnaire was designed and validated to assess obstetricians' and midwives' use of current fetal-monitoring techniques and their views towards continuous monitoring. 125 of 173 received responses (72% obstetricians, 28% midwives) were analysed. Professionals had the strongest views about supporting evidence for the most commonly employed fetal-monitoring techniques (maternal awareness of fetal movements, ultrasound assessment of fetal growth and umbilical artery Doppler). 45.1% of professionals agreed that a continuous monitoring device would be beneficial (versus 28.7% who disagreed); this perceived benefit was not influenced by professionals' views regarding current techniques or professional background. Professionals have limited experience of continuous fetal monitoring, but most respondents believed that it would increase maternal anxiety (64.3%) and would have concerns with its use in clinical practice (81.7%). Continuous fetal monitoring would be acceptable to the majority of professionals. However, development of these technologies must be accompanied by extended examination of professionals' and women's views to determine barriers to its introduction.

40 CFR 60.1815 - How do I monitor the temperature of flue gases at the inlet of my particulate matter control device?

Code of Federal Regulations, 2012 CFR

2012-07-01

... 40 Protection of Environment 7 2012-07-01 2012-07-01 false How do I monitor the temperature of... I monitor the temperature of flue gases at the inlet of my particulate matter control device? You must install, calibrate, maintain, and operate a device to continuously measure the temperature of the...

40 CFR 60.1815 - How do I monitor the temperature of flue gases at the inlet of my particulate matter control device?

Code of Federal Regulations, 2013 CFR

2013-07-01

... 40 Protection of Environment 7 2013-07-01 2013-07-01 false How do I monitor the temperature of... I monitor the temperature of flue gases at the inlet of my particulate matter control device? You must install, calibrate, maintain, and operate a device to continuously measure the temperature of the...

40 CFR 60.1815 - How do I monitor the temperature of flue gases at the inlet of my particulate matter control device?

Code of Federal Regulations, 2014 CFR

2014-07-01

... 40 Protection of Environment 7 2014-07-01 2014-07-01 false How do I monitor the temperature of... I monitor the temperature of flue gases at the inlet of my particulate matter control device? You must install, calibrate, maintain, and operate a device to continuously measure the temperature of the...

Patient attitudes towards remote continuous vital signs monitoring on general surgery wards: An interview study.

PubMed

Downey, C L; Brown, J M; Jayne, D G; Randell, R

2018-06-01

Vital signs monitoring is used to identify deteriorating patients in hospital. The most common tool for vital signs monitoring is an early warning score, although emerging technologies allow for remote, continuous patient monitoring. A number of reviews have examined the impact of continuous monitoring on patient outcomes, but little is known about the patient experience. This study aims to discover what patients think of monitoring in hospital, with a particular emphasis on intermittent early warning scores versus remote continuous monitoring, in order to inform future implementations of continuous monitoring technology. Semi-structured interviews were undertaken with 12 surgical inpatients as part of a study testing a remote continuous monitoring device. All patients were monitored with both an early warning score and the new device. Interviews were audio-recorded, transcribed verbatim and analysed using thematic analysis. Patients can see the value in remote, continuous monitoring, particularly overnight. However, patients appreciate the face-to-face aspect of early warning score monitoring as it allows for reassurance, social interaction, and gives them further opportunity to ask questions about their medical care. Early warning score systems are widely used to facilitate detection of the deteriorating patient. Continuous monitoring technologies may provide added reassurance. However, patients value personal contact with their healthcare professionals and remote monitoring should not replace this. We suggest that remote monitoring is best introduced in a phased manner, and initially as an adjunct to usual care, with careful consideration of the patient experience throughout. Copyright © 2018 Elsevier B.V. All rights reserved.

Design, development, and evaluation of a novel microneedle array-based continuous glucose monitor.

PubMed

Jina, Arvind; Tierney, Michael J; Tamada, Janet A; McGill, Scott; Desai, Shashi; Chua, Beelee; Chang, Anna; Christiansen, Mark

2014-05-01

The development of accurate, minimally invasive continuous glucose monitoring (CGM) devices has been the subject of much work by several groups, as it is believed that a less invasive and more user-friendly device will result in greater adoption of CGM by persons with insulin-dependent diabetes. This article presents the results of preliminary clinical studies in subjects with diabetes of a novel prototype microneedle-based continuous glucose monitor. In this device, an array of tiny hollow microneedles is applied into the epidermis from where glucose in interstitial fluid (ISF) is transported via passive diffusion to an amperometric glucose sensor external to the body. Comparison of 1396 paired device glucose measurements and fingerstick blood glucose readings for up to 72-hour wear in 10 diabetic subjects shows the device to be accurate and well tolerated by the subjects. Overall mean absolute relative difference (MARD) is 15% with 98.4% of paired points in the A+B region of the Clarke error grid. The prototype device has demonstrated clinically accurate glucose readings over 72 hours, the first time a microneedle-based device has achieved such performance. © 2014 Diabetes Technology Society.

40 CFR 63.114 - Process vent provisions-monitoring requirements.

Code of Federal Regulations, 2010 CFR

2010-07-01

..., temperature monitoring devices shall be installed in the gas stream immediately before and after the catalyst... but not limited to a thermocouple, ultra-violet beam sensor, or infrared sensor) capable of... monitoring device in the firebox equipped with a continuous recorder. This requirement does not apply to gas...

40 CFR 63.114 - Process vent provisions-monitoring requirements.

Code of Federal Regulations, 2011 CFR

2011-07-01

..., temperature monitoring devices shall be installed in the gas stream immediately before and after the catalyst... but not limited to a thermocouple, ultra-violet beam sensor, or infrared sensor) capable of... monitoring device in the firebox equipped with a continuous recorder. This requirement does not apply to gas...

40 CFR 60.663 - Monitoring of emissions and operations.

Code of Federal Regulations, 2014 CFR

2014-07-01

... Volatile Organic Compound (VOC) Emissions From Synthetic Organic Chemical Manufacturing Industry (SOCMI... continuous recorder, or (ii) An organic monitoring device used to indicate the concentration level of organic... expressed in degrees Celsius or ±0.5 °C, whichever is greater, or (ii) An organic monitoring device used to...

40 CFR 60.663 - Monitoring of emissions and operations.

Code of Federal Regulations, 2013 CFR

2013-07-01

... Volatile Organic Compound (VOC) Emissions From Synthetic Organic Chemical Manufacturing Industry (SOCMI... continuous recorder, or (ii) An organic monitoring device used to indicate the concentration level of organic... expressed in degrees Celsius or ±0.5 °C, whichever is greater, or (ii) An organic monitoring device used to...

40 CFR 60.663 - Monitoring of emissions and operations.

Code of Federal Regulations, 2012 CFR

2012-07-01

... Volatile Organic Compound (VOC) Emissions From Synthetic Organic Chemical Manufacturing Industry (SOCMI... continuous recorder, or (ii) An organic monitoring device used to indicate the concentration level of organic... expressed in degrees Celsius or ±0.5 °C, whichever is greater, or (ii) An organic monitoring device used to...

Fully integrated biochip platforms for advanced healthcare.

PubMed

Carrara, Sandro; Ghoreishizadeh, Sara; Olivo, Jacopo; Taurino, Irene; Baj-Rossi, Camilla; Cavallini, Andrea; de Beeck, Maaike Op; Dehollain, Catherine; Burleson, Wayne; Moussy, Francis Gabriel; Guiseppi-Elie, Anthony; De Micheli, Giovanni

2012-01-01

Recent advances in microelectronics and biosensors are enabling developments of innovative biochips for advanced healthcare by providing fully integrated platforms for continuous monitoring of a large set of human disease biomarkers. Continuous monitoring of several human metabolites can be addressed by using fully integrated and minimally invasive devices located in the sub-cutis, typically in the peritoneal region. This extends the techniques of continuous monitoring of glucose currently being pursued with diabetic patients. However, several issues have to be considered in order to succeed in developing fully integrated and minimally invasive implantable devices. These innovative devices require a high-degree of integration, minimal invasive surgery, long-term biocompatibility, security and privacy in data transmission, high reliability, high reproducibility, high specificity, low detection limit and high sensitivity. Recent advances in the field have already proposed possible solutions for several of these issues. The aim of the present paper is to present a broad spectrum of recent results and to propose future directions of development in order to obtain fully implantable systems for the continuous monitoring of the human metabolism in advanced healthcare applications.

Fully Integrated Biochip Platforms for Advanced Healthcare

PubMed Central

Carrara, Sandro; Ghoreishizadeh, Sara; Olivo, Jacopo; Taurino, Irene; Baj-Rossi, Camilla; Cavallini, Andrea; de Beeck, Maaike Op; Dehollain, Catherine; Burleson, Wayne; Moussy, Francis Gabriel; Guiseppi-Elie, Anthony; De Micheli, Giovanni

2012-01-01

Recent advances in microelectronics and biosensors are enabling developments of innovative biochips for advanced healthcare by providing fully integrated platforms for continuous monitoring of a large set of human disease biomarkers. Continuous monitoring of several human metabolites can be addressed by using fully integrated and minimally invasive devices located in the sub-cutis, typically in the peritoneal region. This extends the techniques of continuous monitoring of glucose currently being pursued with diabetic patients. However, several issues have to be considered in order to succeed in developing fully integrated and minimally invasive implantable devices. These innovative devices require a high-degree of integration, minimal invasive surgery, long-term biocompatibility, security and privacy in data transmission, high reliability, high reproducibility, high specificity, low detection limit and high sensitivity. Recent advances in the field have already proposed possible solutions for several of these issues. The aim of the present paper is to present a broad spectrum of recent results and to propose future directions of development in order to obtain fully implantable systems for the continuous monitoring of the human metabolism in advanced healthcare applications. PMID:23112644

40 CFR 60.403 - Monitoring of emissions and operations.

Code of Federal Regulations, 2010 CFR

2010-07-01

... measurement of the pressure loss of the gas stream through the scrubber. The monitoring device must be certified by the manufacturer to be accurate within ±250 pascals (±1 inch water) gauge pressure. (2) A monitoring device for the continuous measurement of the scrubbing liquid supply pressure to the control...

40 CFR 60.563 - Monitoring requirements.

Code of Federal Regulations, 2014 CFR

2014-07-01

... item as follows: (1) A temperature monitoring device to measure and record continuously the operating temperature to within 1 percent (relative to degrees Celsius) or ±0.5 °C (±0.9 °F), whichever is greater. (2) A flame monitoring device, such as a thermocouple, an ultraviolet sensor, an infrared beam sensor...

40 CFR 60.563 - Monitoring requirements.

Code of Federal Regulations, 2013 CFR

2013-07-01

... item as follows: (1) A temperature monitoring device to measure and record continuously the operating temperature to within 1 percent (relative to degrees Celsius) or ±0.5 °C (±0.9 °F), whichever is greater. (2) A flame monitoring device, such as a thermocouple, an ultraviolet sensor, an infrared beam sensor...

40 CFR 60.563 - Monitoring requirements.

Code of Federal Regulations, 2012 CFR

2012-07-01

... item as follows: (1) A temperature monitoring device to measure and record continuously the operating temperature to within 1 percent (relative to degrees Celsius) or ±0.5 °C (±0.9 °F), whichever is greater. (2) A flame monitoring device, such as a thermocouple, an ultraviolet sensor, an infrared beam sensor...

40 CFR 60.563 - Monitoring requirements.

Code of Federal Regulations, 2011 CFR

2011-07-01

... item as follows: (1) A temperature monitoring device to measure and record continuously the operating temperature to within 1 percent (relative to degrees Celsius) or ±0.5 °C (±0.9 °F), whichever is greater. (2) A flame monitoring device, such as a thermocouple, an ultraviolet sensor, an infrared beam sensor...

40 CFR 60.563 - Monitoring requirements.

Code of Federal Regulations, 2010 CFR

2010-07-01

... item as follows: (1) A temperature monitoring device to measure and record continuously the operating temperature to within 1 percent (relative to degrees Celsius) or ±0.5 °C (±0.9 °F), whichever is greater. (2) A flame monitoring device, such as a thermocouple, an ultraviolet sensor, an infrared beam sensor...

40 CFR 63.1324 - Batch process vents-monitoring equipment.

Code of Federal Regulations, 2013 CFR

2013-07-01

... beam sensor, or infrared sensor) capable of continuously detecting the presence of a pilot flame is...) Where an incinerator is used, a temperature monitoring device equipped with a continuous recorder is required. (i) Where an incinerator other than a catalytic incinerator is used, the temperature monitoring...

40 CFR 63.1324 - Batch process vents-monitoring equipment.

Code of Federal Regulations, 2014 CFR

2014-07-01

... beam sensor, or infrared sensor) capable of continuously detecting the presence of a pilot flame is...) Where an incinerator is used, a temperature monitoring device equipped with a continuous recorder is required. (i) Where an incinerator other than a catalytic incinerator is used, the temperature monitoring...

Detection of essential hypertension with physiological signals from wearable devices.

PubMed

Ghosh, Arindam; Torres, Juan Manuel Mayor; Danieli, Morena; Riccardi, Giuseppe

2015-08-01

Early detection of essential hypertension can support the prevention of cardiovascular disease, a leading cause of death. The traditional method of identification of hypertension involves periodic blood pressure measurement using brachial cuff-based measurement devices. While these devices are non-invasive, they require manual setup for each measurement and they are not suitable for continuous monitoring. Research has shown that physiological signals such as Heart Rate Variability, which is a measure of the cardiac autonomic activity, is correlated with blood pressure. Wearable devices capable of measuring physiological signals such as Heart Rate, Galvanic Skin Response, Skin Temperature have recently become ubiquitous. However, these signals are not accurate and are prone to noise due to different artifacts. In this paper a) we present a data collection protocol for continuous non-invasive monitoring of physiological signals from wearable devices; b) we implement signal processing techniques for signal estimation; c) we explore how the continuous monitoring of these physiological signals can be used to identify hypertensive patients; d) We conduct a pilot study with a group of normotensive and hypertensive patients to test our techniques. We show that physiological signals extracted from wearable devices can distinguish between these two groups with high accuracy.

Device Would Monitor Body Parameters Continuously

NASA Technical Reports Server (NTRS)

Cook, Joseph S., Jr.

1995-01-01

Proposed miniature electronic circuit continuously measures temperature of human subject. Once mounted on subject's skin with medical adhesive tape, electronic thermometer remains in thermal equilibrium with subject's body; thereafter, no need to wait until thermometer reaches body temperature before taking reading. Design provides for switches used to set alarm alerting medical attendants if subject's temperature exceeds critical level. For use on very young child, electronic thermometer sewed into shirt or other suitable garment; device held in contact with skin, and child could not swallow it. Replacement of sensor and computing algorithm changes temperature monitor to cardiorespiratory monitor.

21 CFR 880.2460 - Electrically powered spinal fluid pressure monitor.

Code of Federal Regulations, 2013 CFR

2013-04-01

... SERVICES (CONTINUED) MEDICAL DEVICES GENERAL HOSPITAL AND PERSONAL USE DEVICES General Hospital and... electrical signal. The device includes signal amplification, conditioning, and display equipment. (b...

21 CFR 880.2460 - Electrically powered spinal fluid pressure monitor.

Code of Federal Regulations, 2012 CFR

2012-04-01

... SERVICES (CONTINUED) MEDICAL DEVICES GENERAL HOSPITAL AND PERSONAL USE DEVICES General Hospital and... electrical signal. The device includes signal amplification, conditioning, and display equipment. (b...

21 CFR 880.2460 - Electrically powered spinal fluid pressure monitor.

Code of Federal Regulations, 2014 CFR

2014-04-01

... SERVICES (CONTINUED) MEDICAL DEVICES GENERAL HOSPITAL AND PERSONAL USE DEVICES General Hospital and... electrical signal. The device includes signal amplification, conditioning, and display equipment. (b...

40 CFR 60.734 - Monitoring of emissions and operations.

Code of Federal Regulations, 2010 CFR

2010-07-01

... operator of an affected facility subject to the provisions of this subpart who uses a dry control device to... control device. (b) In lieu of a continuous opacity monitoring system, the owner or operator of a ball... vermiculite fluid bed dryer, or a vermiculite rotary dryer who uses a dry control device may have a certified...

PhysioDroid: Combining Wearable Health Sensors and Mobile Devices for a Ubiquitous, Continuous, and Personal Monitoring

PubMed Central

Villalonga, Claudia; Damas, Miguel

2014-01-01

Technological advances on the development of mobile devices, medical sensors, and wireless communication systems support a new generation of unobtrusive, portable, and ubiquitous health monitoring systems for continuous patient assessment and more personalized health care. There exist a growing number of mobile apps in the health domain; however, little contribution has been specifically provided, so far, to operate this kind of apps with wearable physiological sensors. The PhysioDroid, presented in this paper, provides a personalized means to remotely monitor and evaluate users' conditions. The PhysioDroid system provides ubiquitous and continuous vital signs analysis, such as electrocardiogram, heart rate, respiration rate, skin temperature, and body motion, intended to help empower patients and improve clinical understanding. The PhysioDroid is composed of a wearable monitoring device and an Android app providing gathering, storage, and processing features for the physiological sensor data. The versatility of the developed app allows its use for both average users and specialists, and the reduced cost of the PhysioDroid puts it at the reach of most people. Two exemplary use cases for health assessment and sports training are presented to illustrate the capabilities of the PhysioDroid. Next technical steps include generalization to other mobile platforms and health monitoring devices. PMID:25295301

PhysioDroid: combining wearable health sensors and mobile devices for a ubiquitous, continuous, and personal monitoring.

PubMed

Banos, Oresti; Villalonga, Claudia; Damas, Miguel; Gloesekoetter, Peter; Pomares, Hector; Rojas, Ignacio

2014-01-01

Technological advances on the development of mobile devices, medical sensors, and wireless communication systems support a new generation of unobtrusive, portable, and ubiquitous health monitoring systems for continuous patient assessment and more personalized health care. There exist a growing number of mobile apps in the health domain; however, little contribution has been specifically provided, so far, to operate this kind of apps with wearable physiological sensors. The PhysioDroid, presented in this paper, provides a personalized means to remotely monitor and evaluate users' conditions. The PhysioDroid system provides ubiquitous and continuous vital signs analysis, such as electrocardiogram, heart rate, respiration rate, skin temperature, and body motion, intended to help empower patients and improve clinical understanding. The PhysioDroid is composed of a wearable monitoring device and an Android app providing gathering, storage, and processing features for the physiological sensor data. The versatility of the developed app allows its use for both average users and specialists, and the reduced cost of the PhysioDroid puts it at the reach of most people. Two exemplary use cases for health assessment and sports training are presented to illustrate the capabilities of the PhysioDroid. Next technical steps include generalization to other mobile platforms and health monitoring devices.

40 CFR 63.4168 - What are the requirements for continuous parameter monitoring system installation, operation, and...

Code of Federal Regulations, 2014 CFR

2014-07-01

... add-on control device, you must monitor the total regeneration desorbing gas (e.g., steam or nitrogen) mass flow for each regeneration cycle, the carbon bed temperature after each regeneration and cooling... regeneration desorbing gas mass flow monitor must be an integrating device having a measurement sensitivity of...

40 CFR 63.1505 - Emission standards for affected sources and emission units.

Code of Federal Regulations, 2010 CFR

2010-07-01

...-on air pollution control device if a continuous opacity monitor (COM) or visible emissions monitoring... percent opacity from any PM add-on air pollution control device if a COM is chosen as the monitoring.../delacquering kiln/decoating kiln is equipped with an afterburner having a design residence time of at least 1...

Method and apparatus for continuous fluid leak monitoring and detection in analytical instruments and instrument systems

DOEpatents

Weitz, Karl K [Pasco, WA; Moore, Ronald J [West Richland, WA

2010-07-13

A method and device are disclosed that provide for detection of fluid leaks in analytical instruments and instrument systems. The leak detection device includes a collection tube, a fluid absorbing material, and a circuit that electrically couples to an indicator device. When assembled, the leak detection device detects and monitors for fluid leaks, providing a preselected response in conjunction with the indicator device when contacted by a fluid.

40 CFR 63.7113 - What are my monitoring installation, operation, and maintenance requirements?

Code of Federal Regulations, 2014 CFR

2014-07-01

... monitor an add-on air pollution control device, you must meet the requirements in paragraphs (g)(1) and (2... PROTECTION AGENCY (CONTINUED) AIR PROGRAMS (CONTINUED) NATIONAL EMISSION STANDARDS FOR HAZARDOUS AIR POLLUTANTS FOR SOURCE CATEGORIES (CONTINUED) National Emission Standards for Hazardous Air Pollutants for...

40 CFR 63.7113 - What are my monitoring installation, operation, and maintenance requirements?

Code of Federal Regulations, 2012 CFR

2012-07-01

... monitor an add-on air pollution control device, you must meet the requirements in paragraphs (g)(1) and (2... PROTECTION AGENCY (CONTINUED) AIR PROGRAMS (CONTINUED) NATIONAL EMISSION STANDARDS FOR HAZARDOUS AIR POLLUTANTS FOR SOURCE CATEGORIES (CONTINUED) National Emission Standards for Hazardous Air Pollutants for...

40 CFR 63.7113 - What are my monitoring installation, operation, and maintenance requirements?

Code of Federal Regulations, 2011 CFR

2011-07-01

... monitor an add-on air pollution control device, you must meet the requirements in paragraphs (g)(1) and (2... PROTECTION AGENCY (CONTINUED) AIR PROGRAMS (CONTINUED) NATIONAL EMISSION STANDARDS FOR HAZARDOUS AIR POLLUTANTS FOR SOURCE CATEGORIES (CONTINUED) National Emission Standards for Hazardous Air Pollutants for...

40 CFR 63.7113 - What are my monitoring installation, operation, and maintenance requirements?

Code of Federal Regulations, 2013 CFR

2013-07-01

... monitor an add-on air pollution control device, you must meet the requirements in paragraphs (g)(1) and (2... PROTECTION AGENCY (CONTINUED) AIR PROGRAMS (CONTINUED) NATIONAL EMISSION STANDARDS FOR HAZARDOUS AIR POLLUTANTS FOR SOURCE CATEGORIES (CONTINUED) National Emission Standards for Hazardous Air Pollutants for...

Wearable physiological systems and technologies for metabolic monitoring.

PubMed

Gao, Wei; Brooks, George A; Klonoff, David C

2018-03-01

Wearable sensors allow continuous monitoring of metabolites for diabetes, sports medicine, exercise science, and physiology research. These sensors can continuously detect target analytes in skin interstitial fluid (ISF), tears, saliva, and sweat. In this review, we will summarize developments on wearable devices and their potential applications in research, clinical practice, and recreational and sporting activities. Sampling skin ISF can require insertion of a needle into the skin, whereas sweat, tears, and saliva can be sampled by devices worn outside the body. The most widely sampled metabolite from a wearable device is glucose in skin ISF for monitoring diabetes patients. Continuous ISF glucose monitoring allows estimation of the glucose concentration in blood without the pain, inconvenience, and blood waste of fingerstick capillary blood glucose testing. This tool is currently used by diabetes patients to provide information for dosing insulin and determining a diet and exercise plan. Similar technologies for measuring concentrations of other analytes in skin ISF could be used to monitor athletes, emergency responders, warfighters, and others in states of extreme physiological stress. Sweat is a potentially useful substrate for sampling analytes for metabolic monitoring during exercise. Lactate, sodium, potassium, and hydrogen ions can be measured in sweat. Tools for converting the concentrations of these analytes sampled from sweat, tears, and saliva into blood concentrations are being developed. As an understanding of the relationships between the concentrations of analytes in blood and easily sampled body fluid increases, then the benefits of new wearable devices for metabolic monitoring will also increase.

A history of continuous glucose monitors (CGMs) in self-monitoring of diabetes mellitus.

PubMed

Olczuk, David; Priefer, Ronny

Self-monitoring of glucose for individuals afflicted with diabetes mellitus has allowed patients to take control of their disease and thus directly affect the outcomes related to it. It has been almost a century since the first test to monitor one's sugar was developed; that being a urine test. The most well-known and prominent medical device for monitor blood glucose for individuals with diabetes are the finger-prick devices. This itself is an approximately 50year old technology. More recently has been the introduction of continuous glucose monitors (CGMs) which entered the market place in the last year of the 20th century. As this technology has been further refined and improved, limitations associated with it have decreased. The scope of this review is to present a brief history of CGMs, both with the development of these medical devices and the challenges/limitations that they have shown. Copyright © 2017 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Smartphone-based Continuous Blood Pressure Measurement Using Pulse Transit Time.

PubMed

Gholamhosseini, Hamid; Meintjes, Andries; Baig, Mirza; Linden, Maria

2016-01-01

The increasing availability of low cost and easy to use personalized medical monitoring devices has opened the door for new and innovative methods of health monitoring to emerge. Cuff-less and continuous methods of measuring blood pressure are particularly attractive as blood pressure is one of the most important measurements of long term cardiovascular health. Current methods of noninvasive blood pressure measurement are based on inflation and deflation of a cuff with some effects on arteries where blood pressure is being measured. This inflation can also cause patient discomfort and alter the measurement results. In this work, a mobile application was developed to collate the PhotoPlethysmoGramm (PPG) waveform provided by a pulse oximeter and the electrocardiogram (ECG) for calculating the pulse transit time. This information is then indirectly related to the user's systolic blood pressure. The developed application successfully connects to the PPG and ECG monitoring devices using Bluetooth wireless connection and stores the data onto an online server. The pulse transit time is estimated in real time and the user's systolic blood pressure can be estimated after the system has been calibrated. The synchronization between the two devices was found to pose a challenge to this method of continuous blood pressure monitoring. However, the implemented continuous blood pressure monitoring system effectively serves as a proof of concept. This combined with the massive benefits that an accurate and robust continuous blood pressure monitoring system would provide indicates that it is certainly worthwhile to further develop this system.

An intelligent remote monitoring system for artificial heart.

PubMed

Choi, Jaesoon; Park, Jun W; Chung, Jinhan; Min, Byoung G

2005-12-01

A web-based database system for intelligent remote monitoring of an artificial heart has been developed. It is important for patients with an artificial heart implant to be discharged from the hospital after an appropriate stabilization period for better recovery and quality of life. Reliable continuous remote monitoring systems for these patients with life support devices are gaining practical meaning. The authors have developed a remote monitoring system for this purpose that consists of a portable/desktop monitoring terminal, a database for continuous recording of patient and device status, a web-based data access system with which clinicians can access real-time patient and device status data and past history data, and an intelligent diagnosis algorithm module that noninvasively estimates blood pump output and makes automatic classification of the device status. The system has been tested with data generation emulators installed on remote sites for simulation study, and in two cases of animal experiments conducted at remote facilities. The system showed acceptable functionality and reliability. The intelligence algorithm also showed acceptable practicality in an application to animal experiment data.

21 CFR 870.2640 - Portable leakage current alarm.

Code of Federal Regulations, 2014 CFR

2014-04-01

... (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2640 Portable... the electrical leakage current between any two points of an electrical system and to sound an alarm if...

21 CFR 870.2640 - Portable leakage current alarm.

Code of Federal Regulations, 2013 CFR

2013-04-01

... (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2640 Portable... the electrical leakage current between any two points of an electrical system and to sound an alarm if...

21 CFR 870.2640 - Portable leakage current alarm.

Code of Federal Regulations, 2012 CFR

2012-04-01

... (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2640 Portable... the electrical leakage current between any two points of an electrical system and to sound an alarm if...

40 CFR 60.1325 - How do I monitor the temperature of flue gases at the inlet of my particulate matter control device?

Code of Federal Regulations, 2013 CFR

2013-07-01

... 40 Protection of Environment 7 2013-07-01 2013-07-01 false How do I monitor the temperature of... June 6, 2001 Other Monitoring Requirements § 60.1325 How do I monitor the temperature of flue gases at... a device to continuously measure the temperature of the flue gas stream at the inlet of each...

40 CFR 60.1325 - How do I monitor the temperature of flue gases at the inlet of my particulate matter control device?

Code of Federal Regulations, 2012 CFR

2012-07-01

... 40 Protection of Environment 7 2012-07-01 2012-07-01 false How do I monitor the temperature of... June 6, 2001 Other Monitoring Requirements § 60.1325 How do I monitor the temperature of flue gases at... a device to continuously measure the temperature of the flue gas stream at the inlet of each...

40 CFR 60.1325 - How do I monitor the temperature of flue gases at the inlet of my particulate matter control device?

Code of Federal Regulations, 2014 CFR

2014-07-01

... 40 Protection of Environment 7 2014-07-01 2014-07-01 false How do I monitor the temperature of... June 6, 2001 Other Monitoring Requirements § 60.1325 How do I monitor the temperature of flue gases at... a device to continuously measure the temperature of the flue gas stream at the inlet of each...

Method and apparatus for monitoring mercury emissions

DOEpatents

Durham, Michael D.; Schlager, Richard J.; Sappey, Andrew D.; Sagan, Francis J.; Marmaro, Roger W.; Wilson, Kevin G.

1997-01-01

A mercury monitoring device that continuously monitors the total mercury concentration in a gas. The device uses the same chamber for converting speciated mercury into elemental mercury and for measurement of the mercury in the chamber by radiation absorption techniques. The interior of the chamber is resistant to the absorption of speciated and elemental mercury at the operating temperature of the chamber.

40 CFR 63.3547 - What are the requirements for continuous parameter monitoring system installation, operation, and...

Code of Federal Regulations, 2012 CFR

2012-07-01

... adsorber as an add-on control device, you must monitor the total regeneration desorbing gas (e.g., steam or nitrogen) mass flow for each regeneration cycle, the carbon bed temperature after each regeneration and... regeneration desorbing gas mass flow monitor must be an integrating device having an accuracy of ±10 percent...

40 CFR 63.3547 - What are the requirements for continuous parameter monitoring system installation, operation, and...

Code of Federal Regulations, 2013 CFR

2013-07-01

... adsorber as an add-on control device, you must monitor the total regeneration desorbing gas (e.g., steam or nitrogen) mass flow for each regeneration cycle, the carbon bed temperature after each regeneration and... regeneration desorbing gas mass flow monitor must be an integrating device having an accuracy of ±10 percent...

40 CFR 63.3547 - What are the requirements for continuous parameter monitoring system installation, operation, and...

Code of Federal Regulations, 2014 CFR

2014-07-01

... adsorber as an add-on control device, you must monitor the total regeneration desorbing gas (e.g., steam or nitrogen) mass flow for each regeneration cycle, the carbon bed temperature after each regeneration and... regeneration desorbing gas mass flow monitor must be an integrating device having an accuracy of ±10 percent...

Method and apparatus for monitoring mercury emissions

DOEpatents

Durham, M.D.; Schlager, R.J.; Sappey, A.D.; Sagan, F.J.; Marmaro, R.W.; Wilson, K.G.

1997-10-21

A mercury monitoring device that continuously monitors the total mercury concentration in a gas. The device uses the same chamber for converting speciated mercury into elemental mercury and for measurement of the mercury in the chamber by radiation absorption techniques. The interior of the chamber is resistant to the absorption of speciated and elemental mercury at the operating temperature of the chamber. 15 figs.

40 CFR 60.613 - Monitoring of emissions and operations.

Code of Federal Regulations, 2011 CFR

2011-07-01

..., photoionization, or thermal conductivity, each equipped with a continuous recorder. (2) Where a condenser is the final recovery device in a recovery system: (i) A condenser exit (product side) temperature monitoring... incinerator, boiler, process heater, or flare; or recovery devices other than an absorber, condenser, or...

40 CFR 62.14595 - What are the operator training and qualification requirements?

Code of Federal Regulations, 2010 CFR

2010-07-01

... charging, and shutdown procedures. (iv) Combustion controls and monitoring. (v) Operation of air pollution... the incinerator and air pollution control devices. (vii) Actions to correct malfunctions or conditions... requirements. (xiii) Methods to continuously monitor CISWI unit and air pollution control device operating...

40 CFR 62.14595 - What are the operator training and qualification requirements?

Code of Federal Regulations, 2011 CFR

2011-07-01

... charging, and shutdown procedures. (iv) Combustion controls and monitoring. (v) Operation of air pollution... the incinerator and air pollution control devices. (vii) Actions to correct malfunctions or conditions... requirements. (xiii) Methods to continuously monitor CISWI unit and air pollution control device operating...

Glucose Sensing for Diabetes Monitoring: Recent Developments

PubMed Central

Bruen, Danielle; Delaney, Colm; Florea, Larisa

2017-01-01

This review highlights recent advances towards non-invasive and continuous glucose monitoring devices, with a particular focus placed on monitoring glucose concentrations in alternative physiological fluids to blood. PMID:28805693

21 CFR 870.2780 - Hydraulic, pneumatic, or photoelectric plethysmographs.

Code of Federal Regulations, 2012 CFR

2012-04-01

... HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices..., pneumatic, or photoelectric plethysmograph is a device used to estimate blood flow in a region of the body using hydraulic, pneumatic, or photoelectric measurement techniques. (b) Classification. Class II...

21 CFR 870.2780 - Hydraulic, pneumatic, or photoelectric plethysmographs.

Code of Federal Regulations, 2014 CFR

2014-04-01

... HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices..., pneumatic, or photoelectric plethysmograph is a device used to estimate blood flow in a region of the body using hydraulic, pneumatic, or photoelectric measurement techniques. (b) Classification. Class II...

21 CFR 870.2780 - Hydraulic, pneumatic, or photoelectric plethysmographs.

Code of Federal Regulations, 2013 CFR

2013-04-01

... HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices..., pneumatic, or photoelectric plethysmograph is a device used to estimate blood flow in a region of the body using hydraulic, pneumatic, or photoelectric measurement techniques. (b) Classification. Class II...

40 CFR 60.384 - Monitoring of operations.

Code of Federal Regulations, 2010 CFR

2010-07-01

... wet scrubbing emission control device. The monitoring device must be certified by the manufacturer to be accurate within ±250 pascals (±1 inch water) gauge pressure and must be calibrated on an annual... continuous measurement of the scrubbing liquid flow rate to a wet scrubber for any affected facility using...

40 CFR 60.384 - Monitoring of operations.

Code of Federal Regulations, 2011 CFR

2011-07-01

... wet scrubbing emission control device. The monitoring device must be certified by the manufacturer to be accurate within ±250 pascals (±1 inch water) gauge pressure and must be calibrated on an annual... continuous measurement of the scrubbing liquid flow rate to a wet scrubber for any affected facility using...

40 CFR 60.384 - Monitoring of operations.

Code of Federal Regulations, 2012 CFR

2012-07-01

... wet scrubbing emission control device. The monitoring device must be certified by the manufacturer to be accurate within ±250 pascals (±1 inch water) gauge pressure and must be calibrated on an annual... continuous measurement of the scrubbing liquid flow rate to a wet scrubber for any affected facility using...

40 CFR 60.384 - Monitoring of operations.

Code of Federal Regulations, 2014 CFR

2014-07-01

... wet scrubbing emission control device. The monitoring device must be certified by the manufacturer to be accurate within ±250 pascals (±1 inch water) gauge pressure and must be calibrated on an annual... continuous measurement of the scrubbing liquid flow rate to a wet scrubber for any affected facility using...

40 CFR 60.384 - Monitoring of operations.

Code of Federal Regulations, 2013 CFR

2013-07-01

... wet scrubbing emission control device. The monitoring device must be certified by the manufacturer to be accurate within ±250 pascals (±1 inch water) gauge pressure and must be calibrated on an annual... continuous measurement of the scrubbing liquid flow rate to a wet scrubber for any affected facility using...

40 CFR 63.5355 - How do I monitor and collect data to demonstrate continuous compliance?

Code of Federal Regulations, 2010 CFR

2010-07-01

... periods in assessing the compliance ratio, and, if an emission control device is used, in assessing the...) For emission control devices, except for monitor malfunctions, associated repairs, and required quality assurance or control activities (including, as applicable, calibration checks and required zero...

40 CFR 63.1657 - Monitoring requirements.

Code of Federal Regulations, 2012 CFR

2012-07-01

... pollution control practices that minimizes emissions per § 63.6(e)(1)(i). (c) Shop opacity. The owner or... monitoring device that continuously records the volumetric flow rate through each separately ducted hood. (3... records the volumetric flow rate at the inlet of the air pollution control device and must check and...

40 CFR 63.1657 - Monitoring requirements.

Code of Federal Regulations, 2014 CFR

2014-07-01

... pollution control practices that minimizes emissions per § 63.6(e)(1)(i). (c) Shop opacity. The owner or... monitoring device that continuously records the volumetric flow rate through each separately ducted hood. (3... records the volumetric flow rate at the inlet of the air pollution control device and must check and...

40 CFR 63.1657 - Monitoring requirements.

Code of Federal Regulations, 2013 CFR

2013-07-01

... pollution control practices that minimizes emissions per § 63.6(e)(1)(i). (c) Shop opacity. The owner or... monitoring device that continuously records the volumetric flow rate through each separately ducted hood. (3... records the volumetric flow rate at the inlet of the air pollution control device and must check and...

21 CFR 862.3350 - Diphenylhydantoin test system.

Code of Federal Regulations, 2010 CFR

2010-04-01

... (CONTINUED) MEDICAL DEVICES CLINICAL CHEMISTRY AND CLINICAL TOXICOLOGY DEVICES Clinical Toxicology Test... monitoring levels of diphenylhydantoin to ensure appropriate therapy. (b) Classification. Class II. ...

40 CFR 60.5407 - What are the requirements for monitoring of emissions and operations from my sweetening unit...

Code of Federal Regulations, 2013 CFR

2013-07-01

... concentration in the acid gas from the sweetening unit for each 24-hour period. At least one sample per 24-hour... sampling schedule. (3) The average acid gas flow rate from the sweetening unit. You must install and operate a monitoring device to continuously measure the flow rate of acid gas. The monitoring device...

40 CFR 60.5407 - What are the requirements for monitoring of emissions and operations from my sweetening unit...

Code of Federal Regulations, 2014 CFR

2014-07-01

... concentration in the acid gas from the sweetening unit for each 24-hour period. At least one sample per 24-hour... sampling schedule. (3) The average acid gas flow rate from the sweetening unit. You must install and operate a monitoring device to continuously measure the flow rate of acid gas. The monitoring device...

An Electronic Pillbox for Continuous Monitoring of Medication Adherence

PubMed Central

Hayes, Tamara. L.; Hunt, John M.; Adami, Andre; Kaye, Jeffrey A.

2010-01-01

We have developed an instrumented pillbox, called a MedTracker, which allows monitoring of medication adherence on a continuous basis. This device improves on existing systems by providing mobility, frequent and automatic data collection, more detailed information about nonadherence and medication errors, and the familiar interface of a 7-day drug store pillbox. We report on the design of the MedTracker, and on the results of a field trial in 39 homes to evaluate the device. PMID:17946369

21 CFR 870.2100 - Cardiovascular blood flowmeter.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Cardiovascular blood flowmeter. 870.2100 Section... (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2100 Cardiovascular blood flowmeter. (a) Identification. A cardiovascular blood flowmeter is a device that is...

Fetal heart and uterine contraction monitor (image)

MedlinePlus

The fetal heart monitor and uterine contraction monitor provide a continuous record of the baby's heart rate and the mother's contraction rate as labor progresses. This device can provide early warning of fetal distress.

[A design and study of a novel electronic device for cuff-pressure monitoring].

PubMed

Wang, Shupeng; Li, Wei; Li, Wen; Song, Dejing; Chen, Desheng; Duan, Jun; Li, Chen; Li, Gang

2017-06-01

To design a novel electronic device for measuring the pressure in the cuff of the artificial airway; and to study the advantage of this device on continuous and intermittent cuff pressure monitoring. (1) a portable electronic device for cuff pressure measurement was invented, which could turn pressure signal into electrical signal through a pressure transducer. Meantime, it was possible to avoid pressure leak from the joint and the inside of the apparatus by modified Luer taper and sophisticated design. If the cuff pressure was out of the normal range, the apparatus could release a sound and light alarm. (2) Six traditional mechanical manometers were used to determine the cuff pressure in 6 tracheal tubes. The cuff pressure was maintain at 30 cmH 2 O (1 cmH 2 O = 0.098 kPa) by the manometer first, and repeated every 30 seconds for 4 times. (3) Study of continuous cuff pressure monitoring: We used a random number generator to randomize 6 tracheal tubes, 6 mechanical manometers and 6 our products by number 1-6, which has the same number of a group. Every group was further randomized into two balanced groups, one group used the mechanical manometer first, and the other used our product first. The baseline pressure was 30 cmH 2 O, measurement was performed every 4 hours for 6 times. When traditional mechanical manometer was used for cuff pressure monitoring, cuff pressure was decreased by an average of 2.9 cmH 2 O for each measurement (F = 728.2, P = 0.000). In study of continually monitoring, at each monitoring point, the pressure measured by electronic manometer was higher than the mechanical manometer. All the pressures measured by mechanical manometer were dropped below 20 cmH 2 O at 8th hour, and there was no pressure decrease below 20 cmH 2 O measured by electronic manometer in 24 hours by contrast. In study of intermittent monitoring, the same result was found. The pressure was dropped significantly with time when measured by mechanical manometer (F = 61.795, P = 0.000), the drops below 20 cmH 2 O began at 8th hour; but when measured by electronic manometer, all the value stayed unchanged around the baseline in 24 hours (F = 0.511, P = 0.796). Compared with traditional mechanical manometer, cuff pressures monitored by our novel electronic manometer were steadier in both continuous and intermittent monitoring. The device is compact and convenient, and can provide a good solution for continuously monitor of the tracheal cuff pressure.

21 CFR 26.45 - Monitoring continued equivalence.

Code of Federal Regulations, 2010 CFR

2010-04-01

... MUTUAL RECOGNITION OF PHARMACEUTICAL GOOD MANUFACTURING PRACTICE REPORTS, MEDICAL DEVICE QUALITY SYSTEM AUDIT REPORTS, AND CERTAIN MEDICAL DEVICE PRODUCT EVALUATION REPORTS: UNITED STATES AND THE EUROPEAN...

40 CFR 60.5417 - What are the continuous control device monitoring requirements for my storage vessel or...

Code of Federal Regulations, 2014 CFR

2014-07-01

... monitoring requirements for my storage vessel or centrifugal compressor affected facility? 60.5417 Section 60... requirements for my storage vessel or centrifugal compressor affected facility? You must meet the applicable... standards for your storage vessel or centrifugal compressor affected facility. (a) For each control device...

40 CFR 63.3000 - What notifications and reports must I submit?

Code of Federal Regulations, 2010 CFR

2010-07-01

... reporting period. (v) The date of the latest continuous parameter monitoring system certification or audit... parameter monitoring system, or add-on control device since the last semiannual reporting period. (4) No...-on control devices no later than 60 days after completing the tests as specified in § 63.10(d)(2...

Validation of the Somnotouch-NIBP noninvasive continuous blood pressure monitor according to the European Society of Hypertension International Protocol revision 2010.

PubMed

Bilo, Grzegorz; Zorzi, Cristina; Ochoa Munera, Juan E; Torlasco, Camilla; Giuli, Valentina; Parati, Gianfranco

2015-10-01

The present study aimed to evaluate the accuracy of the Somnotouch-NIBP noninvasive continuous blood pressure monitor according to the European Society of Hypertension International Protocol revision 2010. Systolic and diastolic blood pressures were sequentially measured in 33 adults (11 women, mean age 63.5±11.9 years) using a mercury sphygmomanometer (two observers) and the Somnotouch-NIBP device (one supervisor). A total of 99 pairs of comparisons were obtained from 33 participants for judgments in two parts with three grading phases. All the validation requirements were fulfilled. The Somnotouch-NIBP device fulfilled the requirements of the part 1 of the validation study. The number of absolute differences between device and observers within 5, 10, and 15 mmHg was 75/99, 90/99, and 96/99, respectively, for systolic blood pressure and 90/99, 99/99, and 99/99, respectively, for diastolic blood pressure. The device also fulfilled the criteria in part 2 of the validation study. Twenty-seven and 31 participants had at least two of the three device-observers differences less than or equal to 5 mmHg for systolic and diastolic blood pressure, respectively. All three device-observer differences were greater than 5 mmHg in two participants for systolic and in one participant for diastolic blood pressure. The Somnotouch-NIBP noninvasive continuous blood pressure monitor has passed the requirements of the International Protocol revision 2010, and hence can be recommended for blood pressure monitoring in adults, at least under conditions corresponding to those investigated in our study.

A flexible skin patch for continuous physiological monitoring of mental disorders

NASA Astrophysics Data System (ADS)

Jang, Won Ick; Lee, Bong Kuk; Ryu, Jin Hwa; Baek, In-Bok; Yu, Han Young; Kim, Seunghwan

2017-10-01

In this study, we have newly developed a flexible adhesive skin patch of electrocardiogram (ECG) device for continuous physiological monitoring of mental disorders. In addition, this flexible patch did not cause any damage to the skin even after 24 hours attachment. We have also suggested the possibility of novel interconnection for copper film on polyimide and polydimethylsiloxane (PDMS) layers of the flexible patch. Self-align and soldering of IC chips such as resistor between metal pads on flexible skin patch have also successfully fabricated for 5 min at 180 °C in vacuum oven. Low temperature interconnection technology based on a Sn42/Bi58 solder was also developed for flexible ECG devices. As a result, we can monitor the mental health status through a comprehensive analysis of biological signals from flexible ECG devices.

ENVIRONMENTAL TECHNOLOGY VERIFICATION (ETV) TEST OF DIOXIN EMISSION MONITORS

EPA Science Inventory

The performance of four dioxin emission monitors including two long-term sampling devices, the DMS (DioxinMonitoringSystem) and AMESA (Adsorption Method for Sampling Dioxins and Furans), and two semi-real-time continuous monitors, RIMMPA-TOFMS (Resonance Ionization with Multi-Mir...

40 CFR Table 12 to Subpart G of... - Monitoring Requirements for Treatment Processes

Code of Federal Regulations, 2013 CFR

2013-07-01

... Appropriate methods as specified in § 63.143 and as approved by permitting authority. 2. Steam stripper (i... recorder. (ii) Wastewater feed mass flow rate; and Continuously Liquid flow meter installed at stripper... operating temperature Continuously (A) Liquid temperature monitoring device installed at stripper influent...

40 CFR Table 12 to Subpart G of... - Monitoring Requirements for Treatment Processes

Code of Federal Regulations, 2010 CFR

2010-07-01

... Appropriate methods as specified in § 63.143 and as approved by permitting authority. 2. Steam stripper (i... recorder. (ii) Wastewater feed mass flow rate; and Continuously Liquid flow meter installed at stripper... operating temperature Continuously (A) Liquid temperature monitoring device installed at stripper influent...

40 CFR Table 12 to Subpart G of... - Monitoring Requirements for Treatment Processes

Code of Federal Regulations, 2011 CFR

2011-07-01

... Appropriate methods as specified in § 63.143 and as approved by permitting authority. 2. Steam stripper (i... recorder. (ii) Wastewater feed mass flow rate; and Continuously Liquid flow meter installed at stripper... operating temperature Continuously (A) Liquid temperature monitoring device installed at stripper influent...

40 CFR Table 12 to Subpart G of... - Monitoring Requirements for Treatment Processes

Code of Federal Regulations, 2014 CFR

2014-07-01

... Appropriate methods as specified in § 63.143 and as approved by permitting authority. 2. Steam stripper (i... recorder. (ii) Wastewater feed mass flow rate; and Continuously Liquid flow meter installed at stripper... operating temperature Continuously (A) Liquid temperature monitoring device installed at stripper influent...

40 CFR Table 12 to Subpart G of... - Monitoring Requirements for Treatment Processes

Code of Federal Regulations, 2012 CFR

2012-07-01

... Appropriate methods as specified in § 63.143 and as approved by permitting authority. 2. Steam stripper (i... recorder. (ii) Wastewater feed mass flow rate; and Continuously Liquid flow meter installed at stripper... operating temperature Continuously (A) Liquid temperature monitoring device installed at stripper influent...

40 CFR Table 7 to Subpart Vvvv of... - Applicability and Timing of Notifications

Code of Federal Regulations, 2010 CFR

2010-07-01

... § 63.9(e). b. A notification of the date for the continuous monitoring system performance evaluation as... control device performance test and continuous monitoring system performance evaluation. ... Notifications 7 Table 7 to Subpart VVVV of Part 63 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY...

21 CFR 862.1550 - Urinary pH (nonquantitative) test system.

Code of Federal Regulations, 2010 CFR

2010-04-01

... (CONTINUED) MEDICAL DEVICES CLINICAL CHEMISTRY AND CLINICAL TOXICOLOGY DEVICES Clinical Chemistry Test... the monitoring of patients with certain diets. (b) Classification. Class I (general controls). The...

21 CFR 870.2340 - Electrocardiograph.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Electrocardiograph. 870.2340 Section 870.2340 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2340 Electrocardiograph. (a...

21 CFR 870.2320 - Ballistocardiograph.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Ballistocardiograph. 870.2320 Section 870.2320 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2320 Ballistocardiograph...

21 CFR 870.2400 - Vectorcardiograph.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Vectorcardiograph. 870.2400 Section 870.2400 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2400 Vectorcardiograph. (a...

21 CFR 870.2320 - Ballistocardiograph.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Ballistocardiograph. 870.2320 Section 870.2320 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2320 Ballistocardiograph...

21 CFR 870.2340 - Electrocardiograph.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Electrocardiograph. 870.2340 Section 870.2340 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2340 Electrocardiograph. (a...

21 CFR 870.2400 - Vectorcardiograph.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Vectorcardiograph. 870.2400 Section 870.2400 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2400 Vectorcardiograph. (a...

Wireless physiological monitoring system for psychiatric patients.

PubMed

Rademeyer, A J; Blanckenberg, M M; Scheffer, C

2009-01-01

Patients in psychiatric hospitals that are sedated or secluded are at risk of death or injury if they are not continuously monitored. Some psychiatric patients are restless and aggressive, and hence the monitoring device should be robust and must transmit the data wirelessly. Two devices, a glove that measures oxygen saturation and a dorsally-mounted device that measures heart rate, skin temperature and respiratory rate were designed and tested. Both devices connect to one central monitoring station using two separate Bluetooth connections, ensuring a completely wireless setup. A Matlab graphical user interface (GUI) was developed for signal processing and monitoring of the vital signs of the psychiatric patient. Detection algorithms were implemented to detect ECG arrhythmias such as premature ventricular contraction and atrial fibrillation. The prototypes were manufactured and tested in a laboratory setting on healthy volunteers.

Cardiopulmonary Laboratory AFSC 904X0

DTIC Science & Technology

1990-10-01

SET UP POSITIVE END EXPIRATORY PRESSURE (PEEP) DEVICES 100 J321 SET UP CONTINUOUS POSITIVE AIRWAY PRESSURE ( CPAP ) DEVICES 100 J298 ASSIST PHYSICIAN IN...PRESSURE VENTILATORS 61 COMPUTERIZED PULMONARY FUNCTION ANALYZERS 61 TREADMILLS 59 HOLTER MONITOR EQUIPMENT 57 CPAP EQUIPMENT 54 PRESSURE REGULATORS 48...SUCTIONING PROCEDURES 95 J321 SET UP CONTINUOUS POSITIVE AIRWAY PRESSURE ( CPAP ) DEVICES 95 J332 SET UP VOLUME VENTILATORS 93 F148 PERFORM ARTERIAL PUNCTURES 93

21 CFR 868.2775 - Electrical peripheral nerve stimulator.

Code of Federal Regulations, 2012 CFR

2012-04-01

... a device used to apply an electrical current to a patient to test the level of pharmacological... 21 Food and Drugs 8 2012-04-01 2012-04-01 false Electrical peripheral nerve stimulator. 868.2775... (CONTINUED) MEDICAL DEVICES ANESTHESIOLOGY DEVICES Monitoring Devices § 868.2775 Electrical peripheral nerve...

21 CFR 868.2775 - Electrical peripheral nerve stimulator.

Code of Federal Regulations, 2013 CFR

2013-04-01

... a device used to apply an electrical current to a patient to test the level of pharmacological... 21 Food and Drugs 8 2013-04-01 2013-04-01 false Electrical peripheral nerve stimulator. 868.2775... (CONTINUED) MEDICAL DEVICES ANESTHESIOLOGY DEVICES Monitoring Devices § 868.2775 Electrical peripheral nerve...

40 CFR 63.9355 - What records must I keep?

Code of Federal Regulations, 2010 CFR

2010-07-01

... occurred during a period of SSM of the control device and associated monitoring equipment. (2) The records in § 63.6(e)(3)(iii) through (v) related to SSM. (3) The records required to show continuous... records in § 63.6(e)(3)(iii) through (v) related to SSM of the control device and associated monitoring...

40 CFR 63.9355 - What records must I keep?

Code of Federal Regulations, 2012 CFR

2012-07-01

... occurred during a period of SSM of the control device and associated monitoring equipment. (2) The records in § 63.6(e)(3)(iii) through (v) related to SSM. (3) The records required to show continuous... records in § 63.6(e)(3)(iii) through (v) related to SSM of the control device and associated monitoring...

40 CFR 63.9355 - What records must I keep?

Code of Federal Regulations, 2014 CFR

2014-07-01

... occurred during a period of SSM of the control device and associated monitoring equipment. (2) The records in § 63.6(e)(3)(iii) through (v) related to SSM. (3) The records required to show continuous... records in § 63.6(e)(3)(iii) through (v) related to SSM of the control device and associated monitoring...

40 CFR 63.9355 - What records must I keep?

Code of Federal Regulations, 2013 CFR

2013-07-01

... occurred during a period of SSM of the control device and associated monitoring equipment. (2) The records in § 63.6(e)(3)(iii) through (v) related to SSM. (3) The records required to show continuous... records in § 63.6(e)(3)(iii) through (v) related to SSM of the control device and associated monitoring...

40 CFR 63.9355 - What records must I keep?

Code of Federal Regulations, 2011 CFR

2011-07-01

... occurred during a period of SSM of the control device and associated monitoring equipment. (2) The records in § 63.6(e)(3)(iii) through (v) related to SSM. (3) The records required to show continuous... records in § 63.6(e)(3)(iii) through (v) related to SSM of the control device and associated monitoring...

40 CFR 63.1505 - Emission standards for affected sources and emission units.

Code of Federal Regulations, 2014 CFR

2014-07-01

... any PM add-on air pollution control device if a continuous opacity monitor (COM) or visible emissions... percent opacity from any PM add-on air pollution control device if a COM is chosen as the monitoring.../delacquering kiln/decoating kiln is equipped with an afterburner having a design residence time of at least 1...

Biofouling detection monitoring devices: status assessment. Final report

DOE Office of Scientific and Technical Information (OSTI.GOV)

Hillman, R.E.; Anson, D.; Corliss, J.M.

1985-03-01

An inventory of devices to detect and monitor biofouling in power plant condenser systems was prepared. The inventory was developed through a review of manufacturers' product information brochures, a general literature review, and limited personal contact with users and manufacturers. Two macrofouling and seventeen microfouling detection devices were reviewed. A summary analysis of the principal features of each device was prepared. Macrofouling devices are generally simple devices located at or near cooling water intakes. They monitor the growth of larger organisms such as mussels, barnacles, and large seaweeds. Microfouling detectors are usually located in or near the condenser tubes. Theymore » detect and monitor the growth of slime films on the tubes. Some of the devices measure changes in heat transfer or pressure drop in the condenser tubes. Other types include condenser simulators, biofilm samplers, or devices that measure the acoustic properties of the fouling films. Most devices are still in the development stage. Of the few available for general use, the type that measures heat transfer and/or pressure drop are developed to a greater degree than the other types. Recommendations for further research into development of a biofouling detection and monitoring devices include a side-by-side field comparison of selected devices, and the continued development of an effective acoustic device.« less

SU-E-J-72: Design and Study of In-House Web-Camera Based Automatic Continuous Patient Movement Monitoring and Controlling Device for EXRT.

PubMed

Senthil Kumar, S; Suresh Babu, S S; Anand, P; Dheva Shantha Kumari, G

2012-06-01

The purpose of our study was to fabricate in-house web-camera based automatic continuous patient movement monitoring device and control the movement of the patients during EXRT. Web-camera based patient movement monitoring device consists of a computer, digital web-camera, mounting system, breaker circuit, speaker, and visual indicator. The computer is used to control and analyze the patient movement using indigenously developed software. The speaker and the visual indicator are placed in the console room to indicate the positional displacement of the patient. Studies were conducted on phantom and 150 patients with different types of cancers. Our preliminary clinical results indicate that our device is highly reliable and can accurately report smaller movements of the patients in all directions. The results demonstrated that the device was able to detect patient's movements with the sensitivity of about 1 mm. When a patient moves, the receiver activates the circuit; an audible warning sound will be produced in the console. Through real-time measurements, an audible alarm can alert the radiation technologist to stop the treatment if the user defined positional threshold is violated. Simultaneously, the electrical circuit to the teletherapy machine will be activated and radiation will be halted. Patient's movement during the course for radiotherapy was studied. The beam is halted automatically when the threshold level of the system is exceeded. By using the threshold provided in the system, it is possible to monitor the patient continuously with certain fixed limits. An additional benefit is that it has reduced the tension and stress of a treatment team associated with treating patients who are not immobilized. It also enables the technologists to do their work more efficiently, because they don't have to continuously monitor patients with as much scrutiny as was required. © 2012 American Association of Physicists in Medicine.

Phase-shift focus monitoring techniques

NASA Astrophysics Data System (ADS)

McQuillan, Matthew; Roberts, Bill

2006-03-01

Depth of focus (DOF) has become a victim of its mathematical relationship with Numerical Aperture (NA). While NA is being increased towards one to maximize scanner resolution capabilities, DOF is being minimized because of its inverse relationship with NA. Moore's law continues to drive the semiconductor industry towards smaller and smaller devices the need for high NA to resolve these shrinking devices will continue to consume the usable depth of focus (UDOF). Due to the shrinking UDOF a demand has been created for a feature or technology that will give engineers the capability to monitor scanner focus. Developing and implementation of various focus monitoring techniques have been used to prevent undetected tool focus excursions. Two overlay techniques to monitor ArF Scanner focus have been evaluated; our evaluation results will be presented here.

21 CFR 870.2360 - Electrocardiograph electrode.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Electrocardiograph electrode. 870.2360 Section 870.2360 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2360 Electrocardiograph...

21 CFR 870.2675 - Oscillometer.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Oscillometer. 870.2675 Section 870.2675 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2675 Oscillometer. (a) Identification. An...

21 CFR 870.2855 - Implantable Intra-aneurysm Pressure Measurement System.

Code of Federal Regulations, 2012 CFR

2012-04-01

... System. 870.2855 Section 870.2855 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2855 Implantable Intra-aneurysm Pressure Measurement System. (a) Identification. Implantable intra...

21 CFR 870.2855 - Implantable Intra-aneurysm Pressure Measurement System.

Code of Federal Regulations, 2013 CFR

2013-04-01

... System. 870.2855 Section 870.2855 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2855 Implantable Intra-aneurysm Pressure Measurement System. (a) Identification. Implantable intra...

21 CFR 870.2855 - Implantable Intra-aneurysm Pressure Measurement System.

Code of Federal Regulations, 2014 CFR

2014-04-01

... System. 870.2855 Section 870.2855 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2855 Implantable Intra-aneurysm Pressure Measurement System. (a) Identification. Implantable intra...

21 CFR 870.2360 - Electrocardiograph electrode.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Electrocardiograph electrode. 870.2360 Section 870.2360 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2360 Electrocardiograph...

21 CFR 870.2675 - Oscillometer.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Oscillometer. 870.2675 Section 870.2675 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2675 Oscillometer. (a) Identification. An...

21 CFR 870.2750 - Impedance phlebograph.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Impedance phlebograph. 870.2750 Section 870.2750 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2750 Impedance phlebograph...

21 CFR 870.2770 - Impedance plethysmograph.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Impedance plethysmograph. 870.2770 Section 870.2770 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2770 Impedance...

21 CFR 812.46 - Monitoring investigations.

Code of Federal Regulations, 2010 CFR

2010-04-01

... Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED...) Unanticipated adverse device effects. (1) A sponsor shall immediately conduct an evaluation of any unanticipated adverse device effect. (2) A sponsor who determines that an unanticipated adverse device effect presents...

40 CFR 63.644 - Monitoring provisions for miscellaneous process vents.

Code of Federal Regulations, 2010 CFR

2010-07-01

... to a thermocouple, an ultraviolet beam sensor, or an infrared sensor) capable of continuously... the equipment will monitor accurately. (1) Where an incinerator is used, a temperature monitoring... incinerator is used, a temperature monitoring device shall be installed in the firebox or in the ductwork...

40 CFR 63.644 - Monitoring provisions for miscellaneous process vents.

Code of Federal Regulations, 2012 CFR

2012-07-01

... to a thermocouple, an ultraviolet beam sensor, or an infrared sensor) capable of continuously... the equipment will monitor accurately. (1) Where an incinerator is used, a temperature monitoring... incinerator is used, a temperature monitoring device shall be installed in the firebox or in the ductwork...

40 CFR 63.644 - Monitoring provisions for miscellaneous process vents.

Code of Federal Regulations, 2014 CFR

2014-07-01

... to a thermocouple, an ultraviolet beam sensor, or an infrared sensor) capable of continuously... the equipment will monitor accurately. (1) Where an incinerator is used, a temperature monitoring... incinerator is used, a temperature monitoring device shall be installed in the firebox or in the ductwork...

21 CFR 884.2800 - Computerized Labor Monitoring System.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Computerized Labor Monitoring System. 884.2800... Devices § 884.2800 Computerized Labor Monitoring System. (a) Identification. A computerized labor monitoring system is a system intended to continuously measure cervical dilation and fetal head descent and...

Continuous Glucose Monitoring in Resource-Constrained Settings for Hypoglycaemia Detection: Looking at the Problem from the Other Side of the Coin.

PubMed

Bila, Rubao; Varo, Rosauro; Madrid, Lola; Sitoe, Antonio; Bassat, Quique

2018-04-25

The appearance, over a decade ago, of continuous glucose monitoring (CGM) devices has triggered a patient-centred revolution in the control and management of diabetes mellitus and other metabolic conditions, improving the patient’s glycaemic control and quality of life. Such devices, the use of which remains typically restricted to high-income countries on account of their elevated costs, at present show very limited implantation in resource-constrained settings, where many other urgent health priorities beyond diabetes prevention and management still need to be resolved. In this commentary, we argue that such devices could have an additional utility in low-income settings, whereby they could be selectively used among severely ill children admitted to hospital for closer monitoring of paediatric hypoglycaemia, a life-threatening condition often complicating severe cases of malaria, malnutrition, and other common paediatric conditions.

40 CFR 63.5767 - What records must I keep?

Code of Federal Regulations, 2013 CFR

2013-07-01

... facility is not controlled by an add-on control device (i.e., you are complying with organic HAP content... add-on control device, you must keep the records specified in § 63.10(b) relative to control device startup, shut down, and malfunction events; control device performance tests; and continuous monitoring...

40 CFR 63.5767 - What records must I keep?

Code of Federal Regulations, 2012 CFR

2012-07-01

... facility is not controlled by an add-on control device (i.e., you are complying with organic HAP content... add-on control device, you must keep the records specified in § 63.10(b) relative to control device startup, shut down, and malfunction events; control device performance tests; and continuous monitoring...

40 CFR 63.5767 - What records must I keep?

Code of Federal Regulations, 2014 CFR

2014-07-01

... facility is not controlled by an add-on control device (i.e., you are complying with organic HAP content... add-on control device, you must keep the records specified in § 63.10(b) relative to control device startup, shut down, and malfunction events; control device performance tests; and continuous monitoring...

21 CFR 870.2350 - Electrocardiograph lead switching adaptor.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Electrocardiograph lead switching adaptor. 870.2350 Section 870.2350 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2350...

21 CFR 870.2370 - Electrocardiograph surface electrode tester.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Electrocardiograph surface electrode tester. 870.2370 Section 870.2370 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2370...

21 CFR 870.2840 - Apex cardiographic transducer.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Apex cardiographic transducer. 870.2840 Section 870.2840 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2840 Apex...

21 CFR 870.2310 - Apex cardiograph (vibrocardiograph).

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Apex cardiograph (vibrocardiograph). 870.2310 Section 870.2310 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2310 Apex...

21 CFR 870.2890 - Vessel occlusion transducer.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Vessel occlusion transducer. 870.2890 Section 870.2890 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2890 Vessel occlusion...

21 CFR 870.2920 - Telephone electrocardiograph transmitter and receiver.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Telephone electrocardiograph transmitter and receiver. 870.2920 Section 870.2920 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices...

21 CFR 870.2780 - Hydraulic, pneumatic, or photoelectric plethysmographs.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Hydraulic, pneumatic, or photoelectric plethysmographs. 870.2780 Section 870.2780 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices...

21 CFR 870.2700 - Oximeter.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Oximeter. 870.2700 Section 870.2700 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2700 Oximeter. (a) Identification. An oximeter is...

21 CFR 870.2600 - Signal isolation system.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Signal isolation system. 870.2600 Section 870.2600 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2600 Signal isolation...

21 CFR 870.2350 - Electrocardiograph lead switching adaptor.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Electrocardiograph lead switching adaptor. 870.2350 Section 870.2350 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2350...

21 CFR 870.2310 - Apex cardiograph (vibrocardiograph).

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Apex cardiograph (vibrocardiograph). 870.2310 Section 870.2310 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2310 Apex...

21 CFR 870.2920 - Telephone electrocardiograph transmitter and receiver.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Telephone electrocardiograph transmitter and receiver. 870.2920 Section 870.2920 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices...

21 CFR 870.2600 - Signal isolation system.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Signal isolation system. 870.2600 Section 870.2600 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2600 Signal isolation...

21 CFR 870.2890 - Vessel occlusion transducer.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Vessel occlusion transducer. 870.2890 Section 870.2890 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2890 Vessel occlusion...

21 CFR 870.2370 - Electrocardiograph surface electrode tester.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Electrocardiograph surface electrode tester. 870.2370 Section 870.2370 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2370...

21 CFR 870.2780 - Hydraulic, pneumatic, or photoelectric plethysmographs.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Hydraulic, pneumatic, or photoelectric plethysmographs. 870.2780 Section 870.2780 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices...

21 CFR 870.2840 - Apex cardiographic transducer.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Apex cardiographic transducer. 870.2840 Section 870.2840 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2840 Apex...

21 CFR 870.2700 - Oximeter.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Oximeter. 870.2700 Section 870.2700 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2700 Oximeter. (a) Identification. An oximeter is...

Blood Glucose Monitoring Devices

MedlinePlus

... of interferences ability to transmit data to a computer cost of the meter cost of the test ... Performance FDA expands indication for continuous glucose monitoring system, first to replace fingerstick testing for diabetes treatment ...

Implantable cardiac devices: the utility of remote monitoring in a paediatric and CHD population.

PubMed

Olen, Melissa M; Dechert-Crooks, Brynn

2017-01-01

Remote monitoring in the modern era has improved outcomes for patients with cardiac implantable electronic devices. There are many advantages to remote monitoring, including improved quality of life for patients, decreased need for in-office interrogation, and secondary reduced costs. Patient safety and enhanced survival remain the most significant benefit. With most of the published literature on this topic being focussed on adults, paediatric outcomes continue to be defined. This is a review of the benefits of remote monitoring in paediatrics and in patients with CHD.

21 CFR 880.2400 - Bed-patient monitor.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Bed-patient monitor. 880.2400 Section 880.2400 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED... Devices § 880.2400 Bed-patient monitor. (a) Identification. A bed-patient monitor is a battery-powered...

21 CFR 876.2040 - Enuresis alarm.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Enuresis alarm. 876.2040 Section 876.2040 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES GASTROENTEROLOGY-UROLOGY DEVICES Monitoring Devices § 876.2040 Enuresis alarm. (a) Identification. An enuresis...

40 CFR 65.2 - Definitions.

Code of Federal Regulations, 2012 CFR

2012-07-01

... approach; (2) Decreased frequency for non-continuous parameter monitoring or physical inspections; (3... stream components, not carbon equivalents. Car-seal means a seal that is placed on a device that is used..., flow inducing devices that transport gas or vapor from an emission point to a control device. A closed...

21 CFR 870.2710 - Ear oximeter.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Ear oximeter. 870.2710 Section 870.2710 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2710 Ear oximeter. (a) Identification. An ear...

21 CFR 870.2050 - Biopotential amplifier and signal conditioner.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Biopotential amplifier and signal conditioner. 870.2050 Section 870.2050 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2050...

21 CFR 870.2800 - Medical magnetic tape recorder.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Medical magnetic tape recorder. 870.2800 Section 870.2800 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2800 Medical...

21 CFR 870.2855 - Implantable Intra-aneurysm Pressure Measurement System.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Implantable Intra-aneurysm Pressure Measurement System. 870.2855 Section 870.2855 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices...

21 CFR 870.2810 - Paper chart recorder.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Paper chart recorder. 870.2810 Section 870.2810 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2810 Paper chart recorder...

21 CFR 870.2640 - Portable leakage current alarm.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Portable leakage current alarm. 870.2640 Section 870.2640 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2640 Portable...

21 CFR 870.2060 - Transducer signal amplifier and conditioner.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Transducer signal amplifier and conditioner. 870.2060 Section 870.2060 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2060...

21 CFR 870.2060 - Transducer signal amplifier and conditioner.

Code of Federal Regulations, 2014 CFR

2014-04-01

... 21 Food and Drugs 8 2014-04-01 2014-04-01 false Transducer signal amplifier and conditioner. 870.2060 Section 870.2060 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2060...

21 CFR 870.2060 - Transducer signal amplifier and conditioner.

Code of Federal Regulations, 2013 CFR

2013-04-01

... 21 Food and Drugs 8 2013-04-01 2013-04-01 false Transducer signal amplifier and conditioner. 870.2060 Section 870.2060 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2060...

21 CFR 870.2060 - Transducer signal amplifier and conditioner.

Code of Federal Regulations, 2012 CFR

2012-04-01

... 21 Food and Drugs 8 2012-04-01 2012-04-01 false Transducer signal amplifier and conditioner. 870.2060 Section 870.2060 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2060...

21 CFR 870.2120 - Extravascular blood flow probe.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Extravascular blood flow probe. 870.2120 Section 870.2120 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2120 Extravascular...

21 CFR 870.2640 - Portable leakage current alarm.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Portable leakage current alarm. 870.2640 Section 870.2640 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2640 Portable...

21 CFR 870.2050 - Biopotential amplifier and signal conditioner.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Biopotential amplifier and signal conditioner. 870.2050 Section 870.2050 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2050...

21 CFR 870.2870 - Catheter tip pressure transducer.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Catheter tip pressure transducer. 870.2870 Section 870.2870 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2870 Catheter tip...

21 CFR 870.2850 - Extravascular blood pressure transducer.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Extravascular blood pressure transducer. 870.2850 Section 870.2850 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2850 Extravascular...

21 CFR 870.2810 - Paper chart recorder.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Paper chart recorder. 870.2810 Section 870.2810 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2810 Paper chart recorder...

21 CFR 870.2800 - Medical magnetic tape recorder.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Medical magnetic tape recorder. 870.2800 Section 870.2800 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2800 Medical...

21 CFR 870.2060 - Transducer signal amplifier and conditioner.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Transducer signal amplifier and conditioner. 870.2060 Section 870.2060 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2060...

21 CFR 870.2710 - Ear oximeter.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Ear oximeter. 870.2710 Section 870.2710 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2710 Ear oximeter. (a) Identification. An ear...

21 CFR 870.2855 - Implantable Intra-aneurysm Pressure Measurement System.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Implantable Intra-aneurysm Pressure Measurement System. 870.2855 Section 870.2855 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices...

Bioanalytical devices: Technological leap for sweat sensing

NASA Astrophysics Data System (ADS)

Heikenfeld, Jason

2016-01-01

Sweat analysis is an ideal method for continuously tracking a person's physiological state, but developing devices for this is difficult. A wearable sweat monitor that measures several biomarkers is a breakthrough. See Letter p.509

21 CFR 892.1540 - Nonfetal ultrasonic monitor.

Code of Federal Regulations, 2012 CFR

2012-04-01

...) Identification. A nonfetal ultrasonic monitor is a device that projects a continuous high-frequency sound wave... wave and is intended for use in the investigation of nonfetal blood flow and other nonfetal body...

21 CFR 892.1540 - Nonfetal ultrasonic monitor.

Code of Federal Regulations, 2013 CFR

2013-04-01

...) Identification. A nonfetal ultrasonic monitor is a device that projects a continuous high-frequency sound wave... wave and is intended for use in the investigation of nonfetal blood flow and other nonfetal body...

Design and Development of Patient Monitoring System

NASA Astrophysics Data System (ADS)

Hazwanie Azizulkarim, Azra; Jamil, Muhammad Mahadi Abdul; Ambar, Radzi

2017-08-01

Patient monitoring system allows continuous monitoring of patient vital signs, support decision making among medical personnel and help enhance patient care. This system can consist of devices that measure, display and record human’s vital signs, including body temperature, heart rate, blood pressure and other health-related criteria. This paper proposes a system to monitor the patient’s conditions by monitoring the body temperature and pulse rate. The system consists of a pulse rate monitoring software and a wearable device that can measure a subject’s temperature and pulse rate only by using a fingertip. The device is able to record the measurement data and interface to PC via Arduino microcontroller. The recorded data can be viewed as a historical file or can be archived for further analysis. This work also describes the preliminary experimental results of the selected sensors to show the usefulness of the sensors for the proposed patient monitoring system.

A portable ECG monitoring device with Bluetooth and Holter capabilities for telemedicine applications.

PubMed

Lucani, Daniel; Cataldo, Giancarlos; Cruz, Julio; Villegas, Guillermo; Wong, Sara

2006-01-01

A prototype of a portable ECG-monitoring device has been developed for clinical and non-clinical environments as part of a telemedicine system to provide remote and continuous surveillance of patients. The device can acquire, store and/or transmit ECG signals to computer-based platforms or specially configured access points (AP) with Intranet/Internet capabilities in order to reach remote monitoring stations. Acquired data can be stored in a flash memory card in FAT16 format for later recovery, or transmitted via Bluetooth or USB to a local station or AP. This data acquisition module (DAM) operates in two modes: Holter and on-line transmission.

An affordable cuff-less blood pressure estimation solution.

PubMed

Jain, Monika; Kumar, Niranjan; Deb, Sujay

2016-08-01

This paper presents a cuff-less hypertension pre-screening device that non-invasively monitors the Blood Pressure (BP) and Heart Rate (HR) continuously. The proposed device simultaneously records two clinically significant and highly correlated biomedical signals, viz., Electrocardiogram (ECG) and Photoplethysmogram (PPG). The device provides a common data acquisition platform that can interface with PC/laptop, Smart phone/tablet and Raspberry-pi etc. The hardware stores and processes the recorded ECG and PPG in order to extract the real-time BP and HR using kernel regression approach. The BP and HR estimation error is measured in terms of normalized mean square error, Error Standard Deviation (ESD) and Mean Absolute Error (MAE), with respect to a clinically proven digital BP monitor (OMRON HBP1300). The computed error falls under the maximum standard allowable error mentioned by Association for the Advancement of Medical Instrumentation; MAE <; 5 mmHg and ESD <; 8mmHg. The results are validated using two-tailed dependent sample t-test also. The proposed device is a portable low-cost home and clinic bases solution for continuous health monitoring.

40 CFR 63.5767 - What records must I keep?

Code of Federal Regulations, 2011 CFR

2011-07-01

... by an add-on control device (i.e., you are complying with organic HAP content limits, application...-average organic HAP content as determined in § 63.5749. (d) If your facility has an add-on control device... malfunction events; control device performance tests; and continuous monitoring system performance evaluations. ...

40 CFR 63.5767 - What records must I keep?

Code of Federal Regulations, 2010 CFR

2010-07-01

... by an add-on control device (i.e., you are complying with organic HAP content limits, application...-average organic HAP content as determined in § 63.5749. (d) If your facility has an add-on control device... malfunction events; control device performance tests; and continuous monitoring system performance evaluations. ...

21 CFR 866.5910 - Quality control material for cystic fibrosis nucleic acid assays.

Code of Federal Regulations, 2010 CFR

2010-04-01

... HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES IMMUNOLOGY AND MICROBIOLOGY DEVICES Immunological Test Systems § 866.5910 Quality control material for cystic fibrosis nucleic acid assays. (a... cystic fibrosis nucleic acid assays is a device intended to help monitor reliability of a test system by...

21 CFR 870.2900 - Patient transducer and electrode cable (including connector).

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Patient transducer and electrode cable (including connector). 870.2900 Section 870.2900 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices...

21 CFR 870.2450 - Medical cathode-ray tube display.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Medical cathode-ray tube display. 870.2450 Section 870.2450 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2450 Medical...

21 CFR 870.2450 - Medical cathode-ray tube display.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Medical cathode-ray tube display. 870.2450 Section 870.2450 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices § 870.2450 Medical...

21 CFR 870.2900 - Patient transducer and electrode cable (including connector).

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Patient transducer and electrode cable (including connector). 870.2900 Section 870.2900 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring Devices...

21 CFR 26.15 - Monitoring continued equivalence.

Code of Federal Regulations, 2010 CFR

2010-04-01

... MUTUAL RECOGNITION OF PHARMACEUTICAL GOOD MANUFACTURING PRACTICE REPORTS, MEDICAL DEVICE QUALITY SYSTEM... COMMUNITY Specific Sector Provisions for Pharmaceutical Good Manufacturing Practices § 26.15 Monitoring... number of joint inspections; and the conduct of common training sessions. ...

21 CFR 26.15 - Monitoring continued equivalence.

Code of Federal Regulations, 2011 CFR

2011-04-01

... MUTUAL RECOGNITION OF PHARMACEUTICAL GOOD MANUFACTURING PRACTICE REPORTS, MEDICAL DEVICE QUALITY SYSTEM... COMMUNITY Specific Sector Provisions for Pharmaceutical Good Manufacturing Practices § 26.15 Monitoring... number of joint inspections; and the conduct of common training sessions. ...

Lab-on-Skin: A Review of Flexible and Stretchable Electronics for Wearable Health Monitoring.

PubMed

Liu, Yuhao; Pharr, Matt; Salvatore, Giovanni Antonio

2017-10-24

Skin is the largest organ of the human body, and it offers a diagnostic interface rich with vital biological signals from the inner organs, blood vessels, muscles, and dermis/epidermis. Soft, flexible, and stretchable electronic devices provide a novel platform to interface with soft tissues for robotic feedback and control, regenerative medicine, and continuous health monitoring. Here, we introduce the term "lab-on-skin" to describe a set of electronic devices that have physical properties, such as thickness, thermal mass, elastic modulus, and water-vapor permeability, which resemble those of the skin. These devices can conformally laminate on the epidermis to mitigate motion artifacts and mismatches in mechanical properties created by conventional, rigid electronics while simultaneously providing accurate, non-invasive, long-term, and continuous health monitoring. Recent progress in the design and fabrication of soft sensors with more advanced capabilities and enhanced reliability suggest an impending translation of these devices from the research lab to clinical environments. Regarding these advances, the first part of this manuscript reviews materials, design strategies, and powering systems used in soft electronics. Next, the paper provides an overview of applications of these devices in cardiology, dermatology, electrophysiology, and sweat diagnostics, with an emphasis on how these systems may replace conventional clinical tools. The review concludes with an outlook on current challenges and opportunities for future research directions in wearable health monitoring.

40 CFR 63.2997 - What are the requirements for monitoring devices?

Code of Federal Regulations, 2011 CFR

2011-07-01

... continuously the thermal oxidizer temperature at the exit of the combustion zone before any substantial heat exchange occurs or at the location consistent with the manufacturer's recommendations. (2) Continuously...

40 CFR 63.2997 - What are the requirements for monitoring devices?

Code of Federal Regulations, 2010 CFR

2010-07-01

... continuously the thermal oxidizer temperature at the exit of the combustion zone before any substantial heat exchange occurs or at the location consistent with the manufacturer's recommendations. (2) Continuously...

[Telemetry in the clinical setting].

PubMed

Hilbel, Thomas; Helms, Thomas M; Mikus, Gerd; Katus, Hugo A; Zugck, Christian

2008-09-01

Telemetric cardiac monitoring was invented in 1949 by Norman J Holter. Its clinical use started in the early 1960s. In the hospital, biotelemetry allows early mobilization of patients with cardiovascular risk and addresses the need for arrhythmia or oxygen saturation monitoring. Nowadays telemetry either uses vendor-specific UHF band broadcasting or the digital ISM band (Industrial, Scientific, and Medical Band) standardized Wi-Fi network technology. Modern telemetry radio transmitters can measure and send multiple physiological parameters like multi-channel ECG, NIPB and oxygen saturation. The continuous measurement of oxygen saturation is mandatory for the remote monitoring of patients with cardiac pacemakers. Real 12-lead ECG systems with diagnostic quality are an advantage for monitoring patients with chest pain syndromes or in drug testing wards. Modern systems are light-weight and deliver a maximum of carrying comfort due to optimized cable design. Important for the system selection is a sophisticated detection algorithm with a maximum reduction of artifacts. Home-monitoring of implantable cardiac devices with telemetric functionalities are becoming popular because it allows remote diagnosis of proper device functionality and also optimization of the device settings. Continuous real-time monitoring at home for patients with chronic disease may be possible in the future using Digital Video Broadcasting Terrestrial (DVB-T) technology in Europe, but is currently not yet available.

Implantable cardiac resynchronization therapy devices to monitor heart failure clinical status.

PubMed

Fung, Jeffrey Wing-Hong; Yu, Cheuk-Man

2007-03-01

Cardiac resynchronization therapy is a standard therapy for selected patients with heart failure. With advances in technology and storage capacity, the device acts as a convenient platform to provide valuable information about heart failure status in these high-risk patients. Unlike other modalities of investigation which may only allow one-off evaluation, heart failure status can be monitored by device diagnostics including heart rate variability, activity status, and intrathoracic impedance in a continuous basis. These parameters do not just provide long-term prognostic information but also may be useful to predict upcoming heart failure exacerbation. Prompt and early intervention may abort decompensation, prevent hospitalization, improve quality of life, and reduce health care cost. Moreover, this information may be applied to titrate the dosage of medication and monitor response to heart failure treatment. This review will focus on the prognostic and predictive values of heart failure status monitoring provided by these devices.

Continuous minimally-invasive alcohol monitoring using microneedle sensor arrays.

PubMed

Mohan, A M Vinu; Windmiller, Joshua Ray; Mishra, Rupesh K; Wang, Joseph

2017-05-15

The present work describes an attractive skin-worn microneedle sensing device for the minimally invasive electrochemical monitoring of subcutaneous alcohol. The device consists of an assembly of pyramidal microneedle structures integrated with Pt and Ag wires, each with a microcavity opening. The microneedle aperture was modified by electropolymerizing o-phenylene diamine onto the Pt wire microtransducer, followed by the immobilization of alcohol oxidase (AOx) in an intermediate chitosan layer, along with an outer Nafion layer. The resulting microneedle-based enzyme electrode displays an interference-free ethanol detection in artificial interstitial fluid without compromising its sensitivity, stability and response time. The skin penetration ability and the efficaciousness of the biosensor performance towards subcutaneous alcohol monitoring was substantiated by the ex vivo mice skin model analysis. Our results reveal that the new microneedle sensor holds considerable promise for continuous non-invasive alcohol monitoring in real-life situations. Copyright © 2017 Elsevier B.V. All rights reserved.

A multiparameter wearable physiologic monitoring system for space and terrestrial applications

NASA Technical Reports Server (NTRS)

Mundt, Carsten W.; Montgomery, Kevin N.; Udoh, Usen E.; Barker, Valerie N.; Thonier, Guillaume C.; Tellier, Arnaud M.; Ricks, Robert D.; Darling, Robert B.; Cagle, Yvonne D.; Cabrol, Nathalie A.;

Continuous minimally-invasive alcohol monitoring using microneedle sensor arrays

PubMed Central

Vinu Mohan, A. M.; Windmiller, Joshua Ray; Mishra, Rupesh K.; Wang, Joseph

2017-01-01

The present work describes an attractive skin-worn microneedle sensing device for the minimally invasive electrochemical monitoring of subcutaneous alcohol. The device consists of an assembly of pyramidal microneedle structures integrated with Pt and Ag wires, each with a microcavity opening. The microneedle aperture was modified by electropolymerizing o-phenylene diamine onto the Pt wire microtransducer, followed by the immobilization of alcohol oxidase (AOx) in an intermediate chitosan layer, along with an outer Nafion layer. The resulting microneedle-based enzyme electrode displays an interference-free ethanol detection in artificial interstitial fluid without compromising its sensitivity, stability and response time. The skin penetration ability and the efficaciousness of the biosensor performance towards subcutaneous alcohol monitoring was substantiated by the ex vivo mice skin model analysis. Our results reveal that the new microneedle sensor holds considerable promise for continuous non-invasive alcohol monitoring in real-life situations. PMID:28088750

Applications and Methods for Continuous Monitoring of Physiological Chemistry

DTIC Science & Technology

2016-02-04

product and test platform to verify the performance characteristics of the enzymes when used in diagnostic device fabrication. 1.3 Results This...project had three primary objectives: 1. Engineer a cortisol oxidase enzyme suitable for use in diagnostic devices 2. Large scale production and...for both animal and human use , and for direct sale to other entities to manufacture biosensors and other products for human monitoring. The enzymes

Resource-Aware Mobile-Based Health Monitoring.

PubMed

Masud, Mohammad M; Adel Serhani, Mohamed; Navaz, Alramzana Nujum

2017-03-01

Monitoring heart diseases often requires frequent measurements of electrocardiogram (ECG) signals at different periods of the day, and at different situations (e.g., traveling, and exercising). This can only be implemented using mobile devices in order to cope with mobility of patients under monitoring, thus supporting continuous monitoring practices. However, these devices are energy-aware, have limited computing resources (e.g., CPU speed and memory), and might lose network connectivity, which makes it very challenging to maintain a continuity of the monitoring episode. In this paper, we propose a mobile monitoring solution to cope with these challenges by compromising on the fly resources availability, battery level, and network intermittence. In order to solve this problem, first we divide the whole process into several subtasks such that each subtask can be executed sequentially either in the server or in the mobile or in parallel in both devices. Then, we developed a mathematical model that considers all the constraints and finds a dynamic programing solution to obtain the best execution path (i.e., which substep should be done where). The solution guarantees an optimum execution time, while considering device battery availability, execution and transmission time, and network availability. We conducted a series of experiments to evaluate our proposed approach using some key monitoring tasks starting from preprocessing to classification and prediction. The results we have obtained proved that our approach gives the best (lowest) running time for any combination of factors including processing speed, input size, and network bandwidth. Compared to several greedy but nonoptimal solutions, the execution time of our approach was at least 10 times faster and consumed 90% less energy.

A Low-Power and Portable Biomedical Device for Respiratory Monitoring with a Stable Power Source

PubMed Central

Yang, Jiachen; Chen, Bobo; Zhou, Jianxiong; Lv, Zhihan

2015-01-01

Continuous respiratory monitoring is an important tool for clinical monitoring. Associated with the development of biomedical technology, it has become more and more important, especially in the measuring of gas flow and CO2 concentration, which can reflect the status of the patient. In this paper, a new type of biomedical device is presented, which uses low-power sensors with a piezoresistive silicon differential pressure sensor to measure gas flow and with a pyroelectric sensor to measure CO2 concentration simultaneously. For the portability of the biomedical device, the sensors and low-power measurement circuits are integrated together, and the airway tube also needs to be miniaturized. Circuits are designed to ensure the stability of the power source and to filter out the existing noise. Modulation technology is used to eliminate the fluctuations at the trough of the waveform of the CO2 concentration signal. Statistical analysis with the coefficient of variation was performed to find out the optimal driving voltage of the pressure transducer. Through targeted experiments, the biomedical device showed a high accuracy, with a measuring precision of 0.23 mmHg, and it worked continuously and stably, thus realizing the real-time monitoring of the status of patients. PMID:26270665

40 CFR 60.423 - Monitoring of operations.

Code of Federal Regulations, 2014 CFR

2014-07-01

... (CONTINUED) STANDARDS OF PERFORMANCE FOR NEW STATIONARY SOURCES Standards of Performance for Ammonium Sulfate Manufacture § 60.423 Monitoring of operations. (a) The owner or operator of any ammonium sulfate manufacturing... monitoring devices which can be used to determine the mass flow of ammonium sulfate feed material streams to...

40 CFR 60.423 - Monitoring of operations.

Code of Federal Regulations, 2010 CFR

2010-07-01

... (CONTINUED) STANDARDS OF PERFORMANCE FOR NEW STATIONARY SOURCES Standards of Performance for Ammonium Sulfate Manufacture § 60.423 Monitoring of operations. (a) The owner or operator of any ammonium sulfate manufacturing... monitoring devices which can be used to determine the mass flow of ammonium sulfate feed material streams to...

40 CFR 60.423 - Monitoring of operations.

Code of Federal Regulations, 2011 CFR

2011-07-01

... (CONTINUED) STANDARDS OF PERFORMANCE FOR NEW STATIONARY SOURCES Standards of Performance for Ammonium Sulfate Manufacture § 60.423 Monitoring of operations. (a) The owner or operator of any ammonium sulfate manufacturing... monitoring devices which can be used to determine the mass flow of ammonium sulfate feed material streams to...

40 CFR 60.423 - Monitoring of operations.

Code of Federal Regulations, 2012 CFR

2012-07-01

... (CONTINUED) STANDARDS OF PERFORMANCE FOR NEW STATIONARY SOURCES Standards of Performance for Ammonium Sulfate Manufacture § 60.423 Monitoring of operations. (a) The owner or operator of any ammonium sulfate manufacturing... monitoring devices which can be used to determine the mass flow of ammonium sulfate feed material streams to...

40 CFR 60.423 - Monitoring of operations.

Code of Federal Regulations, 2013 CFR

2013-07-01

... (CONTINUED) STANDARDS OF PERFORMANCE FOR NEW STATIONARY SOURCES Standards of Performance for Ammonium Sulfate Manufacture § 60.423 Monitoring of operations. (a) The owner or operator of any ammonium sulfate manufacturing... monitoring devices which can be used to determine the mass flow of ammonium sulfate feed material streams to...

40 CFR 63.996 - General monitoring requirements for control and recovery devices.

Code of Federal Regulations, 2010 CFR

2010-07-01

... limits established under a referencing subpart. Where the regeneration stream flow and carbon bed temperature are monitored, the range shall be in terms of the total regeneration stream flow per regeneration... regeneration cooling cycle. (d) Alternatives to monitoring requirements—(1) Alternatives to the continuous...

40 CFR 63.996 - General monitoring requirements for control and recovery devices.

Code of Federal Regulations, 2012 CFR

2012-07-01

... limits established under a referencing subpart. Where the regeneration stream flow and carbon bed temperature are monitored, the range shall be in terms of the total regeneration stream flow per regeneration... regeneration cooling cycle. (d) Alternatives to monitoring requirements—(1) Alternatives to the continuous...

40 CFR 63.996 - General monitoring requirements for control and recovery devices.

Code of Federal Regulations, 2011 CFR

2011-07-01

... limits established under a referencing subpart. Where the regeneration stream flow and carbon bed temperature are monitored, the range shall be in terms of the total regeneration stream flow per regeneration... regeneration cooling cycle. (d) Alternatives to monitoring requirements—(1) Alternatives to the continuous...

40 CFR 63.996 - General monitoring requirements for control and recovery devices.

Code of Federal Regulations, 2014 CFR

2014-07-01

... limits established under a referencing subpart. Where the regeneration stream flow and carbon bed temperature are monitored, the range shall be in terms of the total regeneration stream flow per regeneration... regeneration cooling cycle. (d) Alternatives to monitoring requirements—(1) Alternatives to the continuous...

40 CFR 63.996 - General monitoring requirements for control and recovery devices.

Code of Federal Regulations, 2013 CFR

2013-07-01

... limits established under a referencing subpart. Where the regeneration stream flow and carbon bed temperature are monitored, the range shall be in terms of the total regeneration stream flow per regeneration... regeneration cooling cycle. (d) Alternatives to monitoring requirements—(1) Alternatives to the continuous...

40 CFR 63.6125 - What are my monitor installation, operation, and maintenance requirements?

Code of Federal Regulations, 2012 CFR

2012-07-01

... Stationary Combustion Turbines Testing and Initial Compliance Requirements § 63.6125 What are my monitor installation, operation, and maintenance requirements? (a) If you are operating a stationary combustion turbine... emission control device, you must monitor on a continuous basis your catalyst inlet temperature in order to...

Description of a Portable Wireless Device for High-Frequency Body Temperature Acquisition and Analysis

PubMed Central

Cuesta-Frau, David; Varela, Manuel; Aboy, Mateo; Miró-Martínez, Pau

2009-01-01

We describe a device for dual channel body temperature monitoring. The device can operate as a real time monitor or as a data logger, and has Bluetooth capabilities to enable for wireless data download to the computer used for data analysis. The proposed device is capable of sampling temperature at a rate of 1 sample per minute with a resolution of 0.01 °C . The internal memory allows for stand-alone data logging of up to 10 days. The device has a battery life of 50 hours in continuous real-time mode. In addition to describing the proposed device in detail, we report the results of a statistical analysis conducted to assess its accuracy and reproducibility. PMID:22408473

Description of a portable wireless device for high-frequency body temperature acquisition and analysis.

PubMed

Cuesta-Frau, David; Varela, Manuel; Aboy, Mateo; Miró-Martínez, Pau

2009-01-01

We describe a device for dual channel body temperature monitoring. The device can operate as a real time monitor or as a data logger, and has Bluetooth capabilities to enable for wireless data download to the computer used for data analysis. The proposed device is capable of sampling temperature at a rate of 1 sample per minute with a resolution of 0.01 °C . The internal memory allows for stand-alone data logging of up to 10 days. The device has a battery life of 50 hours in continuous real-time mode. In addition to describing the proposed device in detail, we report the results of a statistical analysis conducted to assess its accuracy and reproducibility.

40 CFR 63.3547 - What are the requirements for continuous parameter monitoring system installation, operation, and...

Code of Federal Regulations, 2011 CFR

2011-07-01

... section for each gas temperature monitoring device. (i) Locate the temperature sensor in a position that..., install a gas temperature monitor in the firebox of the thermal oxidizer or in the duct immediately... a gas temperature monitor according to paragraph (c)(2)(i) or (ii) of this section. (i) If you...

40 CFR 63.3557 - What are the requirements for continuous parameter monitoring system installation, operation, and...

Code of Federal Regulations, 2010 CFR

2010-07-01

... (ii) of this section for each gas temperature monitoring device. (i) Locate the temperature sensor in... oxidizer, install a gas temperature monitor in the firebox of the thermal oxidizer or in the duct... oxidizer, install a gas temperature monitor according to paragraph (c)(2)(i) or (ii) of this section. (i...

40 CFR 63.3547 - What are the requirements for continuous parameter monitoring system installation, operation, and...

Code of Federal Regulations, 2010 CFR

2010-07-01

... section for each gas temperature monitoring device. (i) Locate the temperature sensor in a position that..., install a gas temperature monitor in the firebox of the thermal oxidizer or in the duct immediately... a gas temperature monitor according to paragraph (c)(2)(i) or (ii) of this section. (i) If you...

40 CFR 63.4967 - What are the requirements for continuous parameter monitoring system installation, operation, and...

Code of Federal Regulations, 2011 CFR

2011-07-01

... section for each gas temperature monitoring device. (i) Locate the temperature sensor in a position that... oxidizer, install a gas temperature monitor in the firebox of the thermal oxidizer or in the duct... oxidizer, install a gas temperature monitor in the gas stream immediately before the catalyst bed, and if...

40 CFR 63.4967 - What are the requirements for continuous parameter monitoring system installation, operation, and...

Code of Federal Regulations, 2010 CFR

2010-07-01

... section for each gas temperature monitoring device. (i) Locate the temperature sensor in a position that... oxidizer, install a gas temperature monitor in the firebox of the thermal oxidizer or in the duct... oxidizer, install a gas temperature monitor in the gas stream immediately before the catalyst bed, and if...

40 CFR 63.3557 - What are the requirements for continuous parameter monitoring system installation, operation, and...

Code of Federal Regulations, 2011 CFR

2011-07-01

... (ii) of this section for each gas temperature monitoring device. (i) Locate the temperature sensor in... oxidizer, install a gas temperature monitor in the firebox of the thermal oxidizer or in the duct... oxidizer, install a gas temperature monitor according to paragraph (c)(2)(i) or (ii) of this section. (i...

The Monitoring Case of Ground-Based Synthetic Aperture Radar with Frequency Modulated Continuous Wave System

NASA Astrophysics Data System (ADS)

Zhang, H. Y.; Zhai, Q. P.; Chen, L.; Liu, Y. J.; Zhou, K. Q.; Wang, Y. S.; Dou, Y. D.

2017-09-01

The features of the landslide geological disaster are wide distribution, variety, high frequency, high intensity, destructive and so on. It has become a natural disaster with harmful and wide range of influence. The technology of ground-based synthetic aperture radar is a novel deformation monitoring technology developed in recent years. The features of the technology are large monitoring area, high accuracy, long distance without contact and so on. In this paper, fast ground-based synthetic aperture radar (Fast-GBSAR) based on frequency modulated continuous wave (FMCW) system is used to collect the data of Ma Liuzui landslide in Chongqing. The device can reduce the atmospheric errors caused by rapidly changing environment. The landslide deformation can be monitored in severe weather conditions (for example, fog) by Fast-GBSAR with acquisition speed up to 5 seconds per time. The data of Ma Liuzui landslide in Chongqing are analyzed in this paper. The result verifies that the device can monitor landslide deformation under severe weather conditions.

Remote Monitoring for Follow-up of Patients with Cardiac Implantable Electronic Devices

PubMed Central

Morichelli, Loredana; Varma, Niraj

2014-01-01

Follow-up of patients with cardiac implantable electronic devices is challenging due to the increasing number and technical complexity of devices coupled to increasing clinical complexity of patients. Remote monitoring (RM) offers the opportunity to optimise clinic workflow and to improve device monitoring and patient management. Several randomised clinical trials and registries have demonstrated that RM may reduce number of hospital visits, time required for patient follow-up, physician and nurse time, hospital and social costs. Furthermore, patient retention and adherence to follow-up schedule are significantly improved by RM. Continuous wireless monitoring of data stored in the device memory with automatic alerts allows early detection of device malfunctions and of events requiring clinical reaction, such as atrial fibrillation, ventricular arrhythmias and heart failure. Early reaction may improve patient outcome. RM is easy to use and patients showed a high level of acceptance and satisfaction. Implementing RM in daily practice may require changes in clinic workflow. To this purpose, new organisational models have been introduced. In spite of a favourable cost:benefit ratio, RM reimbursement still represents an issue in several European countries. PMID:26835079

Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment.

PubMed

2018-01-01

Type 1 diabetes is a condition in which the pancreas produces little or no insulin. People with type 1 diabetes must manage their blood glucose levels by monitoring the amount of glucose in their blood and administering appropriate amounts of insulin via injection or an insulin pump. Continuous glucose monitoring may be beneficial compared to self-monitoring of blood glucose using a blood glucose meter. It provides insight into a person's blood glucose levels on a continuous basis, and can identify whether blood glucose levels are trending up or down. We conducted a health technology assessment, which included an evaluation of clinical benefit, value for money, and patient preferences related to continuous glucose monitoring. We compared continuous glucose monitoring with self-monitoring of blood glucose using a finger-prick and a blood glucose meter. We performed a systematic literature search for studies published since January 1, 2010. We created a Markov model projecting the lifetime horizon of adults with type 1 diabetes, and performed a budget impact analysis from the perspective of the health care payer. We also conducted interviews and focus group discussions with people who self-manage their type 1 diabetes or support the management of a child with type 1 diabetes. Twenty studies were included in the clinical evidence review. Compared with self-monitoring of blood glucose, continuous glucose monitoring improved the percentage of time patients spent in the target glycemic range by 9.6% (95% confidence interval 8.0-11.2) to 10.0% (95% confidence interval 6.75-13.25) and decreased the number of severe hypoglycemic events.Continuous glucose monitoring was associated with higher costs and small increases in health benefits (quality-adjusted life-years). Incremental cost-effectiveness ratios (ICERs) ranged from $592,206 to $1,108,812 per quality-adjusted life-year gained in analyses comparing four continuous glucose monitoring interventions to usual care. However, the uncertainty around the ICERs was large. The net budget impact of publicly funding continuous glucose monitoring assuming a 20% annual increase in adoption of continuous glucose monitoring would range from $8.5 million in year 1 to $16.2 million in year 5.Patient engagement surrounding the topic of continuous glucose monitoring was robust. Patients perceived that these devices provided important social, emotional, and medical and safety benefits in managing type 1 diabetes, especially in children. Continuous glucose monitoring was more effective than self-monitoring of blood glucose in managing type 1 diabetes for some outcomes, such as time spent in the target glucose range and time spent outside the target glucose range (moderate certainty in this evidence). We were less certain that continuous glucose monitoring would reduce the number of severe hypoglycemic events. Compared with self-monitoring of blood glucose, the costs of continuous glucose monitoring were higher, with only small increases in health benefits. Publicly funding continuous glucose monitoring for the type 1 diabetes population in Ontario would result in additional costs to the health system over the next 5 years. Adult patients and parents of children with type 1 diabetes reported very positive experiences with continuous glucose monitoring. The high ongoing cost of continuous glucose monitoring devices was seen as the greatest barrier to their widespread use.

Continuous Monitoring of Glucose for Type 1 Diabetes: A Health Technology Assessment

PubMed Central

Vandersluis, Stacey; Kabali, Conrad; Djalalov, Sandjar; Gajic-Veljanoski, Olga; Wells, David; Holubowich, Corinne

2018-01-01

Background Type 1 diabetes is a condition in which the pancreas produces little or no insulin. People with type 1 diabetes must manage their blood glucose levels by monitoring the amount of glucose in their blood and administering appropriate amounts of insulin via injection or an insulin pump. Continuous glucose monitoring may be beneficial compared to self-monitoring of blood glucose using a blood glucose meter. It provides insight into a person's blood glucose levels on a continuous basis, and can identify whether blood glucose levels are trending up or down. Methods We conducted a health technology assessment, which included an evaluation of clinical benefit, value for money, and patient preferences related to continuous glucose monitoring. We compared continuous glucose monitoring with self-monitoring of blood glucose using a finger-prick and a blood glucose meter. We performed a systematic literature search for studies published since January 1, 2010. We created a Markov model projecting the lifetime horizon of adults with type 1 diabetes, and performed a budget impact analysis from the perspective of the health care payer. We also conducted interviews and focus group discussions with people who self-manage their type 1 diabetes or support the management of a child with type 1 diabetes. Results Twenty studies were included in the clinical evidence review. Compared with self-monitoring of blood glucose, continuous glucose monitoring improved the percentage of time patients spent in the target glycemic range by 9.6% (95% confidence interval 8.0–11.2) to 10.0% (95% confidence interval 6.75–13.25) and decreased the number of severe hypoglycemic events. Continuous glucose monitoring was associated with higher costs and small increases in health benefits (quality-adjusted life-years). Incremental cost-effectiveness ratios (ICERs) ranged from $592,206 to $1,108,812 per quality-adjusted life-year gained in analyses comparing four continuous glucose monitoring interventions to usual care. However, the uncertainty around the ICERs was large. The net budget impact of publicly funding continuous glucose monitoring assuming a 20% annual increase in adoption of continuous glucose monitoring would range from $8.5 million in year 1 to $16.2 million in year 5. Patient engagement surrounding the topic of continuous glucose monitoring was robust. Patients perceived that these devices provided important social, emotional, and medical and safety benefits in managing type 1 diabetes, especially in children. Conclusions Continuous glucose monitoring was more effective than self-monitoring of blood glucose in managing type 1 diabetes for some outcomes, such as time spent in the target glucose range and time spent outside the target glucose range (moderate certainty in this evidence). We were less certain that continuous glucose monitoring would reduce the number of severe hypoglycemic events. Compared with self-monitoring of blood glucose, the costs of continuous glucose monitoring were higher, with only small increases in health benefits. Publicly funding continuous glucose monitoring for the type 1 diabetes population in Ontario would result in additional costs to the health system over the next 5 years. Adult patients and parents of children with type 1 diabetes reported very positive experiences with continuous glucose monitoring. The high ongoing cost of continuous glucose monitoring devices was seen as the greatest barrier to their widespread use. PMID:29541282

Specification and Verification of Medical Monitoring System Using Petri-nets.

PubMed

Majma, Negar; Babamir, Seyed Morteza

2014-07-01

To monitor the patient behavior, data are collected from patient's body by a medical monitoring device so as to calculate the output using embedded software. Incorrect calculations may endanger the patient's life if the software fails to meet the patient's requirements. Accordingly, the veracity of the software behavior is a matter of concern in the medicine; moreover, the data collected from the patient's body are fuzzy. Some methods have already dealt with monitoring the medical monitoring devices; however, model based monitoring fuzzy computations of such devices have been addressed less. The present paper aims to present synthesizing a fuzzy Petri-net (FPN) model to verify behavior of a sample medical monitoring device called continuous infusion insulin (INS) because Petri-net (PN) is one of the formal and visual methods to verify the software's behavior. The device is worn by the diabetic patients and then the software calculates the INS dose and makes a decision for injection. The input and output of the infusion INS software are not crisp in the real world; therefore, we present them in fuzzy variables. Afterwards, we use FPN instead of clear PN to model the fuzzy variables. The paper follows three steps to synthesize an FPN to deal with verification of the infusion INS device: (1) Definition of fuzzy variables, (2) definition of fuzzy rules and (3) design of the FPN model to verify the software behavior.

40 CFR 63.5895 - How do I monitor and collect data to demonstrate continuous compliance?

Code of Federal Regulations, 2014 CFR

2014-07-01

... 40 Protection of Environment 13 2014-07-01 2014-07-01 false How do I monitor and collect data to... data to demonstrate continuous compliance? (a) During production, you must collect and keep a record of data as indicated in 40 CFR part 63, subpart SS, if you are using an add-on control device. (b) You...

40 CFR 63.5895 - How do I monitor and collect data to demonstrate continuous compliance?

Code of Federal Regulations, 2013 CFR

2013-07-01

... 40 Protection of Environment 13 2013-07-01 2012-07-01 true How do I monitor and collect data to... data to demonstrate continuous compliance? (a) During production, you must collect and keep a record of data as indicated in 40 CFR part 63, subpart SS, if you are using an add-on control device. (b) You...

40 CFR Table 24 to Subpart Uuu of... - Continuous Monitoring Systems for Inorganic HAP Emissions From Catalytic Reforming Units

Code of Federal Regulations, 2010 CFR

2010-07-01

... Inorganic HAP Emissions From Catalytic Reforming Units As stated in § 63.1567(b)(1), you shall meet each requirement in the following table that applies to you. If you use this type of control device for your vent . . . You shall install and operate this type of continuous monitoring system . . . 1. Wet scrubber...

40 CFR 503.46 - Frequency of monitoring.

Code of Federal Regulations, 2010 CFR

2010-07-01

... arsenic, cadmium, chromium, lead, and nickel in sewage sludge fed to a sewage sludge incinerator shall be..., cadmium, chromium, lead, and nickel. (b) Total hydrocarbons, oxygen concentration, information to... monitored continuously. (c) Air pollution control device operating parameters.For sewage sludge incinerators...

40 CFR 503.46 - Frequency of monitoring.

Code of Federal Regulations, 2011 CFR

2011-07-01

... arsenic, cadmium, chromium, lead, and nickel in sewage sludge fed to a sewage sludge incinerator shall be..., cadmium, chromium, lead, and nickel. (b) Total hydrocarbons, oxygen concentration, information to... monitored continuously. (c) Air pollution control device operating parameters.For sewage sludge incinerators...

A Brief Review of Non-invasive Monitoring of Respiratory Condition for Extubated Patients with or at Risk for Obstructive Sleep Apnea after Surgery

PubMed Central

Zhang, Xuezheng; Kassem, Mahmoud Attia Mohamed; Zhou, Ying; Shabsigh, Muhammad; Wang, Quanguang; Xu, Xuzhong

2017-01-01

Obstructive sleep apnea (OSA) is one of the important risk factors contributing to postoperative airway complications. OSA alters the respiratory physiology and increases the sensitivity of muscle tone of the upper airway after surgery to residual anesthetic medication. In addition, the prevalence of OSA was reported to be much higher among surgical patients than the general population. Therefore, appropriate monitoring to detect early respiratory impairment in postoperative extubated patients with possible OSA is challenging. Based on the comprehensive clinical observation, several equipment have been used for monitoring the respiratory conditions of OSA patients after surgery, including the continuous pulse oximetry, capnography, photoplethysmography (PPG), and respiratory volume monitor (RVM). To date, there has been no consensus on the most suitable device as a recommended standard of care. In this review, we describe the advantages and disadvantages of some possible monitoring strategies under certain clinical conditions. According to the literature, the continuous pulse oximetry, with its high sensitivity, is still the most widely used device. It is also cost-effective and convenient to use but has low specificity and does not reflect ventilation. Capnography is the most widely used device for detection of hypoventilation, but it may not provide reliable data for extubated patients. Even normal capnography cannot exclude the existence of hypoxia. PPG shows the state of both ventilation and oxygenation, but its sensitivity needs further improvement. RVM provides real-time detection of hypoventilation, quantitative precise demonstration of respiratory rate, tidal volume, and MV for extubated patients, but no reflection of oxygenation. Altogether, the sole use of any of these devices is not ideal for monitoring of extubated patients with or at risk for OSA after surgery. However, we expect that the combined use of continuous pulse oximetry and RVM may be promising for these patients due to their complementary function, which need further study. PMID:28337439

40 CFR 63.9306 - What are my continuous parameter monitoring system (CPMS) installation, operation, and...

Code of Federal Regulations, 2010 CFR

2010-07-01

... section for each gas temperature monitoring device. (i) Locate the temperature sensor in a position that... temperature sensor system from electromagnetic interference and chemical contaminants. (iv) If a gas...) of this section. (1) For a thermal oxidizer, install a gas temperature monitor in the firebox of the...

40 CFR 63.9306 - What are my continuous parameter monitoring system (CPMS) installation, operation, and...

Code of Federal Regulations, 2011 CFR

2011-07-01

... section for each gas temperature monitoring device. (i) Locate the temperature sensor in a position that... temperature sensor system from electromagnetic interference and chemical contaminants. (iv) If a gas...) of this section. (1) For a thermal oxidizer, install a gas temperature monitor in the firebox of the...

A hazard of the Intraflo continuous flush system.

PubMed

Schwartz, A J; Stoner, B B; Jobes, D R

1977-01-01

Patency of pressure sensing systems can be provided by the Intraflow Continuous Flush System (Sorenson Research Company, Salt Lake City, UT 84115). This device allows continuous flow of flush solution through a regulatory valve while preventing transmission of the high pressure of the flush solution. The case presented describes the recognition of a false elevation of a monitored pressure secondary to the malfunction of the Intraflo regulatory valve. Elimination of the flush solution high pressure during monitoring prevents inappropriate data collection.

40 CFR 63.4568 - What are the requirements for continuous parameter monitoring system installation, operation, and...

Code of Federal Regulations, 2010 CFR

2010-07-01

..., install a gas temperature monitor in the firebox of the thermal oxidizer or in the duct immediately... gas temperature monitors upstream and/or downstream of the catalyst bed as required in § 63.3967(b... (a) and (c)(3)(i) through (v) of this section for each gas temperature monitoring device. (i) Locate...

40 CFR 63.4568 - What are the requirements for continuous parameter monitoring system installation, operation, and...

Code of Federal Regulations, 2011 CFR

2011-07-01

..., install a gas temperature monitor in the firebox of the thermal oxidizer or in the duct immediately... gas temperature monitors upstream and/or downstream of the catalyst bed as required in § 63.3967(b... (a) and (c)(3)(i) through (v) of this section for each gas temperature monitoring device. (i) Locate...

The Timer-Logger-Communicator for Continuous, Mobile Measurement of Wheelchair Pressure Reliefs

PubMed Central

Grip, Jeffrey C.; Merbitz, Charles T.

1985-01-01

A recently developed device which provides continuous, direct monitoring of the pressure-relief performance of persons confined to wheelchairs is reported. A custom portable computer records the data, which is transferred for analysis to an Apple IIe. The mobile computer can also signal the patient to relieve pressure based on preset criteria and the patient's performance. Teaching lift-offs to prevent ischial pressure sores is the object. Data collected with the device are used clinically and for research. Examples of such data are presented. The benefits of the device are reviewed.

A novel low-complexity digital filter design for wearable ECG devices

PubMed Central

Mehrnia, Alireza

2017-01-01

Wearable and implantable Electrocardiograph (ECG) devices are becoming prevailing tools for continuous real-time personal health monitoring. The ECG signal can be contaminated by various types of noise and artifacts (e.g., powerline interference, baseline wandering) that must be removed or suppressed for accurate ECG signal processing. Limited device size, power consumption and cost are critical issues that need to be carefully considered when designing any portable health monitoring device, including a battery-powered ECG device. This work presents a novel low-complexity noise suppression reconfigurable finite impulse response (FIR) filter structure for wearable ECG and heart monitoring devices. The design relies on a recently introduced optimally-factored FIR filter method. The new filter structure and several of its useful features are presented in detail. We also studied the hardware complexity of the proposed structure and compared it with the state-of-the-art. The results showed that the new ECG filter has a lower hardware complexity relative to the state-of-the-art ECG filters. PMID:28384272

A novel low-complexity digital filter design for wearable ECG devices.

PubMed

Asgari, Shadnaz; Mehrnia, Alireza

2017-01-01

Wearable and implantable Electrocardiograph (ECG) devices are becoming prevailing tools for continuous real-time personal health monitoring. The ECG signal can be contaminated by various types of noise and artifacts (e.g., powerline interference, baseline wandering) that must be removed or suppressed for accurate ECG signal processing. Limited device size, power consumption and cost are critical issues that need to be carefully considered when designing any portable health monitoring device, including a battery-powered ECG device. This work presents a novel low-complexity noise suppression reconfigurable finite impulse response (FIR) filter structure for wearable ECG and heart monitoring devices. The design relies on a recently introduced optimally-factored FIR filter method. The new filter structure and several of its useful features are presented in detail. We also studied the hardware complexity of the proposed structure and compared it with the state-of-the-art. The results showed that the new ECG filter has a lower hardware complexity relative to the state-of-the-art ECG filters.

40 CFR 63.9340 - How do I demonstrate continuous compliance with the emission limitations?

Code of Federal Regulations, 2012 CFR

2012-07-01

... with §§ 63.6(e) and 63.7(e)(1), deviations that occur during a period of SSM of control devices and... deviations that occur during a period of SSM of control devices and associated monitoring equipment are...

40 CFR 63.9340 - How do I demonstrate continuous compliance with the emission limitations?

Code of Federal Regulations, 2013 CFR

2013-07-01

... with §§ 63.6(e) and 63.7(e)(1), deviations that occur during a period of SSM of control devices and... deviations that occur during a period of SSM of control devices and associated monitoring equipment are...

40 CFR 63.9340 - How do I demonstrate continuous compliance with the emission limitations?

Code of Federal Regulations, 2014 CFR

2014-07-01

... with §§ 63.6(e) and 63.7(e)(1), deviations that occur during a period of SSM of control devices and... deviations that occur during a period of SSM of control devices and associated monitoring equipment are...

40 CFR 63.9340 - How do I demonstrate continuous compliance with the emission limitations?

Code of Federal Regulations, 2010 CFR

2010-07-01

... with §§ 63.6(e) and 63.7(e)(1), deviations that occur during a period of SSM of control devices and... deviations that occur during a period of SSM of control devices and associated monitoring equipment are...

40 CFR 63.9340 - How do I demonstrate continuous compliance with the emission limitations?

Code of Federal Regulations, 2011 CFR

2011-07-01

... with §§ 63.6(e) and 63.7(e)(1), deviations that occur during a period of SSM of control devices and... deviations that occur during a period of SSM of control devices and associated monitoring equipment are...

21 CFR 870.2910 - Radiofrequency physiological signal transmitter and receiver.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Radiofrequency physiological signal transmitter and receiver. 870.2910 Section 870.2910 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring...

21 CFR 870.2910 - Radiofrequency physiological signal transmitter and receiver.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Radiofrequency physiological signal transmitter and receiver. 870.2910 Section 870.2910 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED) MEDICAL DEVICES CARDIOVASCULAR DEVICES Cardiovascular Monitoring...

A reference architecture for telemonitoring.

PubMed

Clarke, Malcolm

2004-01-01

The Telecare Interactive Continuous Monitoring System exploits GPRS to provide an ambulatory device that monitors selected vital signs on a continuous basis. Alarms are sent when parameters fall outside preset limits, and accompanying physiological data may also be transmitted. The always-connected property of GPRS allows continuous interactive control of the device and its sensors, permitting changes to monitoring parameters or even enabling continuous monitoring of a sensor in emergency. A new personal area network (PAN) has been developed to support short-range wireless connection to sensors worn on the body including ECG and finger worn SpO2. Most notable is use of ultra low radio frequency to reduce power to minimum. The system has been designed to use a hierarchical architecture for sensors and "derived" signals, such as HR from ECG, so that each can be independently controlled and managed. Sensors are treated as objects, and functions are defined to control aspects of behaviour. These are refined in order to define a generic set of abstract functions to handle the majority of functions, leaving a minimum of sensor specific commands. The intention is to define a reference architecture in order to research the functionality and system architecture of a telemonitoring system. The Telecare project is funded through a grant from the European Commission (IST programme).

Home oxygen therapy: re-thinking the role of devices.

PubMed

Melani, Andrea S; Sestini, Piersante; Rottoli, Paola

2018-03-01

A range of devices are available for delivering and monitoring home oxygen therapy (HOT). Guidelines do not give indications for the choice of the delivery device but recommend the use of an ambulatory system in subjects on HOT whilst walking. Areas covered: We provide a clinical overview of HOT and review traditional and newer delivery and monitoring devices for HOT. Despite relevant technology advancements, clinicians, faced with many challenges when they prescribe oxygen therapy, often remain familiar to traditional devices and continuous flow delivery of oxygen. Some self-filling delivery-less devices could increase the users' level of independence with ecological advantage and, perhaps, reduced cost. Some newer portable oxygen concentrators are being available, but more work is needed to understand their performances in different diseases and clinical settings. Pulse oximetry has gained large diffusion worldwide and some models permit long-term monitoring. Some closed-loop portable monitoring devices are also able to adjust oxygen flow automatically in accordance with the different needs of everyday life. This might help to improve adherence and the practice of proper oxygen titration that has often been omitted because difficult to perform and time-consuming. Expert commentary: The prescribing physicians should know the characteristics of newer devices and use technological advancements to improve the practice of HOT.

Smart wearable body sensors for patient self-assessment and monitoring.

PubMed

Appelboom, Geoff; Camacho, Elvis; Abraham, Mickey E; Bruce, Samuel S; Dumont, Emmanuel Lp; Zacharia, Brad E; D'Amico, Randy; Slomian, Justin; Reginster, Jean Yves; Bruyère, Olivier; Connolly, E Sander

2014-01-01

Innovations in mobile and electronic healthcare are revolutionizing the involvement of both doctors and patients in the modern healthcare system by extending the capabilities of physiological monitoring devices. Despite significant progress within the monitoring device industry, the widespread integration of this technology into medical practice remains limited. The purpose of this review is to summarize the developments and clinical utility of smart wearable body sensors. We reviewed the literature for connected device, sensor, trackers, telemonitoring, wireless technology and real time home tracking devices and their application for clinicians. Smart wearable sensors are effective and reliable for preventative methods in many different facets of medicine such as, cardiopulmonary, vascular, endocrine, neurological function and rehabilitation medicine. These sensors have also been shown to be accurate and useful for perioperative monitoring and rehabilitation medicine. Although these devices have been shown to be accurate and have clinical utility, they continue to be underutilized in the healthcare industry. Incorporating smart wearable sensors into routine care of patients could augment physician-patient relationships, increase the autonomy and involvement of patients in regards to their healthcare and will provide for novel remote monitoring techniques which will revolutionize healthcare management and spending.

Development of a thick film PZT foil sensor for use in structural health monitoring applications.

PubMed

Pickwell, Andrew J; Dorey, Robert A; Mba, David

2013-02-01

Acoustic emission (AE) monitoring is a technique of growing interest in the field of nondestructive testing (NDT). The use of AE devices to monitor the health of structural components is currently limited by the cost of AE equipment, which prohibits the permanent placement of AE devices on structures for the purposes of continuous monitoring and the monitoring of areas with limited access. Micro electromechanical systems (MEMS) can provide solutions to these problems. We present the manufacture of a 4.4-μm-thick lead zirconate titanate (PZT) film on a 110-μm-thick titanium foil substrate for use as an AE sensor. The thick-film sensor is benchmarked against commercially available AE sensors in static and dynamic monitoring applications. The thick-film AE device is found to perform well in the detection of AE in static applications. A low signal-to-noise ratio is found to prohibit the detection of AE in a dynamic application.

Rapid, low cost prototyping of transdermal devices for personal healthcare monitoring.

PubMed

Sharma, Sanjiv; Saeed, Anwer; Johnson, Christopher; Gadegaard, Nikolaj; Cass, Anthony Eg

2017-04-01

The next generation of devices for personal healthcare monitoring will comprise molecular sensors to monitor analytes of interest in the skin compartment. Transdermal devices based on microneedles offer an excellent opportunity to explore the dynamics of molecular markers in the interstitial fluid, however good acceptability of these next generation devices will require several technical problems associated with current commercially available wearable sensors to be overcome. These particularly include reliability, comfort and cost. An essential pre-requisite for transdermal molecular sensing devices is that they can be fabricated using scalable technologies which are cost effective. We present here a minimally invasive microneedle array as a continuous monitoring platform technology. Method for scalable fabrication of these structures is presented. The microneedle arrays were characterised mechanically and were shown to penetrate human skin under moderate thumb pressure. They were then functionalised and evaluated as glucose, lactate and theophylline biosensors. The results suggest that this technology can be employed in the measurement of metabolites, therapeutic drugs and biomarkers and could have an important role to play in the management of chronic diseases.

Glucose Biosensors: An Overview of Use in Clinical Practice

PubMed Central

Yoo, Eun-Hyung; Lee, Soo-Youn

2010-01-01

Blood glucose monitoring has been established as a valuable tool in the management of diabetes. Since maintaining normal blood glucose levels is recommended, a series of suitable glucose biosensors have been developed. During the last 50 years, glucose biosensor technology including point-of-care devices, continuous glucose monitoring systems and noninvasive glucose monitoring systems has been significantly improved. However, there continues to be several challenges related to the achievement of accurate and reliable glucose monitoring. Further technical improvements in glucose biosensors, standardization of the analytical goals for their performance, and continuously assessing and training lay users are required. This article reviews the brief history, basic principles, analytical performance, and the present status of glucose biosensors in the clinical practice. PMID:22399892

Noninvasive monitoring of blood pressure using optical Ballistocardiography and Photoplethysmograph approaches.

PubMed

Chen, Zhihao; Yang, Xiufeng; Teo, Ju Teng; Ng, Soon Huat

2013-01-01

A new all optical method for long term and continuous blood pressure measurement and monitoring without using cuffs is proposed by using Ballistocardiography (BCG) and Photoplethysmograph (PPG). Based on BCG signal and PPG signal, a time delay between these two signals is obtained to calculate both systolic blood pressure and diastolic blood pressure via linear regression analysis. The fabricated noninvasive blood pressure monitoring device consists of a fiber sensor mat to measure BCG signal and a SpO2 sensor to measure PPG signal. A commercial digital oscillometric blood pressure meter is used to obtain reference values and for calibration. It has been found that by comparing with the reference device, our prototype has typical means and standard deviations of 9+/-5.6 mmHg for systolic blood pressure, 1.8+/-1.3 mmHg for diastolic blood pressure and 0.6+/-0.9 bpm for pulse rate, respectively. If the fiber optic SpO2 probe is used, this new all fiber cuffless noninvasive blood pressure monitoring device will truly be a MRI safe blood pressure measurement and monitoring device.

Estimating Plasma Glucose from Interstitial Glucose: The Issue of Calibration Algorithms in Commercial Continuous Glucose Monitoring Devices

PubMed Central

Rossetti, Paolo; Bondia, Jorge; Vehí, Josep; Fanelli, Carmine G.

2010-01-01

Evaluation of metabolic control of diabetic people has been classically performed measuring glucose concentrations in blood samples. Due to the potential improvement it offers in diabetes care, continuous glucose monitoring (CGM) in the subcutaneous tissue is gaining popularity among both patients and physicians. However, devices for CGM measure glucose concentration in compartments other than blood, usually the interstitial space. This means that CGM need calibration against blood glucose values, and the accuracy of the estimation of blood glucose will also depend on the calibration algorithm. The complexity of the relationship between glucose dynamics in blood and the interstitial space, contrasts with the simplistic approach of calibration algorithms currently implemented in commercial CGM devices, translating in suboptimal accuracy. The present review will analyze the issue of calibration algorithms for CGM, focusing exclusively on the commercially available glucose sensors. PMID:22163505

Review of traffic monitoring factor groupings and the determination of seasonal adjustment factors for cars and trucks.

DOT National Transportation Integrated Search

2009-11-01

One of the most common traffic volume parameters reported by statewide traffic monitoring programs is annual average daily traffic (AADT). Departments of Transportation (DOT) and other state agencies use a series of continuous vehicle detection devic...

A Device for Fetal Monitoring by Means of Control Over Cardiovascular Parameters Based on Acoustic Data

NASA Astrophysics Data System (ADS)

Khokhlova, L. A.; Seleznev, A. I.; Zhdanov, D. S.; Zemlyakov, I. Yu; Kiseleva, E. Yu

2016-01-01

The problem of monitoring fetal health is topical at the moment taking into account a reduction in the level of fertile-age women's health and changes in the concept of perinatal medicine with reconsideration of live birth criteria. Fetal heart rate monitoring is a valuable means of assessing fetal health during pregnancy. The routine clinical measurements are usually carried out by the means of ultrasound cardiotocography. Although the cardiotocography monitoring provides valuable information on the fetal health status, the high quality ultrasound devices are expensive, they are not available for home care use. The recommended number of measurement is also limited. The passive and fully non-invasive acoustic recording provides an alternative low-cost measurement method. The article describes a device for fetal and maternal health monitoring by analyzing the frequency and periodicity of heart beats by means of acoustic signal received on the maternal abdomen. Based on the usage of this device a phonocardiographic fetal telemedicine system, which will allow to reduce the antenatal fetal mortality rate significantly due to continuous monitoring over the state of fetus regardless of mother's location, can be built.

Analyzing the value of monitoring duodenal mucosal perfusion using photoplethysmography.

PubMed

Fink, Mitchell P

2014-10-13

Photoplethysmography (PPG) is a technique that permits noninvasive measurement of changes in the volume of tissues. A novel device uses PPG to assess changes in duodenal mucosal perfusion. When tested in septic piglets, data obtained using this device correlate with the blood lactate concentration and duodenal serosal microvascular blood flow as measured with a laser Doppler flowmeter. This new PPG-based approach for continuously monitoring gut mucosal perfusion warrants further development, leading to prospective clinical trials in patients.

78 FR 25308 - Proposed Collection; Comment Request; Coal Mine Dust Sampling Devices

Federal Register 2010, 2011, 2012, 2013, 2014

2013-04-30

...; Coal Mine Dust Sampling Devices AGENCY: Mine Safety and Health Administration, Labor. ACTION: 60-Day.... Background Continuous Personal Dust Monitors (CPDMs) determine the concentration of respirable dust in coal mines. CPDMs must be designed and constructed for coal miners to wear and operate without impeding their...

Evaluation of a minimally invasive glucose biosensor for continuous tissue monitoring.

PubMed

Sharma, Sanjiv; Huang, Zhenyi; Rogers, Michelle; Boutelle, Martyn; Cass, Anthony E G

2016-11-01

We describe here a minimally invasive glucose biosensor based on a microneedle array electrode fabricated from an epoxy-based negative photoresist (SU8 50) and designed for continuous measurement in the dermal compartment with minimal pain. These minimally invasive, continuous monitoring sensor devices (MICoMS) were produced by casting the structures in SU8 50, crosslinking and then metallising them with platinum or silver to obtain the working and reference electrodes, respectively. The metallised microneedle array electrodes were subsequently functionalised by entrapping glucose oxidase in electropolymerised polyphenol (PP) film. Sensor performance in vitro showed that glucose concentrations down to 0.5 mM could be measured with a response times (T 90 ) of 15 s. The effect of sterilisation by Co60 irradiation was evaluated. In preparation for further clinical studies, these sensors were tested in vivo in a healthy volunteer for a period of 3-6 h. The sensor currents were compared against point measurements obtained with a commercial capillary blood glucometer. The epoxy MICoMS devices showed currents values that could be correlated with these. Graphical Abstract Microneedle arrays for continuous glucose monitoring in dermal interstitial fluid.

40 CFR 63.114 - Process vent provisions-monitoring requirements.

Code of Federal Regulations, 2014 CFR

2014-07-01

... but not limited to a thermocouple, ultra-violet beam sensor, or infrared sensor) capable of... accurately. (1) Where an incinerator is used, a temperature monitoring device equipped with a continuous recorder is required. (i) Where an incinerator other than a catalytic incinerator is used, a temperature...

40 CFR 63.114 - Process vent provisions-monitoring requirements.

Code of Federal Regulations, 2012 CFR

2012-07-01

... but not limited to a thermocouple, ultra-violet beam sensor, or infrared sensor) capable of... accurately. (1) Where an incinerator is used, a temperature monitoring device equipped with a continuous recorder is required. (i) Where an incinerator other than a catalytic incinerator is used, a temperature...

40 CFR 63.114 - Process vent provisions-monitoring requirements.

Code of Federal Regulations, 2013 CFR

2013-07-01

... but not limited to a thermocouple, ultra-violet beam sensor, or infrared sensor) capable of... accurately. (1) Where an incinerator is used, a temperature monitoring device equipped with a continuous recorder is required. (i) Where an incinerator other than a catalytic incinerator is used, a temperature...

In-situ continuous water monitoring system

DOEpatents

Thompson, Cyril V.; Wise, Marcus B.

1998-01-01

An in-situ continuous liquid monitoring system for continuously analyzing volatile components contained in a water source comprises: a carrier gas supply, an extraction container and a mass spectrometer. The carrier gas supply continuously supplies the carrier gas to the extraction container and is mixed with a water sample that is continuously drawn into the extraction container by the flow of carrier gas into the liquid directing device. The carrier gas continuously extracts the volatile components out of the water sample. The water sample is returned to the water source after the volatile components are extracted from it. The extracted volatile components and the carrier gas are delivered continuously to the mass spectrometer and the volatile components are continuously analyzed by the mass spectrometer.

In-situ continuous water monitoring system

DOEpatents

Thompson, C.V.; Wise, M.B.

1998-03-31

An in-situ continuous liquid monitoring system for continuously analyzing volatile components contained in a water source comprises: a carrier gas supply, an extraction container and a mass spectrometer. The carrier gas supply continuously supplies the carrier gas to the extraction container and is mixed with a water sample that is continuously drawn into the extraction container by the flow of carrier gas into the liquid directing device. The carrier gas continuously extracts the volatile components out of the water sample. The water sample is returned to the water source after the volatile components are extracted from it. The extracted volatile components and the carrier gas are delivered continuously to the mass spectrometer and the volatile components are continuously analyzed by the mass spectrometer. 2 figs.

Accuracy of continuous noninvasive arterial pressure monitoring in living-liver donors during transplantation.

PubMed

Araz, Coskun; Zeyneloglu, Pinar; Pirat, Arash; Veziroglu, Nukhet; Camkiran Firat, Aynur; Arslan, Gulnaz

2015-04-01

Hemodynamic monitoring is vital during liver transplant surgeries because distinct hemodynamic changes are expected. The continuous noninvasive arterial pressure (CNAP) monitor is a noninvasive device for continuous arterial pressure measurement by a tonometric method. This study compared continuous noninvasive arterial pressure monitoring with invasive direct arterial pressure monitoring in living-liver donors during transplant. There were 40 patients analyzed while undergoing hepatic lobectomy for liver transplant. Invasive pressure monitoring was established at the radial artery and continuous noninvasive arterial pressure monitoring using a finger sensor was recorded simultaneously from the contralateral arm. Systolic, diastolic, and mean arterial pressures from the 2 methods were compared. Correlation between the 2 methods was calculated. A total of 5433 simultaneous measurements were obtained. For systolic arterial blood pressure, 55% continuous noninvasive arterial pressure measurements were within 10% direct arterial measurement; the correlation was 0.479, continuous noninvasive arterial pressure bias was -0.3 mm Hg, and limits of agreement were 32.0 mm Hg. For diastolic arterial blood pressure, 50% continuous noninvasive arterial pressure measurements were within 10% direct arterial measurement; the correlation was 0.630, continuous noninvasive arterial pressure bias was -0.4 mm Hg, and limits of agreement were 21.1 mm Hg. For mean arterial blood pressure, 60% continuous noninvasive arterial pressure measurements were within 10% direct arterial measurement; the correlation was 0.692, continuous noninvasive arterial pressure bias was +0.4 mm Hg, and limits of agreement were 20.8 mm Hg. The 2 monitoring techniques did not show acceptable agreement. Our results suggest that continuous noninvasive arterial pressure monitoring is not equivalent to invasive arterial pressure monitoring in donors during living-donor liver transplant.

Continuous and Cuffless Blood Pressure Monitoring Based on ECG and SpO2 Signals ByUsing Microsoft Visual C Sharp.

PubMed

Younessi Heravi, M A; Khalilzadeh, M A; Joharinia, S

2014-03-01

One of the main problems especially in operating room and monitoring devices is measurement of Blood Pressure (BP) by sphygmomanometer cuff. Objective :In this study we designed a new method to measure BP changes continuously for detecting information between cuff inflation times by using vital signals in monitoring devices. This will be achieved by extraction of the time difference between each cardiac cycle and a relative pulse wave. Finger pulse and ECG signals in lead I were recorded by a monitoring device. The output of monitoring device wasinserted in a computer by serial network communication. A software interface (Microsoft Visual C#.NET ) was used to display and process the signals in the computer. Time difference between each cardiac cycle and pulse signal was calculated throughout R wave detection in ECG and peak of pulse signal by the software. The relation between time difference in two waves and BP was determined then the coefficients of equation were obtained in different physical situations. The results of estimating BP were compared with the results of sphygmomanometer method and the error rate was calculated. In this study, 25 subjects participated among them 15 were male and 10 were female. The results showed that BP was linearly related to time difference. Average of coefficient correlation was 0.9±0.03 for systolic and 0.82±0.04 for diastolic blood pressure. The highest error percentage was calculated 8% for male and 11% for female group. Significant difference was observed between the different physical situation and arm movement changes. The relationship between time difference and age was estimated in a linear relationship with a correlation coefficient of 0.76. By determining linear relation values with high accuracy, BP can be measured with insignificant error. Therefore it can be suggested as a new method to measure the blood pressure continuously.

Influence of Insulation Monitoring Devices on the Operation of DC Control Circuits

DOE Office of Scientific and Technical Information (OSTI.GOV)

Olszowiec, Piotr, E-mail: olpio@o2.pl

The insulation level of DC control circuits is an important safety-critical factor and, thus, should be subject to continuous and periodic monitoring. The methods used for monitoring the insulation in live circuits may, however, disturb the reliable operation of control relays. The risks of misoperation and failure to reset of relays posed by the operation of various insulation monitoring and fault location systems are evaluated.

Advanced Pulse Oximetry System for Remote Monitoring and Management

PubMed Central

Pak, Ju Geon; Park, Kee Hyun

2012-01-01

Pulse oximetry data such as saturation of peripheral oxygen (SpO2) and pulse rate are vital signals for early diagnosis of heart disease. Therefore, various pulse oximeters have been developed continuously. However, some of the existing pulse oximeters are not equipped with communication capabilities, and consequently, the continuous monitoring of patient health is restricted. Moreover, even though certain oximeters have been built as network models, they focus on exchanging only pulse oximetry data, and they do not provide sufficient device management functions. In this paper, we propose an advanced pulse oximetry system for remote monitoring and management. The system consists of a networked pulse oximeter and a personal monitoring server. The proposed pulse oximeter measures a patient's pulse oximetry data and transmits the data to the personal monitoring server. The personal monitoring server then analyzes the received data and displays the results to the patient. Furthermore, for device management purposes, operational errors that occur in the pulse oximeter are reported to the personal monitoring server, and the system configurations of the pulse oximeter, such as thresholds and measurement targets, are modified by the server. We verify that the proposed pulse oximetry system operates efficiently and that it is appropriate for monitoring and managing a pulse oximeter in real time. PMID:22933841

Advanced pulse oximetry system for remote monitoring and management.

PubMed

Pak, Ju Geon; Park, Kee Hyun

2012-01-01

Pulse oximetry data such as saturation of peripheral oxygen (SpO(2)) and pulse rate are vital signals for early diagnosis of heart disease. Therefore, various pulse oximeters have been developed continuously. However, some of the existing pulse oximeters are not equipped with communication capabilities, and consequently, the continuous monitoring of patient health is restricted. Moreover, even though certain oximeters have been built as network models, they focus on exchanging only pulse oximetry data, and they do not provide sufficient device management functions. In this paper, we propose an advanced pulse oximetry system for remote monitoring and management. The system consists of a networked pulse oximeter and a personal monitoring server. The proposed pulse oximeter measures a patient's pulse oximetry data and transmits the data to the personal monitoring server. The personal monitoring server then analyzes the received data and displays the results to the patient. Furthermore, for device management purposes, operational errors that occur in the pulse oximeter are reported to the personal monitoring server, and the system configurations of the pulse oximeter, such as thresholds and measurement targets, are modified by the server. We verify that the proposed pulse oximetry system operates efficiently and that it is appropriate for monitoring and managing a pulse oximeter in real time.

Annual update: drugs, diagnostics and devices.

PubMed

Berardinelli, Candace; Kupecz, Deborah

2003-03-01

As NPs continue to play an important role in health care as administers of prescriptions, the value of reviewing the latest Food and Drug Administration (FDA) approvals for new drugs and devices is immeasurable. In 2002, the FDA approved several new drugs and devices, as well as monitored previously approved drugs for adverse reactions and untoward events. This article provides a brief review of relevant primary care topics.

Accuracy of a continuous noninvasive hemoglobin monitor in intensive care unit patients.

PubMed

Frasca, Denis; Dahyot-Fizelier, Claire; Catherine, Karen; Levrat, Quentin; Debaene, Bertrand; Mimoz, Olivier

2011-10-01

To determine whether noninvasive hemoglobin measurement by Pulse CO-Oximetry could provide clinically acceptable absolute and trend accuracy in critically ill patients, compared to other invasive methods of hemoglobin assessment available at bedside and the gold standard, the laboratory analyzer. Prospective study. Surgical intensive care unit of a university teaching hospital. Sixty-two patients continuously monitored with Pulse CO-Oximetry (Masimo Radical-7). None. Four hundred seventy-one blood samples were analyzed by a point-of-care device (HemoCue 301), a satellite lab CO-Oximeter (Siemens RapidPoint 405), and a laboratory hematology analyzer (Sysmex XT-2000i), which was considered the reference device. Hemoglobin values reported from the invasive methods were compared to the values reported by the Pulse CO-Oximeter at the time of blood draw. When the case-to-case variation was assessed, the bias and limits of agreement were 0.0±1.0 g/dL for the Pulse CO-Oximeter, 0.3±1.3g/dL for the point-of-care device, and 0.9±0.6 g/dL for the satellite lab CO-Oximeter compared to the reference method. Pulse CO-Oximetry showed similar trend accuracy as satellite lab CO-Oximetry, whereas the point-of-care device did not appear to follow the trend of the laboratory analyzer as well as the other test devices. When compared to laboratory reference values, hemoglobin measurement with Pulse CO-Oximetry has absolute accuracy and trending accuracy similar to widely used, invasive methods of hemoglobin measurement at bedside. Hemoglobin measurement with pulse CO-Oximetry has the additional advantages of providing continuous measurements, noninvasively, which may facilitate hemoglobin monitoring in the intensive care unit.

40 CFR 63.9307 - What are my continuous emissions monitoring system installation, operation, and maintenance...

Code of Federal Regulations, 2013 CFR

2013-07-01

... install, operate, and maintain each CEMS to monitor carbon monoxide (CO) or total hydrocarbons (THC) and... emission control device. (b) To comply with the CO or THC percent reduction emission limitation, you may install, operate, and maintain a CEMS to monitor CO or THC and O2 at both the inlet and the outlet of the...

40 CFR 63.9307 - What are my continuous emissions monitoring system installation, operation, and maintenance...

Code of Federal Regulations, 2014 CFR

2014-07-01

... install, operate, and maintain each CEMS to monitor carbon monoxide (CO) or total hydrocarbons (THC) and... emission control device. (b) To comply with the CO or THC percent reduction emission limitation, you may install, operate, and maintain a CEMS to monitor CO or THC and O2 at both the inlet and the outlet of the...

40 CFR 63.9307 - What are my continuous emissions monitoring system installation, operation, and maintenance...

Code of Federal Regulations, 2012 CFR

2012-07-01

... install, operate, and maintain each CEMS to monitor carbon monoxide (CO) or total hydrocarbons (THC) and... emission control device. (b) To comply with the CO or THC percent reduction emission limitation, you may install, operate, and maintain a CEMS to monitor CO or THC and O2 at both the inlet and the outlet of the...

40 CFR 63.9307 - What are my continuous emissions monitoring system installation, operation, and maintenance...

Code of Federal Regulations, 2010 CFR

2010-07-01

... install, operate, and maintain each CEMS to monitor carbon monoxide (CO) or total hydrocarbons (THC) and... emission control device. (b) To comply with the CO or THC percent reduction emission limitation, you may install, operate, and maintain a CEMS to monitor CO or THC and O2 at both the inlet and the outlet of the...

40 CFR 63.9307 - What are my continuous emissions monitoring system installation, operation, and maintenance...

Code of Federal Regulations, 2011 CFR

2011-07-01

... install, operate, and maintain each CEMS to monitor carbon monoxide (CO) or total hydrocarbons (THC) and... emission control device. (b) To comply with the CO or THC percent reduction emission limitation, you may install, operate, and maintain a CEMS to monitor CO or THC and O2 at both the inlet and the outlet of the...

Continuous positive airway pressure: Physiology and comparison of devices.

PubMed

Gupta, Samir; Donn, Steven M

2016-06-01

Nasal continuous positive airway pressure (CPAP) is increasingly used for respiratory support in preterm babies at birth and after extubation from mechanical ventilation. Various CPAP devices are available for use that can be broadly grouped into continuous flow and variable flow. There are potential physiologic differences between these CPAP systems and the choice of a CPAP device is too often guided by individual expertise and experience rather than by evidence. When interpreting the evidence clinicians should take into account the pressure generation sources, nasal interface, and the factors affecting the delivery of pressure, such as mouth position and respiratory drive. With increasing use of these devices, better monitoring techniques are required to assess the efficacy and early recognition of babies who are failing and in need of escalated support. Copyright © 2016 Elsevier Ltd. All rights reserved.

Development and testing of an artificial arterial and venous pulse oximeter.

PubMed

Cloete, G; Fourie, P R; Scheffer, C

2013-01-01

The monitoring of patients healthcare is of a prime importance to ensure their efficient and effective treatment. Monitoring blood oxygen saturation is a field which has grown significantly in recent times and more specifically in tissues affected by diseases or conditions that may negatively affect the function of the tissue. This study involved the development and testing of a highly sensitive non-invasive blood oxygen saturation monitoring device. A device that can be used to continuously monitor the condition of tissue affected by diseases which affect the blood flow through the tissue, and the oxygen usage in tissue. The device's system was designed to specifically monitor occluded tissue which has low oxygen saturations and low perfusion. Although with limitted validation the system was unable to accurately measure the venous oxygenation specifically, but it was able to measure the mixed oxygen saturation. With further research it would be possible to validate the system for measuring both the arterial and venous oxygen saturations.

Wearable and flexible electronics for continuous molecular monitoring.

PubMed

Yang, Yiran; Gao, Wei

2018-04-03

Wearable biosensors have received tremendous attention over the past decade owing to their great potential in predictive analytics and treatment toward personalized medicine. Flexible electronics could serve as an ideal platform for personalized wearable devices because of their unique properties such as light weight, low cost, high flexibility and great conformability. Unlike most reported flexible sensors that mainly track physical activities and vital signs, the new generation of wearable and flexible chemical sensors enables real-time, continuous and fast detection of accessible biomarkers from the human body, and allows for the collection of large-scale information about the individual's dynamic health status at the molecular level. In this article, we review and highlight recent advances in wearable and flexible sensors toward continuous and non-invasive molecular analysis in sweat, tears, saliva, interstitial fluid, blood, wound exudate as well as exhaled breath. The flexible platforms, sensing mechanisms, and device and system configurations employed for continuous monitoring are summarized. We also discuss the key challenges and opportunities of the wearable and flexible chemical sensors that lie ahead.

A wearable device for monitoring and prevention of repetitive ankle sprain.

PubMed

Attia, Mohammed; Taher, Mona F

2015-01-01

This study presents the design and implementation of a wearable wireless device, connected to a smart phone, which monitors and prevents repetitive ankle sprain due to chronic ankle instability (CAI). The device prevents this common foot injury by electrical stimulation of the peroneal muscles using surface electrodes which causes dorsiflexion of the foot. This is done after measuring ankle kinematics using inertial motion sensors and predicting ankle sprain. The prototype implemented here has a fast response time of 7 msec which enables prevention of ankle sprain before ligament damage occurs. Wireless communication between the components of the device, in addition to their small size, low cost and low power consumption, makes it unobtrusive, easy to wear and not hinder normal activities. The device connects via Bluetooth to an android smart phone application for continuous data logging and reporting to keep track of the incidences of possible ankle sprain and correction. This is a significant feature of this device since it enables monitoring of patients with CAI and quantifying progression of the condition or improvement in the case of treatment.

A Wearable System for Real-Time Continuous Monitoring of Physical Activity

PubMed Central

2018-01-01

Over the last decades, wearable systems have gained interest for monitoring of physiological variables, promoting health, and improving exercise adherence in different populations ranging from elite athletes to patients. In this paper, we present a wearable system for the continuous real-time monitoring of respiratory frequency (fR), heart rate (HR), and movement cadence during physical activity. The system has been experimentally tested in the laboratory (by simulating the breathing pattern with a mechanical ventilator) and by collecting data from one healthy volunteer. Results show the feasibility of the proposed device for real-time continuous monitoring of fR, HR, and movement cadence both in resting condition and during activity. Finally, different synchronization techniques have been investigated to enable simultaneous data collection from different wearable modules. PMID:29849993

21 CFR 892.1540 - Nonfetal ultrasonic monitor.

Code of Federal Regulations, 2011 CFR

2011-04-01

... 21 Food and Drugs 8 2011-04-01 2011-04-01 false Nonfetal ultrasonic monitor. 892.1540 Section 892.1540 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED... tissues in motion. This generic type of device may include signal analysis and display equipment, patient...

21 CFR 892.1540 - Nonfetal ultrasonic monitor.

Code of Federal Regulations, 2010 CFR

2010-04-01

... 21 Food and Drugs 8 2010-04-01 2010-04-01 false Nonfetal ultrasonic monitor. 892.1540 Section 892.1540 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED... tissues in motion. This generic type of device may include signal analysis and display equipment, patient...

21 CFR 892.1540 - Nonfetal ultrasonic monitor.

Code of Federal Regulations, 2014 CFR

2014-04-01

... 21 Food and Drugs 8 2014-04-01 2014-04-01 false Nonfetal ultrasonic monitor. 892.1540 Section 892.1540 Food and Drugs FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES (CONTINUED... tissues in motion. This generic type of device may include signal analysis and display equipment, patient...

40 CFR 60.695 - Monitoring of operations.

Code of Federal Regulations, 2013 CFR

2013-07-01

... CFR 60.18(f)(2). (b) Where a VOC recovery device other than a carbon adsorber is used to meet the... 40 Protection of Environment 7 2013-07-01 2013-07-01 false Monitoring of operations. 60.695 Section 60.695 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) AIR PROGRAMS...

40 CFR 60.695 - Monitoring of operations.

Code of Federal Regulations, 2012 CFR

2012-07-01

... CFR 60.18(f)(2). (b) Where a VOC recovery device other than a carbon adsorber is used to meet the... 40 Protection of Environment 7 2012-07-01 2012-07-01 false Monitoring of operations. 60.695 Section 60.695 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) AIR PROGRAMS...

40 CFR 60.695 - Monitoring of operations.

Code of Federal Regulations, 2014 CFR

2014-07-01

... CFR 60.18(f)(2). (b) Where a VOC recovery device other than a carbon adsorber is used to meet the... 40 Protection of Environment 7 2014-07-01 2014-07-01 false Monitoring of operations. 60.695 Section 60.695 Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) AIR PROGRAMS...

Electronic skewing circuit monitors exact position of object underwater

NASA Technical Reports Server (NTRS)

Roller, R.; Yaroshuk, N.

1967-01-01

Linear Variable Differential Transformer /LVDT/ electronic skewing circuit guides a long cylindrical capsule underwater into a larger tube so that it does not contact the tube wall. This device detects movement of the capsule from a reference point and provides a continuous signal that is monitored on an oscilloscope.

Complexity of Continuous Glucose Monitoring Data in Critically Ill Patients: Continuous Glucose Monitoring Devices, Sensor Locations, and Detrended Fluctuation Analysis Methods

PubMed Central

Signal, Matthew; Thomas, Felicity; Shaw, Geoffrey M.; Chase, J. Geoffrey

2013-01-01

Background Critically ill patients often experience high levels of insulin resistance and stress-induced hyperglycemia, which may negatively impact outcomes. However, evidence surrounding the causes of negative outcomes remains inconclusive. Continuous glucose monitoring (CGM) devices allow researchers to investigate glucose complexity, using detrended fluctuation analysis (DFA), to determine whether it is associated with negative outcomes. The aim of this study was to investigate the effects of CGM device type/calibration and CGM sensor location on results from DFA. Methods This study uses CGM data from critically ill patients who were each monitored concurrently using Medtronic iPro2s on the thigh and abdomen and a Medtronic Guardian REAL-Time on the abdomen. This allowed interdevice/calibration type and intersensor site variation to be assessed. Detrended fluctuation analysis is a technique that has previously been used to determine the complexity of CGM data in critically ill patients. Two variants of DFA, monofractal and multifractal, were used to assess the complexity of sensor glucose data as well as the precalibration raw sensor current. Monofractal DFA produces a scaling exponent (H), where H is inversely related to complexity. The results of multifractal DFA are presented graphically by the multifractal spectrum. Results From the 10 patients recruited, 26 CGM devices produced data suitable for analysis. The values of H from abdominal iPro2 data were 0.10 (0.03–0.20) higher than those from Guardian REAL-Time data, indicating consistently lower complexities in iPro2 data. However, repeating the analysis on the raw sensor current showed little or no difference in complexity. Sensor site had little effect on the scaling exponents in this data set. Finally, multifractal DFA revealed no significant associations between the multifractal spectrums and CGM device type/calibration or sensor location. Conclusions Monofractal DFA results are dependent on the device/calibration used to obtain CGM data, but sensor location has little impact. Future studies of glucose complexity should consider the findings presented here when designing their investigations. PMID:24351175

Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline.

PubMed

Peters, Anne L; Ahmann, Andrew J; Battelino, Tadej; Evert, Alison; Hirsch, Irl B; Murad, M Hassan; Winter, William E; Wolpert, Howard

2016-11-01

To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes. The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical writer. The American Association for Clinical Chemistry, the American Association of Diabetes Educators, and the European Society of Endocrinology co-sponsored this guideline. The Task Force developed this evidence-based guideline using the Grading of Recommendations, Assessment, Development, and Evaluation system to describe the strength of recommendations and the quality of evidence. The Task Force commissioned one systematic review and used the best available evidence from other published systematic reviews and individual studies. One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of the Endocrine Society, the American Association for Clinical Chemistry, the American Association of Diabetes Educators, and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines. Continuous subcutaneous insulin infusion and continuous glucose monitoring have an important role in the treatment of diabetes. Data from randomized controlled trials are limited on the use of medical devices, but existing studies support the use of diabetes technology for a wide variety of indications. This guideline presents a review of the literature and practice recommendations for appropriate device use.

Noninvasive and continuous blood pressure measurement via superficial temporal artery tonometry.

PubMed

Canning, Julia; Helbert, Kendall; Iashin, Grigoriy; Matthews, Jonathan; Yang, Jason; Delano, Margaret K; Sodini, Charles G; Quan Zhang

2016-08-01

The measurement of blood pressure is an important cardiovascular health assessment, yet the current set of methodologies is limited in resolution, repeatability, accuracy, simplicity, and safety. This paper presents the design and prototype implementation of a novel and easy-to-use medical device for noninvasive and continuous blood pressure monitoring through tonometry at the superficial temporal artery (STA). The device features a stable form factor inspired by over-ear headphones that adjusts easily from person to person using a combination prismatic and rotational joint. A stepper motor and pressure sensor, built into the device, apply a controlled force to flatten the artery and measure the wearer's blood pressure. The design is fully wireless, using Bluetooth communication to connect to a custom control and monitoring interface on the user's laptop that allows for easy calibration and real-time measurement. Preliminary testing of the device showed a percentage error from a blood pressure cuff mean arterial pressure measurement of 7.7% (7.0 mmHg). This was also compared to a Nexfin vascular unloading device, which showed a percentage error from the blood pressure cuff of 7.3% (6.6 mmHg).

USE OF SEMI-PERMEABLE MEMBRANE DEVICES TO MONITOR POLLUTANTS IN WATER AND ASSESS THEIR EFFECTS: A LABORATORY TEST AND FIELD VERIFICATION. (U915464)

EPA Science Inventory

Uptake of eight pesticides of different classes (organochlorines, synthetic pyrethroids, dinitroanilines, amides) by semi-permeable membrane devices (SPMDs) was studied in a laboratory continuous-flow system. After 20 days of exposure, membrane concentration factors were in th...

40 CFR 63.5995 - What are my monitoring installation, operation, and maintenance requirements?

Code of Federal Regulations, 2014 CFR

2014-07-01

... for continuity, oxidation, and galvanic corrosion. (c) For each integrating regeneration stream flow... a device that is capable of recording the total regeneration stream mass or volumetric flow for each regeneration cycle. (d) For any other control device, or for other capture systems, ensure that the CPMS is...

40 CFR 63.5995 - What are my monitoring installation, operation, and maintenance requirements?

Code of Federal Regulations, 2012 CFR

2012-07-01

... for continuity, oxidation, and galvanic corrosion. (c) For each integrating regeneration stream flow... a device that is capable of recording the total regeneration stream mass or volumetric flow for each regeneration cycle. (d) For any other control device, or for other capture systems, ensure that the CPMS is...

40 CFR 63.5995 - What are my monitoring installation, operation, and maintenance requirements?

Code of Federal Regulations, 2013 CFR

2013-07-01

... for continuity, oxidation, and galvanic corrosion. (c) For each integrating regeneration stream flow... a device that is capable of recording the total regeneration stream mass or volumetric flow for each regeneration cycle. (d) For any other control device, or for other capture systems, ensure that the CPMS is...

40 CFR Table 4 of Subpart Bbbbbbb... - Continuous Compliance Demonstration Methods With the Emission Reduction and PM Concentration...

Code of Federal Regulations, 2010 CFR

2010-07-01

... chemical preparations operation was in target HAP service. The control device monitoring data are averaged... Emission Standards for Hazardous Air Pollutants for Area Sources: Chemical Preparations Industry Other... particulate matter control device being used. c. A CPMS, and maintaining records of data verifying that the...

40 CFR 60.57c - Monitoring requirements.

Code of Federal Regulations, 2014 CFR

2014-07-01

... pressure or induced air fabric filters, the bag leak detector shall be installed downstream of the fabric... 60.57c Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) AIR PROGRAMS (CONTINUED... owner or operator of an affected facility using an air pollution control device other than a dry...

40 CFR 60.57c - Monitoring requirements.

Code of Federal Regulations, 2013 CFR

2013-07-01

... pressure or induced air fabric filters, the bag leak detector shall be installed downstream of the fabric... 60.57c Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) AIR PROGRAMS (CONTINUED... owner or operator of an affected facility using an air pollution control device other than a dry...

40 CFR 63.2382 - What notifications must I submit and when and what information should be submitted?

Code of Federal Regulations, 2010 CFR

2010-07-01

... sampling and analysis procedures and quality assurance procedures. (iii) Descriptions of monitoring devices... ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) AIR PROGRAMS (CONTINUED) NATIONAL EMISSION STANDARDS FOR HAZARDOUS... compliance assessments, inspections and repairs, and calculations used to demonstrate initial compliance...

Membrane-based microchannel device for continuous quantitative extraction of dissolved free sulfide from water and from oil.

PubMed

Toda, Kei; Ebisu, Yuki; Hirota, Kazutoshi; Ohira, Shin-Ichi

2012-09-05

Underground fluids are important natural sources of drinking water, geothermal energy, and oil-based fuels. To facilitate the surveying of such underground fluids, a novel microchannel extraction device was investigated for in-line continuous analysis and flow injection analysis of sulfide levels in water and in oil. Of the four designs investigated, the honeycomb-patterned microchannel extraction (HMCE) device was found to offer the most effective liquid-liquid extraction. In the HMCE device, a thin silicone membrane was sandwiched between two polydimethylsiloxane plates in which honeycomb-patterned microchannels had been fabricated. The identical patterns on the two plates were accurately aligned. The extracted sulfide was detected by quenching monitoring of fluorescein mercuric acetate (FMA). The sulfide extraction efficiencies from water and oil samples of the HMCE device and of three other designs (two annular and one rectangular channel) were examined theoretically and experimentally. The best performance was obtained with the HMCE device because of its thin sample layer (small diffusion distance) and large interface area. Quantitative extraction from both water and oil could be obtained using the HMCE device. The estimated limit of detection for continuous monitoring was 0.05 μM, and sulfide concentrations in the range of 0.15-10 μM could be determined when the acceptor was 5 μM FMA alkaline solution. The method was applied to natural water analysis using flow injection mode, and the data agreed with those obtained using headspace gas chromatography-flame photometric detection. The analysis of hydrogen sulfide levels in prepared oil samples was also performed. The proposed device is expected to be used for real time survey of oil wells and groundwater wells. Copyright © 2012 Elsevier B.V. All rights reserved.

Evaluation of Strain Measurement Devices for Inflatable Structures

NASA Technical Reports Server (NTRS)

Litteken, Douglas A.

2017-01-01

Inflatable structures provide a significant volume savings for future NASA deep space missions. The complexity of these structures, however, provides difficulty for engineers in designing, analyzing, and testing. Common strain measurement systems for metallic parts cannot be used directly on fabrics. New technologies must be developed and tested to accuractly measure the strain of inflatable structures. This paper documents the testing of six candidate strain measurement devices for use on fabrics. The resistance devices tested showed significant hysteresis during creep and cyclic testing. The capacitive device, however, showed excellent results and little-to-no hysteresis. Because of this issue, only two out of the six proposed devices will continue in development. The resulting data and lessons learned from this effort provides direction for continued work to produce a structural health monitoring system for inflatable habitats.

Evaluation of Strain Measurement Devices for Inflatable Structures

NASA Technical Reports Server (NTRS)

Litteken, Doug

2017-01-01

Inflatable structures provide a significant volume savings for future NASA deep space missions. The complexity of these structures, however, provides difficulty for engineers in designing, analyzing, and testing. Common strain measurement systems for metallic parts cannot be used directly on fabrics. New technologies must be developed and tested to accurately measure the strain of inflatable structures. This paper documents the testing of six candidate strain measurement devices for use on fabrics. The resistance devices tested showed significant hysteresis during creep and cyclic testing. The capacitive device, however, showed excellent results and little-to-no hysteresis. Because of this issue, only two out of the six proposed devices will continue in development. The resulting data and lessons learned from this effort provides direction for continued work to produce a structural health monitoring system for inflatable habitats.

Design of smart neonatal health monitoring system using SMCC

PubMed Central

Mukherjee, Anwesha; Bhakta, Ishita

2016-01-01

Automated health monitoring and alert system development is a demanding research area today. Most of the currently available monitoring and controlling medical devices are wired which limits freeness of working environment. Wireless sensor network (WSN) is a better alternative in such an environment. Neonatal intensive care unit is used to take care of sick and premature neonates. Hypothermia is an independent risk factor for neonatal mortality and morbidity. To prevent it an automated monitoring system is required. In this Letter, an automated neonatal health monitoring system is designed using sensor mobile cloud computing (SMCC). SMCC is based on WSN and MCC. In the authors’ system temperature sensor, acceleration sensor and heart rate measurement sensor are used to monitor body temperature, acceleration due to body movement and heart rate of neonates. The sensor data are stored inside the cloud. The health person continuously monitors and accesses these data through the mobile device using an Android Application for neonatal monitoring. When an abnormal situation arises, an alert is generated in the mobile device of the health person. By alerting health professional using such an automated system, early care is provided to the affected babies and the probability of recovery is increased. PMID:28261491

Design of smart neonatal health monitoring system using SMCC.

PubMed

De, Debashis; Mukherjee, Anwesha; Sau, Arkaprabha; Bhakta, Ishita

2017-02-01

Automated health monitoring and alert system development is a demanding research area today. Most of the currently available monitoring and controlling medical devices are wired which limits freeness of working environment. Wireless sensor network (WSN) is a better alternative in such an environment. Neonatal intensive care unit is used to take care of sick and premature neonates. Hypothermia is an independent risk factor for neonatal mortality and morbidity. To prevent it an automated monitoring system is required. In this Letter, an automated neonatal health monitoring system is designed using sensor mobile cloud computing (SMCC). SMCC is based on WSN and MCC. In the authors' system temperature sensor, acceleration sensor and heart rate measurement sensor are used to monitor body temperature, acceleration due to body movement and heart rate of neonates. The sensor data are stored inside the cloud. The health person continuously monitors and accesses these data through the mobile device using an Android Application for neonatal monitoring. When an abnormal situation arises, an alert is generated in the mobile device of the health person. By alerting health professional using such an automated system, early care is provided to the affected babies and the probability of recovery is increased.

Monitoring elbow isometric contraction by novel wearable fabric sensing device

NASA Astrophysics Data System (ADS)

Wang, Xi; Tao, Xiaoming; So, Raymond C. H.; Shu, Lin; Yang, Bao; Li, Ying

2016-12-01

Fabric-based wearable technology is highly desirable in sports, as it is light, flexible, soft, and comfortable with little interference to normal sport activities. It can provide accurate information on the in situ deformation of muscles in a continuous and wireless manner. During elbow flexion in isometric contraction, upper arm circumference increases with the contraction of elbow flexors, and it is possible to monitor the muscles’ contraction by limb circumferential strains. This paper presents a new wireless wearable anthropometric monitoring device made from fabric strain sensors for the human upper arm. The materials, structural design and calibration of the device are presented. Using an isokinetic testing system (Biodex3®) and the fabric monitoring device simultaneously, in situ measurements were carried out on elbow flexors in isometric contraction mode with ten subjects for a set of positions. Correlations between the measured values of limb circumferential strain and normalized torque were examined, and a linear relationship was found during isometric contraction. The average correlation coefficient between them is 0.938 ± 0.050. This wearable anthropometric device thus provides a useful index, the limb circumferential strain, for upper arm muscle contraction in isometric mode.

Nekton Interaction Monitoring System

DOE Office of Scientific and Technical Information (OSTI.GOV)

2017-03-15

The software provides a real-time processing system for sonar to detect and track animals, and to extract water column biomass statistics in order to facilitate continuous monitoring of an underwater environment. The Nekton Interaction Monitoring System (NIMS) extracts and archives tracking and backscatter statistics data from a real-time stream of data from a sonar device. NIMS also sends real-time tracking messages over the network that can be used by other systems to generate other metrics or to trigger instruments such as an optical video camera. A web-based user interface provides remote monitoring and control. NIMS currently supports three popular sonarmore » devices: M3 multi-beam sonar (Kongsberg), EK60 split-beam echo-sounder (Simrad) and BlueView acoustic camera (Teledyne).« less

Wearable Beat-to-Beat Blood Pressure Monitor

NASA Technical Reports Server (NTRS)

Lee, Yong Jin

2015-01-01

Linea Research Corporation has developed a wearable noninvasive monitor that provides continuous blood pressure and heart rate measurements in extreme environments. Designed to monitor the physiological effects of astronauts' prolonged exposure to reduced-gravity environments as well as the effectiveness of various countermeasures, the device offers wireless connectivity to allow transfer of both real-time and historical data. It can be modified to monitor the health status of astronaut crew members during extravehicular missions.

Monitoring for neuroprotection. New technologies for the new millennium

NASA Technical Reports Server (NTRS)

Andrews, R. J.

2001-01-01

Monitoring for neuroprotection, like surgery, has placed on emphasis on minimal or non-invasiveness. Monitoring of parameters that truly reflect the degree of injury to the nervous system is another goal. Thus, two themes for the coming decade in neuromonitoring will be: (1) less-invasive monitoring; and (2) parameters that more closely reflect the etiological factors in ischemic or other neuroinjury. In this paper, we review neuromonitoring techniques and devices that can be used readily in the operating room or intensive care unit setting. Those that require transport of the patient to a special facility (e.g., for computed tomography or magnetic resonance imaging/spectroscopy) and those that have been in standard practice for neuromonitoring (e.g., electrophysiological monitoring--EEG, evoked potentials) are not considered. The two techniques considered in detail are (1) continuous multiparameter local brain tissue monitoring with microprobes, and (2) non-invasive continuous local brain tissue oxygenation monitoring by near infrared spectroscopy. Both techniques have been cleared by the Food and Drug Administration (FDA) for clinical use. The rationale for their use, the nature of the devices, and clinical results to date are reviewed. It is expected that both techniques will gain wide acceptance during the coming decade; further advances in neuromonitoring that can be expected further into the twenty-first century are also discussed.

40 CFR 63.3350 - If I use a control device to comply with the emission standards, what monitoring must I do?

Code of Federal Regulations, 2010 CFR

2010-07-01

... must be certified by the manufacturer to be accurate to within ±2.0 percent by mass. (e) Continuous... Pollutants: Paper and Other Web Coating General Requirements for Compliance with the Emission Standards and... standards, what monitoring must I do? (a) A summary of monitoring you must do follows: If you operate a web...

40 CFR 63.3350 - If I use a control device to comply with the emission standards, what monitoring must I do?

Code of Federal Regulations, 2011 CFR

2011-07-01

... must be certified by the manufacturer to be accurate to within ±2.0 percent by mass. (e) Continuous... Pollutants: Paper and Other Web Coating General Requirements for Compliance with the Emission Standards and... standards, what monitoring must I do? (a) A summary of monitoring you must do follows: If you operate a web...

Numerical and clinical precision of continuous glucose monitoring in Colombian patients treated with insulin infusion pump with automated suspension in hypoglycemia.

PubMed

Gómez, Ana M; Marín Sánchez, Alejandro; Muñoz, Oscar M; Colón Peña, Christian Alejandro

2015-12-01

Insulin pump therapy associated with continuous glucose monitoring has shown a positive clinical impact on diabetes control and reduction of hypoglycemia episodes. There are descriptions of the performance of this device in other populations, but its precision and accuracy in Colombia and Latin America are unknown, especially in the routine outpatient setting. Data from 33 type 1 and type 2 diabetes patients with sensor-augmented pump therapy with threshold suspend automation, MiniMed Paradigm® Veo™ (Medtronic, Northridge, California), managed at Hospital Universitario San Ignacio (Bogotá, Colombia) and receiving outpatient treatment, were analyzed. Simultaneous data from continuous glucose monitoring and capillary blood glucose were compared, and their precision and accuracy were calculating with different methods, including Clarke error grid. Analyses included 2,262 continuous glucose monitoring -reference paired glucose values. A mean absolute relative difference of 20.1% was found for all measurements, with a value higher than 23% for glucose levels ≤75mg/dL. Global compliance with the ISO criteria was 64.9%. It was higher for values >75mg/dl (68.3%, 1,308 of 1,916 readings), than for those ≤ 75mg/dl (49.4%, 171 of 346 readings). Clinical accuracy, as assessed by the Clarke error grid, showed that 91.77% of data were within the A and B zones (75.6% in hypoglycemia). A good numerical accuracy was found for continuous glucose monitoring in normo and hyperglycemia situations, with low precision in hypoglycemia. The clinical accuracy of the device was adequate, with no significant safety concerns for patients. Copyright © 2015 SEEN. Published by Elsevier España, S.L.U. All rights reserved.

50 CFR 300.219 - Vessel monitoring system.

Code of Federal Regulations, 2011 CFR

2011-10-01

.... The vessel owner and operator shall continuously operate the VMS unit at all times, except that the...) of this section, provided that the VMS unit is operated continuously and at all times while the... device that is capable of real-time communication with the SAC. The VMS unit used to fulfill the...

50 CFR 300.219 - Vessel monitoring system.

Code of Federal Regulations, 2013 CFR

2013-10-01

.... The vessel owner and operator shall continuously operate the VMS unit at all times, except that the...) of this section, provided that the VMS unit is operated continuously and at all times while the... device that is capable of real-time communication with the SAC. The VMS unit used to fulfill the...

50 CFR 300.219 - Vessel monitoring system.

Code of Federal Regulations, 2010 CFR

2010-10-01

.... The vessel owner and operator shall continuously operate the VMS unit at all times, except that the...) of this section, provided that the VMS unit is operated continuously and at all times while the... device that is capable of real-time communication with the SAC. The VMS unit used to fulfill the...

40 CFR 60.57c - Monitoring requirements.

Code of Federal Regulations, 2012 CFR

2012-07-01

... 60.57c Protection of Environment ENVIRONMENTAL PROTECTION AGENCY (CONTINUED) AIR PROGRAMS (CONTINUED... date, time, and duration. (d) The owner or operator of an affected facility using an air pollution... § 60.52c undergoes an initial air pollution control device inspection that is at least as protective as...

Noninvasive continuous blood pressure monitoring by the ClearSight system during robot-assisted laparoscopic radical prostatectomy.

PubMed

Sakai, Yoko; Yasuo M, Tsutsumi; Oyama, Takuro; Murakami, Chiaki; Kakuta, Nami; Tanaka, Katsuya

2018-01-01

Robot-assisted laparoscopic radical prostatectomy (RALRP) is commonly performed in the surgical treatment of prostate cancer. However, the steep Trendelenburg position (25) and pneumoperitoneum required for this procedure can sometimes cause hemodynamic changes. Although blood pressure is traditionally monitored invasively during RALRP, the ClearSight system (BMEYE, Amsterdam, The Netherlands) enables a totally noninvasive and simple continuous blood pressure and cardiac output monitoring based on finger arterial pressure pulse contour analysis. We therefore investigated whether noninvasive continuous arterial blood pressure measurements using the ClearSight system were comparable to those obtained invasively in patients undergoing RALRP. Ten patients scheduled for RALRP with American Society of Anesthesiologists physical status I-II were included in this study. At each of the seven defined time points, noninvasive and invasive blood pressure measurements were documented and compared in each patient using Bland-Altman analysis. Although the blood pressure measured with the ClearSight system correlated with that measured invasively, a large difference between the values obtained by the two devices was noted. The ClearSight system was unable to detect blood pressure accurately during RALRP, suggesting that blood pressure monitoring using this device alone is not feasible in this small patient population. J. Med. Invest. 65:69-73, February, 2018.

Automated integration of continuous glucose monitor data in the electronic health record using consumer technology

PubMed Central

Kumar, Rajiv B; Goren, Nira D; Stark, David E; Wall, Dennis P; Longhurst, Christopher A

2016-01-01

The diabetes healthcare provider plays a key role in interpreting blood glucose trends, but few institutions have successfully integrated patient home glucose data in the electronic health record (EHR). Published implementations to date have required custom interfaces, which limit wide-scale replication. We piloted automated integration of continuous glucose monitor data in the EHR using widely available consumer technology for 10 pediatric patients with insulin-dependent diabetes. Establishment of a passive data communication bridge via a patient’s/parent’s smartphone enabled automated integration and analytics of patient device data within the EHR between scheduled clinic visits. It is feasible to utilize available consumer technology to assess and triage home diabetes device data within the EHR, and to engage patients/parents and improve healthcare provider workflow. PMID:27018263

40 CFR 63.1429 - Process vent monitoring requirements.

Code of Federal Regulations, 2014 CFR

2014-07-01

... the presence of a pilot flame. (3) Where a boiler or process heater of less than 44 megawatts design... series are used, a scrubbing liquid flow rate meter, or a pressure monitoring device, equipped with a continuous recorder, is required for each absorber in the series. An owner or operator may submit a request...

40 CFR 63.1429 - Process vent monitoring requirements.

Code of Federal Regulations, 2013 CFR

2013-07-01

... the presence of a pilot flame. (3) Where a boiler or process heater of less than 44 megawatts design... series are used, a scrubbing liquid flow rate meter, or a pressure monitoring device, equipped with a continuous recorder, is required for each absorber in the series. An owner or operator may submit a request...

40 CFR 60.5417 - What are the continuous control device monitoring requirements for my storage vessel or...

Code of Federal Regulations, 2013 CFR

2013-07-01

... monitoring requirements for my storage vessel or centrifugal compressor affected facility? 60.5417 Section 60... requirements for my storage vessel or centrifugal compressor affected facility? You must meet the applicable... standards for your storage vessel or centrifugal compressor affected facility. (a) You must install and...

40 CFR 63.5725 - What are the requirements for monitoring and demonstrating continuous compliance?

Code of Federal Regulations, 2012 CFR

2012-07-01

... temperature monitoring device. (i) Locate the temperature sensor in a position that provides a representative temperature. (ii) Use a temperature sensor with a minimum tolerance of 2.2 °C or 0.75 percent of the temperature value, whichever is larger. (iii) Shield the temperature sensor system from electromagnetic...

40 CFR 63.5725 - What are the requirements for monitoring and demonstrating continuous compliance?

Code of Federal Regulations, 2010 CFR

2010-07-01

... temperature monitoring device. (i) Locate the temperature sensor in a position that provides a representative temperature. (ii) Use a temperature sensor with a minimum tolerance of 2.2 °C or 0.75 percent of the temperature value, whichever is larger. (iii) Shield the temperature sensor system from electromagnetic...

40 CFR 63.5725 - What are the requirements for monitoring and demonstrating continuous compliance?

Code of Federal Regulations, 2011 CFR

2011-07-01

... temperature monitoring device. (i) Locate the temperature sensor in a position that provides a representative temperature. (ii) Use a temperature sensor with a minimum tolerance of 2.2 °C or 0.75 percent of the temperature value, whichever is larger. (iii) Shield the temperature sensor system from electromagnetic...

40 CFR 60.203 - Monitoring of operations.

Code of Federal Regulations, 2014 CFR

2014-07-01

... (CONTINUED) STANDARDS OF PERFORMANCE FOR NEW STATIONARY SOURCES Standards of Performance for the Phosphate..., calibrate, maintain, and operate a monitoring device which can be used to determine the mass flow of... maintain a daily record of equivalent P2O5 feed by first determining the total mass rate in Mg/hr of...

Technologies for Continuous Glucose Monitoring: Current Problems and Future Promises

PubMed Central

Vaddiraju, Santhisagar; Burgess, Diane J; Tomazos, Ioannis; Jain, Faquir C; Papadimitrakopoulos, Fotios

2010-01-01

Devices for continuous glucose monitoring (CGM) are currently a major focus of research in the area of diabetes management. It is envisioned that such devices will have the ability to alert a diabetes patient (or the parent or medical care giver of a diabetes patient) of impending hypoglycemic/hyperglycemic events and thereby enable the patient to avoid extreme hypoglycemic/hyperglycemic excursions as well as minimize deviations outside the normal glucose range, thus preventing both life-threatening events and the debilitating complications associated with diabetes. It is anticipated that CGM devices will utilize constant feedback of analytical information from a glucose sensor to activate an insulin delivery pump, thereby ultimately realizing the concept of an artificial pancreas. Depending on whether the CGM device penetrates/breaks the skin and/or the sample is measured extracorporeally, these devices can be categorized as totally invasive, minimally invasive, and noninvasive. In addition, CGM devices are further classified according to the transduction mechanisms used for glucose sensing (i.e., electrochemical, optical, and piezoelectric). However, at present, most of these technologies are plagued by a variety of issues that affect their accuracy and long-term performance. This article presents a critical comparison of existing CGM technologies, highlighting critical issues of device accuracy, foreign body response, calibration, and miniaturization. An outlook on future developments with an emphasis on long-term reliability and performance is also presented. PMID:21129353

Definitions A-Z

MedlinePlus

... and effective products reach the market in a timely way and monitoring products for continued safety after ... findings without any clinical findings associated. spinal cord stimulation (SCS): Electrical device implanted in the spine to ...

40 CFR 64.3 - Monitoring design criteria.

Code of Federal Regulations, 2010 CFR

2010-07-01

... that are adequate to ensure the continuing validity of the data. The owner or operator shall consider... and control device operational variability, the reliability and latitude built into the control...

Continuous on-line steam quality monitoring system of the Bacman Geothermal Production Field, Philippines

DOE Office of Scientific and Technical Information (OSTI.GOV)

Solis, R.P.; Chavez, F.C.; Garcia, S.E.

1997-12-31

In any operating geothermal power plant, steam quality is one of the most important parameters being monitored. In the Bacon-Manito Geothermal Production Field (BGPF), an online steam quality monitoring system have been installed in two operating power plants which provides an accurate, efficient and continuous real-time data which is more responsive to the various requirements of the field operation. The system utilizes sodium as an indicator of steam purity. Sodium concentration is read by the flame photometer located at the interface after aspirating a sample of the condensed steam through a continuous condensate sampler. The condensate has been degassed throughmore » a condensate-NCG separator. The flame photometer analog signal is then converted by a voltage-to-current converter/transmitter and relayed to the processor which is located at the control center through electrical cable to give a digital sodium concentration read-out at the control panel. The system features a high and high-high sodium level alarm, a continuous strip-chart recorder and a central computer for data capture, retrieval, and processing for further interpretation. Safety devices, such as the flame-off indicator at the control center and the automatic fuel cut-off device along the fuel line, are incorporated in the system.« less

Characterizing Graphene-modified Electrodes for Interfacing with Arduino®-based Devices.

PubMed

Arris, Farrah Aida; Ithnin, Mohamad Hafiz; Salim, Wan Wardatul Amani Wan

2016-08-01

Portable low-cost platform and sensing systems for identification and quantitative measurement are in high demand for various environmental monitoring applications, especially in field work. Quantifying parameters in the field requires both minimal sample handling and a device capable of performing measurements with high sensitivity and stability. Furthermore, the one-device-fits-all concept is useful for continuous monitoring of multiple parameters. Miniaturization of devices can be achieved by introducing graphene as part of the transducer in an electrochemical sensor. In this project, we characterize graphene deposition methods on glassy-carbon electrodes (GCEs) with the goal of interfacing with an Arduino-based user-friendly microcontroller. We found that a galvanostatic electrochemical method yields the highest peak current of 10 mA, promising a highly sensitive electrochemical sensor. An Atlas Scientific™ printed circuit board (PCB) was connected to an Arduino® microcontroller using a multi-circuit connection that can be interfaced with graphene-based electrochemical sensors for environmental monitoring.

Efficacy of Monitoring Devices in Support of Prevention of Pressure Injuries: Systematic Review and Meta-analysis.

PubMed

Walia, Gurjot S; Wong, Alison L; Lo, Andrea Y; Mackert, Gina A; Carl, Hannah M; Pedreira, Rachel A; Bello, Ricardo; Aquino, Carla S; Padula, William V; Sacks, Justin M

2016-12-01

To present a systematic review of the literature assessing the efficacy of monitoring devices for reducing the risk of developing pressure injuries. This continuing education activity is intended for physicians, physician assistants, nurse practitioners, and nurses with an interest in skin and wound care. After participating in this educational activity, the participant should be better able to:1. Explain the methodology of the literature review and its results.2. Discuss the scope of the problem and the implications of the research. OBJECTIVE: To assess the efficacy of monitoring devices for reducing the risk of developing pressure injuries (PIs). The authors systematically reviewed the literature by searching PubMed/MEDLINE and CINAHL databases through January 2016. Articles included clinical trials and cohort studies that tested monitoring devices, evaluating PI risk factors on patients in acute and skilled nursing settings. The articles were scored using the Methodological Index for Non-randomized Studies. Using a standardized extraction form, the authors extracted patient inclusion/exclusion criteria, care setting, key baseline, description of monitoring device and methodology, number of patients included in each group, description of any standard of care, follow-up period, and outcomes. Of the identified 1866 publications, 9 met the inclusion criteria. The high-quality studies averaged Methodological Index for Non-randomized Studies scores of 19.4 for clinical trials and 12.2 for observational studies. These studies evaluated monitoring devices that measured interface pressure, subdermal tissue stress, motion, and moisture. Most studies found a statistically significant decrease in PIs; 2 studies were eligible for meta-analysis, demonstrating that use of monitoring devices was associated with an 88% reduction in the risk of developing PIs (Mantel-Haenszel risk ratio, 0.12; 95% confidence interval, 0.04-0.41; I = 0%). Pressure injury monitoring devices are associated with a strong reduction in the risk of developing PIs. These devices provide clinicians and patients with critical information to implement prevention guidelines. Randomized controlled trials would help assess which technologies are most effective at reducing the risk of developing PIs.

Field assessment and enhancement of cognitive performance: development of an ambulatory vigilance monitor.

PubMed

Lieberman, Harris R; Kramer, F Matthew; Montain, Scott J; Niro, Philip

2007-05-01

Limited opportunities to study human cognitive performance in non-laboratory, ambulatory situations exist. However, advances in technology make it possible to extend behavioral assessments to the field. One of the first devices to measure human behavior in the field was the wrist-worn actigraph. This device acquires minute-by-minute information on an individual's physical activity and can distinguish sleep from waking, the most basic aspect of behavior. Our laboratory developed a series of wrist-worn devices, not much larger than a watch, which assess reaction time, vigilance and memory. The devices concurrently assess motor activity with greater temporal resolution than standard actigraphs. They also continuously monitor multiple environmental variables including temperature, humidity, sound, and light. These monitors have been employed during training and simulated military operations to collect behavioral and environmental information that would typically be unavailable under such circumstances. Development of the vigilance monitor, and how each successive version extended capabilities of the device are described. Data from several studies are presented, including studies conducted in harsh field environments during a simulated infantry assault, an officer training course. The monitors simultaneously documented environmental conditions, patterns of sleep and activity and effects of nutritional manipulations on cognitive performance. They provide a new method to relate cognitive performance to real world environmental conditions and assess effects of various interventions on human behavior in the field. They can also monitor cognitive performance in real time, and if it is degraded, attempt to intervene to maintain

Integrated otpical monitoring of MEMS for closed-loop control

NASA Astrophysics Data System (ADS)

Dawson, Jeremy M.; Wang, Limin; McCormick, W. B.; Rittenhouse, S. A.; Famouri, Parviz F.; Hornak, Lawrence A.

2003-01-01

Robust control and failure assessment of MEMS employed in physically demanding, mission critical applications will allow for higher degrees of quality assurance in MEMS operation. Device fault detection and closed-loop control require detailed knowledge of the operational states of MEMS over the lifetime of the device, obtained by a means decoupled from the system. Preliminary through-wafer optical monitoring research efforts have shown that through-wafer optical probing is suitable for characterizing and monitoring the behavior of MEMS, and can be implemented in an integrated optical monitoring package for continuous in-situ device monitoring. This presentation will discuss research undertaken to establish integrated optical device metrology for closed-loop control of a MUMPS fabricated lateral harmonic oscillator. Successful linear closed-loop control results using a through-wafer optical microprobe position feedback signal will be presented. A theoretical optical output field intensity study of grating structures, fabricated on the shuttle of the resonator, was performed to improve the position resolution of the optical microprobe position signal. Through-wafer microprobe signals providing a positional resolution of 2 μm using grating structures will be shown, along with initial binary Fresnel diffractive optical microelement design layout, process development, and testing results. Progress in the design, fabrication, and test of integrated optical elements for multiple microprobe signal delivery and recovery will be discussed, as well as simulation of device system model parameter changes for failure assessment.

Psychology, technology, and diabetes management.

PubMed

Gonder-Frederick, Linda A; Shepard, Jaclyn A; Grabman, Jesse H; Ritterband, Lee M

2016-10-01

Use of technology in diabetes management is rapidly advancing and has the potential to help individuals with diabetes achieve optimal glycemic control. Over the past 40 years, several devices have been developed and refined, including the blood glucose meter, insulin pump, and continuous glucose monitor. When used in tandem, the insulin pump and continuous glucose monitor have prompted the Artificial Pancreas initiative, aimed at developing control system for fully automating glucose monitoring and insulin delivery. In addition to devices, modern technology, such as the Internet and mobile phone applications, have been used to promote patient education, support, and intervention to address the behavioral and emotional challenges of diabetes management. These state-of-the-art technologies not only have the potential to improve clinical outcomes, but there are possible psychological benefits, such as improved quality of life, as well. However, practical and psychosocial limitations related to advanced technology exist and, in the context of several technology-related theoretical frameworks, can influence patient adoption and continued use. It is essential for future diabetes technology research to address these barriers given that the clinical benefits appear to largely depend on patient engagement and consistence of technology use. (PsycINFO Database Record (c) 2016 APA, all rights reserved).

40 CFR 63.8600 - What are my monitoring installation, operation, and maintenance requirements?

Code of Federal Regulations, 2010 CFR

2010-07-01

... continuity, and all mechanical connections for leakage. (d) For each pH measurement device, you must meet the... integrity and all electrical connections for continuity. (e) For each bag leak detection system, you must... leak detection system must be installed, calibrated, operated, and maintained according to the “Fabric...

In Vivo Self-Powered Wireless Cardiac Monitoring via Implantable Triboelectric Nanogenerator.

PubMed

Zheng, Qiang; Zhang, Hao; Shi, Bojing; Xue, Xiang; Liu, Zhuo; Jin, Yiming; Ma, Ye; Zou, Yang; Wang, Xinxin; An, Zhao; Tang, Wei; Zhang, Wei; Yang, Fan; Liu, Yang; Lang, Xilong; Xu, Zhiyun; Li, Zhou; Wang, Zhong Lin

2016-07-26

Harvesting biomechanical energy in vivo is an important route in obtaining sustainable electric energy for powering implantable medical devices. Here, we demonstrate an innovative implantable triboelectric nanogenerator (iTENG) for in vivo biomechanical energy harvesting. Driven by the heartbeat of adult swine, the output voltage and the corresponding current were improved by factors of 3.5 and 25, respectively, compared with the reported in vivo output performance of biomechanical energy conversion devices. In addition, the in vivo evaluation of the iTENG was demonstrated for over 72 h of implantation, during which the iTENG generated electricity continuously in the active animal. Due to its excellent in vivo performance, a self-powered wireless transmission system was fabricated for real-time wireless cardiac monitoring. Given its outstanding in vivo output and stability, iTENG can be applied not only to power implantable medical devices but also possibly to fabricate a self-powered, wireless healthcare monitoring system.

Impact of government regulation on health care technology

NASA Astrophysics Data System (ADS)

Berkowitz, Robert D.

1994-12-01

Increased government regulation of the medical device industry produces higher expenses, a longer time to return investment capital, and greater uncertainty. As a result there are fewer new ventures and reduced efforts to develop new technology in established companies. The current federal regulatory framework has shifted from monitoring the product to monitoring the process. The inability to reach perfect performance in such a regulated environment subject to continuous and fluid interpretation guarantees non-compliance and growing ethical tension. Without new medical technology, we may be unable to maintain quality medical coverage in the face of rising demand. The author proposes risk assessment to set regulatory priorities; the conversion of a national weapons lab to a national device testing lab; the establishment of device standards and the monitoring of in-use performance against these standards; and the education of patients and users as to the results of these examinations.

Noninvasive oxygen monitoring techniques.

PubMed

Wahr, J A; Tremper, K K

1995-01-01

As this article demonstrates, tremendous progress has been made in the techniques of oxygen measurement and monitoring over the past 50 years. From the early developments during and after World War II, to the most recent applications of solid state and microprocessor technology today, every patient in a critical care situation will have several continuous measurements of oxygenation applied simultaneously. Information therefore is available readily to alert personnel of acute problems and to guide appropriate therapy. The majority of effort to date has been placed on measuring oxygenation of arterial or venous blood. The next generation of devices will attempt to provide information about living tissue. Unlike the devices monitoring arterial or venous oxygen content, no "gold standards" exist for tissue oxygenation, so calibration will be difficult, as will interpretation of the data provided. The application of these devices ultimately may lead to a much better understanding of how disease (and the treatment of disease) alters the utilization of oxygen by the tissues.

40 CFR Table 10 to Subpart Eeee of... - Continuous Compliance With Work Practice Standards

Code of Federal Regulations, 2010 CFR

2010-07-01

... liquids, operate a vapor balancing system. i. Monitoring each potential source of vapor leakage in the... requirements of 40 CFR part 63, subpart TT, UU, or H. i. Carrying out a leak detection and repair program in... relief devices, monitoring each potential source of vapor leakage in the system, including, but not...

40 CFR 63.5725 - What are the requirements for monitoring and demonstrating continuous compliance?

Code of Federal Regulations, 2014 CFR

2014-07-01

... Pollutants for Boat Manufacturing Demonstrating Compliance for Open Molding Operations Controlled by Add-on... successive cycles of operation to have a valid hour of data. (2) You must have valid data from at least 90... parameter monitoring system and collect emission capture system and add-on control device parameter data at...

40 CFR 63.5725 - What are the requirements for monitoring and demonstrating continuous compliance?

Code of Federal Regulations, 2013 CFR

2013-07-01

... Pollutants for Boat Manufacturing Demonstrating Compliance for Open Molding Operations Controlled by Add-on... successive cycles of operation to have a valid hour of data. (2) You must have valid data from at least 90... parameter monitoring system and collect emission capture system and add-on control device parameter data at...

40 CFR 63.3168 - What are the requirements for continuous parameter monitoring system installation, operation, and...

Code of Federal Regulations, 2012 CFR

2012-07-01

... regenerative carbon adsorber as an add-on control device, you must monitor the total regeneration desorbing gas (e.g., steam or nitrogen) mass flow for each regeneration cycle, the carbon bed temperature after each regeneration and cooling cycle, and comply with paragraphs (a)(3) through (5) and (d)(1) and (2...

40 CFR 63.6125 - What are my monitor installation, operation, and maintenance requirements?

Code of Federal Regulations, 2014 CFR

2014-07-01

... emission control device, you must monitor on a continuous basis your catalyst inlet temperature in order to... combustion turbine which fires landfill gas or digester gas equivalent to 10 percent or more of the gross... the major source with a non-resettable hour meter to measure the number of hours that distillate oil...

40 CFR 63.6125 - What are my monitor installation, operation, and maintenance requirements?

Code of Federal Regulations, 2010 CFR

2010-07-01

... control device, you must monitor on a continuous basis your catalyst inlet temperature in order to comply... combustion turbine which fires landfill gas or digester gas equivalent to 10 percent or more of the gross... the major source with a non-resettable hour meter to measure the number of hours that distillate oil...

40 CFR 63.6125 - What are my monitor installation, operation, and maintenance requirements?

Code of Federal Regulations, 2011 CFR

2011-07-01

... control device, you must monitor on a continuous basis your catalyst inlet temperature in order to comply... combustion turbine which fires landfill gas or digester gas equivalent to 10 percent or more of the gross... the major source with a non-resettable hour meter to measure the number of hours that distillate oil...

40 CFR 63.6125 - What are my monitor installation, operation, and maintenance requirements?

Code of Federal Regulations, 2013 CFR

2013-07-01

... emission control device, you must monitor on a continuous basis your catalyst inlet temperature in order to... combustion turbine which fires landfill gas or digester gas equivalent to 10 percent or more of the gross... the major source with a non-resettable hour meter to measure the number of hours that distillate oil...

Bladder Monitor

NASA Technical Reports Server (NTRS)

1993-01-01

Diagnostic Ultrasound Corporation's Bladder Scan Monitor continuously records and monitors bladder fullness and alerts the wearer or caretaker when voiding is required. The sensor is held against the lower abdomen by a belt and connected to the monitor by a cable. The sensor obtains bladder volume data from sound waves reflecting off the bladder wall. The device was developed by Langley Research Center, the Ames Research Center and the NASA Technology Applications Team. It utilizes Langley's advanced ultrasound technology. It is licensed to the ARC for medical applications, and sublicensed to Diagnostics Ultrasound. Central monitoring systems are planned for the future.

Cuff for Blood-Vessel Pressure Measurements

NASA Technical Reports Server (NTRS)

Shimizu, M.

1982-01-01

Pressure within blood vessel is measured by new cufflike device without penetration of vessel. Device continuously monitors blood pressure for up to 6 months or longer without harming vessel. Is especially useful for vessels smaller than 4 or 5 millimeters in diameter. Invasive methods damage vessel wall, disturb blood flow, and cause clotting. They do not always give reliable pressure measurements over prolonged periods.

40 CFR Table 4 of Subpart Bbbbbbb... - Continuous Compliance Demonstration Methods With the Emission Reduction and PM Concentration...

Code of Federal Regulations, 2012 CFR

2012-07-01

... compliance by * * * 1. Requirement to route all process vent streams from equipment in target HAP service to a PM control device with a PM percent reduction efficiency of 95 percent (98 percent for new sources... chemical preparations operation was in target HAP service. The control device monitoring data are averaged...

40 CFR Table 4 of Subpart Bbbbbbb... - Continuous Compliance Demonstration Methods With the Emission Reduction and PM Concentration...

Code of Federal Regulations, 2013 CFR

2013-07-01

... compliance by * * * 1. Requirement to route all process vent streams from equipment in target HAP service to a PM control device with a PM percent reduction efficiency of 95 percent (98 percent for new sources... chemical preparations operation was in target HAP service. The control device monitoring data are averaged...

40 CFR Table 4 of Subpart Bbbbbbb... - Continuous Compliance Demonstration Methods With the Emission Reduction and PM Concentration...

Code of Federal Regulations, 2014 CFR

2014-07-01

... compliance by * * * 1. Requirement to route all process vent streams from equipment in target HAP service to a PM control device with a PM percent reduction efficiency of 95 percent (98 percent for new sources... chemical preparations operation was in target HAP service. The control device monitoring data are averaged...

40 CFR Table 4 of Subpart Bbbbbbb... - Continuous Compliance Demonstration Methods With the Emission Reduction and PM Concentration...

Code of Federal Regulations, 2011 CFR

2011-07-01

... compliance by * * * 1. Requirement to route all process vent streams from equipment in target HAP service to a PM control device with a PM percent reduction efficiency of 95 percent (98 percent for new sources... chemical preparations operation was in target HAP service. The control device monitoring data are averaged...

Low-Cost Embedded Oximeter

NASA Astrophysics Data System (ADS)

Laghrouche, M.; Haddab, S.; Lotmani, S.; Mekdoud, K.; Ameur, S.

2010-01-01

Nowadays, many medical devices have been developed for the purposes of diagnosing and treatment. Wearable sensors and systems have evolved to the point that they can be considered ready for clinical application. The use of wearable monitoring devices that allow continuous or intermittent monitoring of physiological signals is critical for the advancement of both the diagnosis as well as treatment of diseases. Patient vital sign monitoring within hospitals requires the use of noninvasive sensors that are hardwired to bedside monitors. This paper describes the initial bench testing of a wireless wearable pulse oximeter. Arterial oxygen saturation in the patient's blood signal was measured with an optical sensor, and then converted to digital data using a microcontroller system. The digital data were then sent to a receiver where it is in 433 MHz FM/FSK transmitter. At the receiver, the digital data were reconverted to analog signal to be monitored and recorded on the PC.

Integrated Environment for Ubiquitous Healthcare and Mobile IPv6 Networks

NASA Astrophysics Data System (ADS)

Cagalaban, Giovanni; Kim, Seoksoo

The development of Internet technologies based on the IPv6 protocol will allow real-time monitoring of people with health deficiencies and improve the independence of elderly people. This paper proposed a ubiquitous healthcare system for the personalized healthcare services with the support of mobile IPv6 networks. Specifically, this paper discusses the integration of ubiquitous healthcare and wireless networks and its functional requirements. This allow an integrated environment where heterogeneous devices such a mobile devices and body sensors can continuously monitor patient status and communicate remotely with healthcare servers, physicians, and family members to effectively deliver healthcare services.

High Power K Sub a -band Transmitter for Planetary Radar and Spacecraft Uplink

NASA Technical Reports Server (NTRS)

Bhanji, A. M.; Hoppe, D. J.; Hartop, R. W.; Stone, E. W.; Imbriale, W. A.; Stone, D.; Caplan, M.

1984-01-01

A proposed conceptual design of a 400 kW continuous wave (CW)K sub a band transmitter and associated microwave components to be used for planetary radar and serve as a prototype for future spacecraft uplinks is discussed. System requirements for such a transmitter are presented. Performance of the proposed high-power millimeter wave tube, the gyroklystron is discussed. Parameters of the proposed power amplifier, beam supply, and monitor and control devices are also presented. Microwave transmission line components consisting of signal monitoring devices, signal filtering devices, and an overmoded corrugated feed are discussed. Finally, an assessment of the state of the art technology to meet the system requirements is given and possible areas of difficulty are summarized.

Continuous intra-arterial blood-gas monitoring

NASA Astrophysics Data System (ADS)

Divers, George A.; Riccitelli, Samuel D.; Blais, Maurice; Hui, Henry K.

1993-05-01

Fiber optic technology and optical fluorescence have made the continuous monitoring of arterial blood gases a reality. Practical products that continuously monitor blood gases by use of an invasive sensor are now available. Anesthesiologists and intensive care physicians are beginning to explore the practical implications of this technology. With the advent of intra- arterial blood gas monitors it is possible to assess arterial blood gas values without the labor intensive steps of drawing blood and transporting a blood sample to the lab followed by the actual analysis. These intra-arterial blood gas monitors use new optical sensor technologies that can be reduced in size to the point that the sensor can be inserted into the arterial blood flow through a 20-gauge arterial cannula. In the best of these technologies the sensors accuracy and precision are similar to those in vitro analyzers. This presentation focuses on background technology and in vivo performance of a device developed, manufactured, and marketed by Puritan-Bennett Corporation.

An integrated, multisensor system for the continuous monitoring of water dynamics in rice fields under different irrigation regimes.

PubMed

Chiaradia, Enrico Antonio; Facchi, Arianna; Masseroni, Daniele; Ferrari, Daniele; Bischetti, Gian Battista; Gharsallah, Olfa; Cesari de Maria, Sandra; Rienzner, Michele; Naldi, Ezio; Romani, Marco; Gandolfi, Claudio

2015-09-01

The cultivation of rice, one of the most important staple crops worldwide, has very high water requirements. A variety of irrigation practices are applied, whose pros and cons, both in terms of water productivity and of their effects on the environment, are not completely understood yet. The continuous monitoring of irrigation and rainfall inputs, as well as of soil water dynamics, is a very important factor in the analysis of these practices. At the same time, however, it represents a challenging and costly task because of the complexity of the processes involved, of the difference in nature and magnitude of the driving variables and of the high variety of field conditions. In this paper, we present the prototype of an integrated, multisensor system for the continuous monitoring of water dynamics in rice fields under different irrigation regimes. The system consists of the following: (1) flow measurement devices for the monitoring of irrigation supply and tailwater drainage; (2) piezometers for groundwater level monitoring; (3) level gauges for monitoring the flooding depth; (4) multilevel tensiometers and moisture sensor clusters to monitor soil water status; (5) eddy covariance station for the estimation of evapotranspiration fluxes and (6) wireless transmission devices and software interface for data transfer, storage and control from remote computer. The system is modular and it is replicable in different field conditions. It was successfully applied over a 2-year period in three experimental plots in Northern Italy, each one with a different water management strategy. In the paper, we present information concerning the different instruments selected, their interconnections and their integration in a common remote control scheme. We also provide considerations and figures on the material and labour costs of the installation and management of the system.

Continuous glucose monitoring in acute coronary syndrome.

PubMed

Rodríguez-Quintanilla, Karina Alejandra; Lavalle-González, Fernando Javier; Mancillas-Adame, Leonardo Guadalupe; Zapata-Garrido, Alfonso Javier; Villarreal-Pérez, Jesús Zacarías; Tamez-Pérez, Héctor Eloy

2013-01-01

Diabetes mellitus is an independent risk factor for cardiovascular disease. To compare the efficacy of devices for continuous glucose monitoring and capillary glucose monitoring in hospitalized patients with acute coronary syndrome using the following parameters: time to achieve normoglycemia, period of time in normoglycemia, and episodes of hypoglycemia. We performed a pilot, non-randomized, unblinded clinical trial that included 16 patients with acute coronary artery syndrome, a capillary or venous blood glucose ≥ 140 mg/dl, and treatment with a continuous infusion of fast acting human insulin. These patients were randomized into 2 groups: a conventional group, in which capillary measurement and recording as well as insulin adjustment were made every 4h, and an intervention group, in which measurement and recording as well as insulin adjustment were made every hour with a subcutaneous continuous monitoring system. Student's t-test was applied for mean differences and the X(2) test for qualitative variables. We observed a statistically significant difference in the mean time for achieving normoglycemia, favoring the conventional group with a P = 0.02. Continuous monitoring systems are as useful as capillary monitoring for achieving normoglycemia. Copyright © 2012 Instituto Nacional de Cardiología Ignacio Chávez. Published by Masson Doyma México S.A. All rights reserved.

A novel in-situ method for real-time monitoring of gas transport in soil

NASA Astrophysics Data System (ADS)

Laemmel, Thomas; Maier, Martin; Schack-Kirchner, Helmer; Lang, Friederike

2017-04-01

Gas exchange between soil and atmosphere is important for the biogeochemistry of soils. Gas transport in soil is commonly assumed to be governed by molecular diffusion and is usually described by the soil gas diffusion coefficient DS characterizing the ability of the soil to "transport passively" gas through the soil. One way to determine DS is sampling soil cores in the field and measuring DS in the lab. Unfortunately this method is destructive and laborious. Moreover, a few previous field studies identified other gas transport processes in soil to significantly enhance the diffusive gas transport. However, until now, no method is available to measure gas transport in situ in the soil. We developed a novel method to monitor gas transport in soil in situ. The method includes a custom made gas sampling device, the continuous injection of an inert tracer gas and inverse gas transport modelling in the soil. The gas sampling device has several sampling depths and can be easily installed into a vertical hole drilled by an auger, which allows for fast installation of the system. Helium (He) as inert tracer gas was injected continuously at the lower end of the device. The resulting steady state distribution of He was used to deduce the depth profile of DS. Gas transport in the soil surrounding the gas-sampling-device/soil system was modeled using the Finite Element Modeling program COMSOL . We tested our new method both in the lab and during two short field studies and compared the results with a reference method using soil cores. DS profiles obtained by our in-situ method were consistent with DS profiles determined based on soil core analyses. During a longer monitoring field campaign, typical soil-moisture effects upon gas diffusivity such as an increase during a drying period or a decrease after rain could be observed consistently. Under windy conditions we additionally measured for the first time the direct enhancement of gas transport in soil due to wind-induced pressure-pumping which could increase the effective DS up to 30% in the topsoil. Our novel monitoring method can be quickly and easily installed and allows for monitoring continuously soil gas transport over a long time. It allows monitoring physical modifications of soil gas diffusivity due to rain events or evaporation but it also allows studying non-diffusive gas transport processes in the soil.

40 CFR 60.276a - Recordkeeping and reporting requirements.

Code of Federal Regulations, 2014 CFR

2014-07-01

... device, and continuous monitoring equipment; (4) Flow diagram of process and emission capture equipment... at values exceeding ±15 percent of the value established under § 60.274a(c) or operation at flow...

40 CFR 60.276a - Recordkeeping and reporting requirements.

Code of Federal Regulations, 2011 CFR

2011-07-01

... device, and continuous monitoring equipment; (4) Flow diagram of process and emission capture equipment... at values exceeding ±15 percent of the value established under § 60.274a(c) or operation at flow...

40 CFR 60.276a - Recordkeeping and reporting requirements.

Code of Federal Regulations, 2013 CFR

2013-07-01

... device, and continuous monitoring equipment; (4) Flow diagram of process and emission capture equipment... at values exceeding ±15 percent of the value established under § 60.274a(c) or operation at flow...

40 CFR 60.276a - Recordkeeping and reporting requirements.

Code of Federal Regulations, 2010 CFR

2010-07-01

... device, and continuous monitoring equipment; (4) Flow diagram of process and emission capture equipment... at values exceeding ±15 percent of the value established under § 60.274a(c) or operation at flow...

40 CFR 60.276a - Recordkeeping and reporting requirements.

Code of Federal Regulations, 2012 CFR

2012-07-01

... device, and continuous monitoring equipment; (4) Flow diagram of process and emission capture equipment... at values exceeding ±15 percent of the value established under § 60.274a(c) or operation at flow...

Wearable dry sensors with bluetooth connection for use in remote patient monitoring systems.

PubMed

Gargiulo, Gaetano; Bifulco, Paolo; Cesarelli, Mario; Jin, Craig; McEwan, Alistair; van Schaik, Andre

2010-01-01

Cost reduction has become the primary theme of healthcare reforms globally. More providers are moving towards remote patient monitoring, which reduces the length of hospital stays and frees up their physicians and nurses for acute cases and helps them to tackle staff shortages. Physiological sensors are commonly used in many human specialties e.g. electrocardiogram (ECG) electrodes, for monitoring heart signals, and electroencephalogram (EEG) electrodes, for sensing the electrical activity of the brain, are the most well-known applications. Consequently there is a substantial unmet need for physiological sensors that can be simply and easily applied by the patient or primary carer, are comfortable to wear, can accurately sense parameters over long periods of time and can be connected to data recording systems using Bluetooth technology. We have developed a small, battery powered, user customizable portable monitor. This prototype is capable of recording three-axial body acceleration, skin temperature, and has up to four bio analogical front ends. Moreover, it is also able of continuous wireless transmission to any Bluetooth device including a PDA or a cellular phone. The bio-front end can use long-lasting dry electrodes or novel textile electrodes that can be embedded in clothes. The device can be powered by a standard mobile phone which has a Ni-MH 3.6 V battery, to sustain more than seven days continuous functioning when using the Bluetooth Sniff mode to reduce TX power. In this paper, we present some of the evaluation experiments of our wearable personal monitor device with a focus on ECG applications.

Telemetry and Telestimulation via Implanted Devices Necessary in Long-Term Experiments Using Conscious Untethered Animals for the Development of New Medical Treatments

NASA Astrophysics Data System (ADS)

Sugimachi, Masaru; Kawada, Toru; Uemura, Kazunori

Effective countermeasures against explosive increase in healthcare expenditures are urgently needed. A paradigm shift in healthcare is called for, and academics and governments worldwide are working hard on the application of information and communication technologies (ICT) as a feasible and effective measure for reducing medical cost. The more prevalent the disease and the easier disease outcome can be improved, the more efficient is medical ICT in reducing healthcare cost. Hypertension and diabetes mellitus are such examples. Chronic heart failure is another disease in which patients may benefit from ICT-based medical practice. It is conceivable that daily monitoring of hemodynamics together with appropriate treatments may obviate the expensive hospitalization. ICT potentially permit continuous monitoring with wearable or implantable medical devices. ICT may also help accelerate the development of new therapeutic devices. Traditionally effectiveness of treatments is sequentially examined by sacrificing a number of animals at a given time point. These inefficient and inaccurate methods can be replaced by applying ICT to the devices used in chronic animal experiments. These devices allow researchers to obtain biosignals and images from live animals without killing them. They include implantable telemetric devices, implantable telestimulation devices, and imaging devices. Implanted rather than wired monitoring and stimulation devices permit experiments to be conducted under even more physiological conditions, i.e., untethered, free-moving states. Wireless communication and ICT are indispensible technologies for the development of such telemetric and telestimulation devices.

40 CFR 63.9306 - What are my continuous parameter monitoring system (CPMS) installation, operation, and...

Code of Federal Regulations, 2012 CFR

2012-07-01

... device to the atmosphere. (ii) Car-seal or lock-and-key valve closures. Secure any bypass line valve in the closed position with a car-seal or a lock-and-key type configuration. You must visually inspect... components for integrity and electrical connections for continuity, oxidation, and galvanic corrosion. (d...

Portable System for Monitoring the Microclimate in the Footwear-Foot Interface

PubMed Central

Sandoval-Palomares, José de Jesús; Yáñez-Mendiola, Javier; Gómez-Espinosa, Alfonso; López-Vela, José Martin

2016-01-01

A new, continuously-monitoring portable device that monitors the diabetic foot has shown to help in reduction of diabetic foot complications. Persons affected by diabetic foot have shown to be particularly sensitive in the plantar surface; this sensitivity coupled with certain ambient conditions may cause dry skin. This dry skin leads to the formation of fissures that may eventually result in a foot ulceration and subsequent hospitalization. This new device monitors the micro-climate temperature and humidity areas between the insole and sole of the footwear. The monitoring system consists of an array of ten sensors that take readings of relative humidity within the range of 100% ± 2% and temperature within the range of −40 °C to 123.8 ± 0.3 °C. Continuous data is collected using embedded C software and the recorded data is processed in Matlab. This allows for the display of data; the implementation of the iterative Gauss-Newton algorithm method was used to display an exponential response curve. Therefore, the aim of our system is to obtain feedback data and provide the critical information to various footwear manufacturers. The footwear manufactures will utilize this critical information to design and manufacture diabetic footwear that reduce the risk of ulcers in diabetic feet. PMID:27399718

40 CFR 63.4768 - What are the requirements for continuous parameter monitoring system installation, operation, and...

Code of Federal Regulations, 2014 CFR

2014-07-01

... using a carbon adsorber as an add-on control device, you must monitor the total regeneration desorbing gas (e.g., steam or nitrogen) mass flow for each regeneration cycle, the carbon bed temperature after each regeneration and cooling cycle, and comply with paragraphs (a)(3) through (5) and (d)(1) and (2...

Environment quality monitoring using ARM processor

NASA Astrophysics Data System (ADS)

Vinaya, C. H.; Krishna Thanikanti, Vamsi; Ramasamy, Sudha

2017-11-01

This paper of air quality monitoring system describes a model of sensors network to continuously monitoring the environment with low cost developed model. At present time all over the world turned into a great revolution in industrial domain and on the other hand environment get polluting in a dangerous value. There are so many technologies present to reduce the polluting contents but still there is no completely reduction of that pollution. Even there are different methods to monitor the pollution content; these are much costly that not everyone can adapt those methods or devices. Now we are proposing a sensors connected network to monitor the environment continuously and displaying the pollutant gases percentage in air surroundings and can transmit the results to our mobiles by message. The advantage of this system is easy to design, establish at area to monitor, maintenance and most cost effective as well.

Biosensors for Real-Time Monitoring of Radiation-Induced Biologic Effects in Space

NASA Technical Reports Server (NTRS)

Baker, James R.; Balogh, Lajos; Majoros, Istvan; Keszler, Balazs; Myc, Andrzej; Kukowska-Latallo, Jolanta; Norris, Theodore; delaiglesia, Felix; Beeson, Nicholas W. (Compiler)

2002-01-01

This work seeks to develop cellular biosensors based on dendritic polymers. Nanoscale polymer structures less than 20 nm in diameter will be used as the basis of the biosensors. The structures will be designed to target into specific cells of an astronaut and be able to monitor health issues such as exposure to radiation. Multiple components can be assembled on the polymers including target directors, analytical devices (such as molecular probes), and reporting agents. The reporting will be accomplished through fluorescence signal monitoring, with the use of multispectral analysis for signal interpretation. These nanosensors could facilitate the success and increase the safety of extended space flight. The design and assembly of these devices has been pioneered at the Center for Biologic Nanotechnology in the University of Michigan. This period, synthesis of the test-bed biosensors continued. Studies were performed on the candidate fluorescent dyes to determine which might be suitable for the biosensor under development. Development continued on producing an artificial capillary bed as a tool for the use in the production of the fluorescence signal monitor. Work was also done on the in vitro multispectral analysis system, which uses the robotic microscope.

Considerations for an institution for evaluation of diabetes technology devices to improve their quality in the European Union.

PubMed

Heinemann, Lutz; Freckmann, Guido; Koschinsky, Theodor

2013-03-01

All medical devices used for self-monitoring of blood glucose (BG), insulin injection, continuous subcutaneous insulin infusion, and continuous glucose monitoring in the European Union (EU) must have a Communauté Européenne (CE) mark. However, the approval process for obtaining this mark is different from that used by the European Medicines Agency in the EU for drugs or by the Food and Drug Administration in the United States for such medical and in vitro diagnostic devices. The notified bodies involved in the CE mark process perform this evaluation in cooperation with the manufacturers. They have only limited diabetes know-how; they have to handle all kinds of medical devices. There are devices for therapy on the market in the EU (i.e., they have market approval) that do not fulfill quality requirements, as indicated, for example, in the international norm ISO 15197 for BG test systems. Evaluation of the performance of such systems is usually provided by the manufacturers. What is missing in the EU is an independent institution that performs regular and critical evaluation of the quality of devices used for diabetes therapy before and also after their market approval. The work of such an institution would focus on BG test systems (these represent two-thirds of the market of medical devices for diabetes treatment) but would also evaluate the performance of other devices. It has to be clarified what legal framework is required for such an institution and how it can be financed; probably this can be done in a shared manner by the manufacturers of such devices and the health insurance companies. Positive evaluation results should be a prerequisite prior to any reimbursement for such devices. © 2013 Diabetes Technology Society.

Wireless miniature implantable devices and ASICs for monitoring, treatment, and study of glaucoma and cardiac disease

NASA Astrophysics Data System (ADS)

Chow, Eric Y.

Glaucoma affects about 65 million people and is the second leading cause of blindness in the world. Although the condition is irreversible and incurable, early detection is vital to slowing and even stopping the progression of the disease. Our work focuses on the design, fabrication, and assembly of a continuous active glaucoma intraocular pressure (IOP) monitor that provides clinicians with the necessary data to more accurately diagnose and treat patients. Major benefits of an active monitoring device include the potential to develop a closed-loop treatment system and to operate independently for extended periods of time. The fully wireless operation uses gigahertzfrequency electromagnetic wave propagation, which allows for an orientation independent transfer of power and data over reasonable distances. Our system is comprised of a MEMS capacitive sensor, capacitive power storage array, ASIC, and monopole antenna assembled into a biocompatible liquid crystal polymer (LCP) package. We have performed in vivo trials on rabbits, both chronic and acute, to validate system functionality, fully wireless feasibility, and biocompatibility. Heart failure (HF) affects approximately 2% of the adult population in developed countries and 6-10% of people over the age of 65. Continuous monitoring of blood pressure, flow, and chemistry from a minimally invasive device can serve as a diagnostic and early-warning system for cardiac health. We developed a miniaturized system attached to the outer surface of an FDA approved stent, used as both the antenna for wireless telemetry/powering and structural support. The system comprises of a MEMS pressure sensor, ASIC for the sensor interface and wireless capabilities, LCP substrate, and FDA approved stent. In vivo studies on pigs validated functionality and fully wireless operation and demonstrate the feasibility of a stent-based wireless implant for continuous monitoring of blood pressure as well as other parameters including oxygen, flow and turbulence, chemistry, and glucose.

Validation of a Wireless, Self-Application, Ambulatory Electroencephalographic Sleep Monitoring Device in Healthy Volunteers.

PubMed

Finan, Patrick H; Richards, Jessica M; Gamaldo, Charlene E; Han, Dingfen; Leoutsakos, Jeannie Marie; Salas, Rachel; Irwin, Michael R; Smith, Michael T

2016-11-15

To evaluate the validity of an ambulatory electroencephalographic (EEG) monitor for the estimation of sleep continuity and architecture in healthy adults. Healthy, good sleeping participants (n = 14) were fit with both an ambulatory EEG monitor (Sleep Profiler) and a full polysomnography (PSG) montage. EEG recordings were gathered from both devices on the same night, during which sleep was permitted uninterrupted for eight hours. The study was set in an inpatient clinical research suite. PSG and Sleep Profiler records were scored by a neurologist board certified in sleep medicine, blinded to record identification. Agreement between the scored PSG record, the physician-scored Sleep Profiler record, and the Sleep Profiler record scored by an automatic algorithm was evaluated for each sleep stage, with the PSG record serving as the reference. Results indicated strong percent agreement across stages. Kappa was strongest for Stage N3 and REM. Specificity was high for all stages; sensitivity was low for Wake and Stage N1, and high for Stage N2, Stage N3, and REM. Agreement indices improved for the manually scored Sleep Profiler record relative to the autoscore record. Overall, the Sleep Profiler yields an EEG record with comparable sleep architecture estimates to PSG. Future studies should evaluate agreement between devices with a clinical sample that has greater periods of wake in order to better understand utility of this device for estimating sleep continuity indices, such as sleep onset latency and wake after sleep onset. © 2016 American Academy of Sleep Medicine

Toward achieving precision health

PubMed Central

Gambhir, Sanjiv Sam; Ge, T. Jessie; Vermesh, Ophir; Spitler, Ryan

2018-01-01

Health care systems primarily focus on patients after they present with disease, not before. The emerging field of precision health encourages disease prevention and earlier detection by monitoring health and disease based on an individual’s risk. Active participation in health care can be encouraged with continuous health-monitoring devices, providing a higher-resolution picture of human health and disease. However, the development of monitoring technologies must prioritize the collection of actionable data and long-term user engagement. PMID:29491186

Expert panel consensus recommendations for home blood pressure monitoring in Asia: the Hope Asia Network.

PubMed

Park, Sungha; Buranakitjaroen, Peera; Chen, Chen-Huan; Chia, Yook-Chin; Divinagracia, Romeo; Hoshide, Satoshi; Shin, Jinho; Siddique, Saulat; Sison, Jorge; Soenarta, Arieska Ann; Sogunuru, Guru Prasad; Tay, Jam Chin; Turana, Yuda; Wang, Ji-Guang; Zhang, Yuqing; Kario, Kazuomi

2018-04-01

Hypertension is the leading cause of mortality throughout Asia. Home blood pressure monitoring has the potential to improve hypertension control and is a useful adjunct to conventional office blood pressure measurements due to its diagnostic accuracy and prognostic value in predicting cardiovascular outcomes. At present, there are no region-specific guidelines addressing the use of home blood pressure monitoring in Asia. Therefore, an expert panel was convened to address the use of home blood pressure monitoring and develop key recommendations to help guide clinical practice throughout the Asia region. The resulting recommendations support the use of home blood pressure monitoring with a validated device as an accurate adjunct for diagnosing hypertension and predicting cardiovascular outcome. Diagnosis and treatment of hypertension should still be guided by conventional office/clinic blood pressure measurements. The expert panel encourages the incorporation of home blood pressure monitoring into local clinical guidelines and offers practical recommendations to ensure continuity of care where a validated home blood pressure device is not available.

Recent advancement in biosensors technology for animal and livestock health management.

PubMed

Neethirajan, Suresh; Tuteja, Satish K; Huang, Sheng-Tung; Kelton, David

2017-12-15

The term biosensors encompasses devices that have the potential to quantify physiological, immunological and behavioural responses of livestock and multiple animal species. Novel biosensing methodologies offer highly specialised monitoring devices for the specific measurement of individual and multiple parameters covering an animal's physiology as well as monitoring of an animal's environment. These devices are not only highly specific and sensitive for the parameters being analysed, but they are also reliable and easy to use, and can accelerate the monitoring process. Novel biosensors in livestock management provide significant benefits and applications in disease detection and isolation, health monitoring and detection of reproductive cycles, as well as monitoring physiological wellbeing of the animal via analysis of the animal's environment. With the development of integrated systems and the Internet of Things, the continuously monitoring devices are expected to become affordable. The data generated from integrated livestock monitoring is anticipated to assist farmers and the agricultural industry to improve animal productivity in the future. The data is expected to reduce the impact of the livestock industry on the environment, while at the same time driving the new wave towards the improvements of viable farming techniques. This review focusses on the emerging technological advancements in monitoring of livestock health for detailed, precise information on productivity, as well as physiology and well-being. Biosensors will contribute to the 4th revolution in agriculture by incorporating innovative technologies into cost-effective diagnostic methods that can mitigate the potentially catastrophic effects of infectious outbreaks in farmed animals. Copyright © 2017 Elsevier B.V. All rights reserved.

Post-operative blood loss monitoring device: a new tool for nursing activities.

PubMed

Logier, R; Carette, D; Sozanski, J P; Jeanne, M; Jounwaz, R; De Jonckheere, J

2012-01-01

In most medical specialties, after surgery, it is usual to place a drain at the operative site level, in order to assist the blood flow-out if necessary. This drainage allows avoiding the formation of hematomas and contributes to tissues recovery. However, postoperative blood loss can lead to serious consequences. Also, it is necessary to continuously check the blood output volume in order to be able to intervene quickly in case of too significant losses. In daily clinical practice, this task is due to the nursing staff that periodically records the blood level inside the supple bag connected to the drain. However, this method is not accurate about the volume of lost blood and does not reflect the flow of losses which is an important parameter regarding the evolution of the patient setting. We have designed and developed a prototype of a blood loss monitoring device based on the continuous weight measurement of the blood bag connected to the drain. This device is fixed on the bed and is able to instantaneously alert the medical staff in case of abnormal blood flow-out.

A microfluidic device for real-time monitoring of Bacillus subtilis bacterial spores during germination based on non-specific physicochemical interactions on the nanoscale level.

PubMed

Zabrocka, L; Langer, K; Michalski, A; Kocik, J; Langer, J J

2015-01-07

A microfluidic device for studies on the germination of bacterial spores (e.g. Bacillus subtilis) based on non-specific interactions on the nanoscale is presented. A decrease in the population of spores during germination followed by the appearance of transition forms and an increase in the number of vegetative cells can be registered directly and simultaneously by using the microfluidic device, which is equipped with a conductive polymer layer (polyaniline) in the form of a nano-network. The lab-on-a-chip-type device, operating in a continuous flow regime, allows monitoring of germination of bacterial spores and analysis of the process in detail. The procedure is fast and accurate enough for quantitative real-time monitoring of the main steps of germination, including final transformation of the spores into vegetative cells. All of this is done without the use of biomarkers or any bio-specific materials, such as enzymes, antibodies and aptamers, and is simply based on an analysis of physicochemical interactions on the nanoscale level.

Solar powered wrist worn acquisition system for continuous photoplethysmogram monitoring.

PubMed

Dieffenderfer, James P; Beppler, Eric; Novak, Tristan; Whitmire, Eric; Jayakumar, Rochana; Randall, Clive; Qu, Weiguo; Rajagopalan, Ramakrishnan; Bozkurt, Alper

2014-01-01

We present a solar-powered, wireless, wrist-worn platform for continuous monitoring of physiological and environmental parameters during the activities of daily life. In this study, we demonstrate the capability to produce photoplethysmogram (PPG) signals using this platform. To adhere to a low power budget for solar-powering, a 574 nm green light source is used where the PPG from the radial artery would be obtained with minimal signal conditioning. The system incorporates two monocrystalline solar cells to charge the onboard 20 mAh lithium polymer battery. Bluetooth Low Energy (BLE) is used to tether the device to a smartphone that makes the phone an access point to a dedicated server for long term continuous storage of data. Two power management schemes have been proposed depending on the availability of solar energy. In low light situations, if the battery is low, the device obtains a 5-second PPG waveform every minute to consume an average power of 0.57 mW. In scenarios where the battery is at a sustainable voltage, the device is set to enter its normal 30 Hz acquisition mode, consuming around 13.7 mW. We also present our efforts towards improving the charge storage capacity of our on-board super-capacitor.

Development of a wearable multi-frequency impedance cardiography device.

PubMed

Weyer, Sören; Menden, Tobias; Leicht, Lennart; Leonhardt, Steffen; Wartzek, Tobias

2015-02-01

Cardiovascular diseases as well as pulmonary oedema can be early diagnosed using vital signs and thoracic bio-impedance. By recording the electrocardiogram (ECG) and the impedance cardiogram (ICG), vital parameters are captured continuously. The aim of this study is the continuous monitoring of ECG and multi-frequency ICG by a mobile system. A mobile measuring system, based on 'low-power' ECG, ICG and an included radio transmission is described. Due to the high component integration, a board size of only 6.5 cm×5 cm could be realized. The measured data can be transmitted via Bluetooth and visualized on a portable monitor. By using energy-efficient hardware, the system can operate for up to 18 hs with a 3 V battery, continuously sending data via Bluetooth. Longer operating times can be realized by decreased transfer rates. The relative error of the impedance measurement was less than 1%. The ECG and ICG measurements allow an approximate calculation of the heart stroke volume. The ECG and the measured impedance showed a high correlation to commercial devices (r=0.83, p<0.05). In addition to commercial devices, the developed system allows a multi-frequency measurement of the thoracic impedance between 5-150 kHz.

Use of near-infrared spectroscopy (NIRS) in cerebral tissue oxygenation monitoring in neonates.

PubMed

Gumulak, Rene; Lucanova, Lucia Casnocha; Zibolen, Mirko

2017-06-01

Near-infrared spectroscopy (NIRS) is a technology capable of non-invasive, continuous measuring of regional tissue oxygen saturation (StO 2 ). StO 2 represents a state of hemodynamic stability, which is influenced by many factors. Extensive research has been done in the field of measuring StO 2 of various organs. The current clinical availability of several NIRS-based devices reflects an important development in prevention, detection and correction of discrepancy in oxygen delivery to the brain and vital organs. Managing cerebral ischemia remains a significant issue in the neonatal intensive care units (NICU). Cerebral tissue oxygenation (cStO 2 ) and cerebral fractional tissue extraction (cFTOE) are reported in a large number of clinical studies. This review provides a summary of the concept of function, current variability of NIRS-based devices used in neonatology, clinical applications in continuous cStO 2 monitoring, limitations, disadvantages, and the potential of current technology.

Automated integration of continuous glucose monitor data in the electronic health record using consumer technology.

PubMed

Kumar, Rajiv B; Goren, Nira D; Stark, David E; Wall, Dennis P; Longhurst, Christopher A

2016-05-01

The diabetes healthcare provider plays a key role in interpreting blood glucose trends, but few institutions have successfully integrated patient home glucose data in the electronic health record (EHR). Published implementations to date have required custom interfaces, which limit wide-scale replication. We piloted automated integration of continuous glucose monitor data in the EHR using widely available consumer technology for 10 pediatric patients with insulin-dependent diabetes. Establishment of a passive data communication bridge via a patient's/parent's smartphone enabled automated integration and analytics of patient device data within the EHR between scheduled clinic visits. It is feasible to utilize available consumer technology to assess and triage home diabetes device data within the EHR, and to engage patients/parents and improve healthcare provider workflow. © The Author 2016. Published by Oxford University Press on behalf of the American Medical Informatics Association.

Continuous Glucose Monitoring (CGM) or Blood Glucose Monitoring (BGM): Interactions and Implications.

PubMed

Heinemann, Lutz

2018-04-01

At the 2017 10th annual International Conference on Advanced Technologies and Treatments for Diabetes (ATTD) in Paris, France, four speakers presented their perspectives on the roles of continuous glucose monitoring (CGM) and of blood glucose monitoring (BGM) in patient management within one symposium. These presentations included discussions of the differences in the accuracy of CGM and BGM, a clinical perspective on the physiological reasons behind differences in CGM and BGM values, and an overview of the impact of variations in device accuracy on patients with diabetes. Subsequently a short summary of these presentations is given, highlighting the value of good accuracy of BGM or CGM systems and the ongoing need for standardization. The important role of both BGM and CGM in patient management was a theme across all presentations.

Tracking and Counting Motion for Monitoring Food Intake Based-On Depth Sensor and UDOO Board: A Comprehensive Review

NASA Astrophysics Data System (ADS)

Kassim, Muhammad Fuad bin; Norzali Haji Mohd, Mohd

2017-08-01

Technology is all about helping people, which created a new opportunity to take serious action in managing their health care. Moreover, Obesity continues to be a serious public health concern in the Malaysia and continuing to rise. Obesity has been a serious health concern among people. Nearly half of Malaysian people overweight. Most of dietary approach is not tracking and detecting the right calorie intake for weight loss, but currently used tools such as food diaries require users to manually record and track the food calories, making them difficult for daily use. We will be developing a new tool that counts the food intake bite by monitoring hand gesture and face jaw motion movement of caloric intake. The Bite count method showed a good significant that can lead to a successful weight loss by simply monitoring the bite taken during eating. The device used was Kinect Xbox One which used a depth camera to detect the motion on person hand and face during food intake. Previous studies showed that most of the method used to count bite device is worn type. The recent trend is now going towards non-wearable devices due to the difficulty when wearing devices and it has high false alarm ratio. The proposed system gets data from the Kinect that will be monitoring the hand and face gesture of the user while eating. Then, the gesture of hand and face data is sent to the microcontroller board to recognize and start counting bite taken by the user. The system recognizes the patterns of bite taken from user by following the algorithm of basic eating type either using hand or chopstick. This system can help people who are trying to follow a proper way to reduce overweight or eating disorders by monitoring their meal intake and controlling eating rate.

Approaching near real-time biosensing: microfluidic microsphere based biosensor for real-time analyte detection.

PubMed

Cohen, Noa; Sabhachandani, Pooja; Golberg, Alexander; Konry, Tania

2015-04-15

In this study we describe a simple lab-on-a-chip (LOC) biosensor approach utilizing well mixed microfluidic device and a microsphere-based assay capable of performing near real-time diagnostics of clinically relevant analytes such cytokines and antibodies. We were able to overcome the adsorption kinetics reaction rate-limiting mechanism, which is diffusion-controlled in standard immunoassays, by introducing the microsphere-based assay into well-mixed yet simple microfluidic device with turbulent flow profiles in the reaction regions. The integrated microsphere-based LOC device performs dynamic detection of the analyte in minimal amount of biological specimen by continuously sampling micro-liter volumes of sample per minute to detect dynamic changes in target analyte concentration. Furthermore we developed a mathematical model for the well-mixed reaction to describe the near real time detection mechanism observed in the developed LOC method. To demonstrate the specificity and sensitivity of the developed real time monitoring LOC approach, we applied the device for clinically relevant analytes: Tumor Necrosis Factor (TNF)-α cytokine and its clinically used inhibitor, anti-TNF-α antibody. Based on the reported results herein, the developed LOC device provides continuous sensitive and specific near real-time monitoring method for analytes such as cytokines and antibodies, reduces reagent volumes by nearly three orders of magnitude as well as eliminates the washing steps required by standard immunoassays. Copyright © 2014 Elsevier B.V. All rights reserved.

In vivo continuous and simultaneous monitoring of brain energy substrates with a multiplex amperometric enzyme-based biosensor device.

PubMed

Cordeiro, C A; de Vries, M G; Ngabi, W; Oomen, P E; Cremers, T I F H; Westerink, B H C

2015-05-15

Enzyme-based amperometric biosensors are widely used for monitoring key biomarkers. In experimental neuroscience there is a growing interest in in vivo continuous and simultaneous monitoring of metabolism-related biomarkers, like glucose, lactate and pyruvate. The use of multiplex biosensors will provide better understanding of brain energy metabolism and its role in neuropathologies such as diabetes, ischemia, and epilepsy. We have developed and characterized an implantable multiplex microbiosensor device (MBD) for simultaneous and continuous in vivo monitoring of glucose, lactate, and pyruvate. First, we developed and characterized amperometric microbiosensors for monitoring lactate and pyruvate. In vitro evaluation allowed us to choose the most suitable biosensors for incorporation into the MBD, along with glucose and background biosensors. Fully assembled MBDs were characterized in vitro. The calculated performance parameters (LOD, LR, LRS, IMAX and appKM) showed that the multiplex MBD was highly selective and sensitive (LRS≥100 nA/mM) for each analyte and within an adequate range for in vivo application. Finally, MBDs were implanted in the mPFC of anesthetized adult male Wistar rats for in vivo evaluation. Following an equilibration period, baseline brain levels of glucose (1.3±0.2 mM), lactate (1.5±0.4 mM) and pyruvate (0.3±0.1 mM) were established. Subsequently, the MBDs recorded the responses of the animals when submitted to hyperglycemic (40% glucose i.v.) and hypoglycemic (5 U/kg insulin i.v.) challenges. Afterwards, MBDs were recalibrated to convert electrochemical readings into accurate substrate concentrations and to assess biofouling. The presented MBD can monitor simultaneously multiple biomarkers in vivo. Copyright © 2014 Elsevier B.V. All rights reserved.

Smart wearable systems: current status and future challenges.

PubMed

Chan, Marie; Estève, Daniel; Fourniols, Jean-Yves; Escriba, Christophe; Campo, Eric

2012-11-01

Extensive efforts have been made in both academia and industry in the research and development of smart wearable systems (SWS) for health monitoring (HM). Primarily influenced by skyrocketing healthcare costs and supported by recent technological advances in micro- and nanotechnologies, miniaturisation of sensors, and smart fabrics, the continuous advances in SWS will progressively change the landscape of healthcare by allowing individual management and continuous monitoring of a patient's health status. Consisting of various components and devices, ranging from sensors and actuators to multimedia devices, these systems support complex healthcare applications and enable low-cost wearable, non-invasive alternatives for continuous 24-h monitoring of health, activity, mobility, and mental status, both indoors and outdoors. Our objective has been to examine the current research in wearable to serve as references for researchers and provide perspectives for future research. Herein, we review the current research and development of and the challenges facing SWS for HM, focusing on multi-parameter physiological sensor systems and activity and mobility measurement system designs that reliably measure mobility or vital signs and integrate real-time decision support processing for disease prevention, symptom detection, and diagnosis. For this literature review, we have chosen specific selection criteria to include papers in which wearable systems or devices are covered. We describe the state of the art in SWS and provide a survey of recent implementations of wearable health-care systems. We describe current issues, challenges, and prospects of SWS. We conclude by identifying the future challenges facing SWS for HM. Copyright © 2012 Elsevier B.V. All rights reserved.

Microcomputer monitor system and device for non-touch measurement of turbine blade vibration

NASA Astrophysics Data System (ADS)

Zheng, Shu-Chen; Liu, Bo; Qu, Zhi-Huan; Din, Ke-Ke

To study the aeroelastic phenomena in turbomachinery, a microcomputer monitor system and device for nonintrusive measurement of turbine blade vibration is developed. The system can continuously measure blade amplitude of vibration, phase angle, and torsional angle, when the machinery blades encounter vibration. In the case of turbine operation, it can display and print the vibrating parameters measured by the system, automatically give out the warning when blade amplitude of vibration is bigger than safety value, or blades break. The vibrating parameters in a span of time before the break occurs is recorded. A forecast is produced as blades enter the flutter boundary.

Design of a prototype device for remote patient care with mild cognitive impairment

NASA Astrophysics Data System (ADS)

Sanchez-Ocampo, M.; Segura-Giraldo, B.; Floréz-Hurtado, R.; Cortés-Aguirre, C.

2016-04-01

This paper describes the design of a prototype telecare system, which allows to provide home care to patients with mild cognitive impairment and thus ensures their permanence in their usual environment. Telecare is oriented towards people who require constant attention due to conditions of advanced age, illness, physical risk or limited capabilities. Telecare offers these people a greater degree of independence. QFD methodology is used to develop electronic devices intended to monitor the environment and physiological state of the user continuously, providing communication between the telecare system and a monitoring center in order to take the most appropriate actions in any abnormal event.

Noninvasive Hemodynamic Measurements During Neurosurgical Procedures in Sitting Position.

PubMed

Schramm, Patrick; Tzanova, Irene; Gööck, Tilman; Hagen, Frank; Schmidtmann, Irene; Engelhard, Kristin; Pestel, Gunther

2017-07-01

Neurosurgical procedures in sitting position need advanced cardiovascular monitoring. Transesophageal echocardiography (TEE) to measure cardiac output (CO)/cardiac index (CI) and stroke volume (SV), and invasive arterial blood pressure measurements for systolic (ABPsys), diastolic (ABPdiast) and mean arterial pressure (MAP) are established monitoring technologies for these kind of procedures. A noninvasive device for continuous monitoring of blood pressure and CO based on a modified Penaz technique (volume-clamp method) was introduced recently. In the present study the noninvasive blood pressure measurements were compared with invasive arterial blood pressure monitoring, and the noninvasive CO monitoring to TEE measurements. Measurements of blood pressure and CO were performed in 35 patients before/after giving a fluid bolus and a change from supine to sitting position, start of surgery, and repositioning from sitting to supine at the end of surgery. Data pairs from the noninvasive device (Nexfin HD) versus arterial line measurements (ABPsys, ABPdiast, MAP) and versus TEE (CO, CI, SV) were compared using Bland-Altman analysis and percentage error. All parameters compared (CO, CI, SV, ABPsys, ABPdiast, MAP) showed a large bias and wide limits of agreement. Percentage error was above 30% for all parameters except ABPsys. The noninvasive device based on a modified Penaz technique cannot replace arterial blood pressure monitoring or TEE in anesthetized patients undergoing neurosurgery in sitting position.

vMon-mobile provides wireless connection to the electronic patient record

NASA Astrophysics Data System (ADS)

Oliveira, Pedro P., Jr.; Rebelo, Marina; Pilon, Paulo E.; Gutierrez, Marco A.; Tachinardi, Umberto

2002-05-01

This work presents the development of a set of tools to help doctors to continuously monitor critical patients. Real-time monitoring signals are displayed via a Web Based Electronic Patient Record (Web-EPR) developed at the Heart Institute. Any computer on the Hospital's Intranet can access the Web-EPR that will open a browser plug-in called vMon. Recently vMon was adapted to wireless mobile devices providing the same real-time visualization of vital signals of its desktop counterpart. The monitoring network communicates with the hospital network through a gateway using HL7 messages and has the ability to export waveforms in real time using the multicast protocol through an API library. A dedicated ActiveX component was built that establishes the streaming of the biomedical signals under monitoring and displays them on an Internet Explorer 5.x browser. The mobile version - called vMon-mobile - will parse the browser window and deliver it to a PDA device connected to a local area network. The result is a virtual monitor presenting real-time data on a mobile device. All parameters and signals acquired from the moment the patient is connected to the monitors are stored for a few days. The most clinically relevant information is added to patient's EPR.

Wireless patient monitoring system for a moving-actuator type artificial heart.

PubMed

Nam, K W; Chung, J; Choi, S W; Sun, K; Min, B G

2006-10-01

In this study, we developed a wireless monitoring system for outpatients equipped with a moving-actuator type pulsatile bi-ventricular assist device, AnyHeart. The developed monitoring system consists of two parts; a Bluetooth-based short-distance self-monitoring system that can monitor and control the operating status of a VAD using a Bluetooth-embedded personal digital assistant or a personal computer within a distance of 10 meters, and a cellular network-based remote monitoring system that can continuously monitor and control the operating status of AnyHeart at any location. Results of in vitro experiments demonstrate the developed system's ability to monitor the operational status of an implanted AnyHeart.

Forward voltage short-pulse technique for measuring high power laser array junction temperature

NASA Technical Reports Server (NTRS)

Meadows, Byron L. (Inventor); Amzajerdian, Frazin (Inventor); Barnes, Bruce W. (Inventor); Baker, Nathaniel R. (Inventor)

2012-01-01

The present invention relates to a method of measuring the temperature of the P-N junction within the light-emitting region of a quasi-continuous-wave or pulsed semiconductor laser diode device. A series of relatively short and low current monitor pulses are applied to the laser diode in the period between the main drive current pulses necessary to cause the semiconductor to lase. At the sufficiently low current level of the monitor pulses, the laser diode device does not lase and behaves similar to an electronic diode. The voltage across the laser diode resulting from each of these low current monitor pulses is measured with a high degree of precision. The junction temperature is then determined from the measured junction voltage using their known linear relationship.

Advanced Materials for Health Monitoring with Skin-Based Wearable Devices.

PubMed

Jin, Han; Abu-Raya, Yasmin Shibli; Haick, Hossam

2017-06-01

Skin-based wearable devices have a great potential that could result in a revolutionary approach to health monitoring and diagnosing disease. With continued innovation and intensive attention to the materials and fabrication technologies, development of these healthcare devices is progressively encouraged. This article gives a concise, although admittedly non-exhaustive, didactic review of some of the main concepts and approaches related to recent advances and developments in the scope of skin-based wearable devices (e.g. temperature, strain, biomarker-analysis werable devices, etc.), with an emphasis on emerging materials and fabrication techniques in the relevant fields. To give a comprehensive statement, part of the review presents and discusses different aspects of these advanced materials, such as the sensitivity, biocompatibility and durability as well as the major approaches proposed for enhancing their chemical and physical properties. A complementary section of the review linking these advanced materials with wearable device technologies is particularly specified. Some of the strong and weak points in development of each wearable material/device are highlighted and criticized. Several ideas regarding further improvement of skin-based wearable devices are also discussed. © 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Monitoring the health of power transformers

DOE Office of Scientific and Technical Information (OSTI.GOV)

Kirtley, J.L. Jr.; Hagman, W.H.; Lesieutre, B.C.

This article reviews MIT`s model-based system which offers adaptive, intelligent surveillance of transformers, and summons attention to anomalous operation through paging devices. Failures of large power transformers are problematic for four reasons. Generally, large transformers are situated so that failures present operational problems to the system. In addition, large power transformers are encased in tanks of flammable and environmentally hazardous fluid. Failures are often accompanied by fire and/or spillage of this fluid. This presents hazards to people, other equipment and property, and the local environment. Finally, large power transformers are costly devices. There is a clear incentive for utilities tomore » keep track of the health of their power transformers. Massachusetts Institute of Technology (MIT) has developed an adaptive, intelligent, monitoring system for large power transformers. Four large transformers on the Boston Edison system are under continuous surveillance by this system, which can summon attention to anomalous operation through paging devices. The monitoring system offers two advantages over more traditional (not adaptive) methods of tracking transformer operation.« less

Pulsed Phase Lock Loop Device for Monitoring Intracranial Pressure During Space Flight

NASA Technical Reports Server (NTRS)

Ueno, Toshiaki; Macias, Brandon R.; Yost, William T.; Hargens, Alan R.

2003-01-01

We have developed an ultrasonic device to monitor ICP waveforms non-invasively from cranial diameter oscillations using a NASA-developed pulsed phase lock loop (PPLL) technique. The purpose of this study was to attempt to validate the PPLL device for reliable recordings of ICP waveforms and analysis of ICP dynamics in vivo. METHODS: PPLL outputs were recorded in patients during invasive ICP monitoring at UCSD Medical Center (n=10). RESULTS: An averaged linear regression coefficient between ICP and PPLL waveform data during one cardiac cycle in all patients is 0.88 +/- 0.02 (mean +/- SE). Coherence function analysis indicated that ICP and PPLL waveforms have high correlation in the lst, 2nd, and 3rd harmonic waves associated with a cardiac cycle. CONCLUSIONS: PPLL outputs represent ICP waveforms in both frequency and time domains. PPLL technology enables in vivo evaluation of ICP dynamics non-invasively, and can acquire continuous ICP waveforms during spaceflight because of compactness and non-invasive nature.

A wearable bluetooth LE sensor for patient monitoring during MRI scans.

PubMed

Vogt, Christian; Reber, Jonas; Waltisberg, Daniel; Buthe, Lars; Marjanovic, Josip; Munzenrieder, Niko; Pruessmann, Klaas P; Troster, Gerhard

2016-08-01

This paper presents a working prototype of a wearable patient monitoring device capable of recording the heart rate, blood oxygen saturation, surface temperature and humidity during an magnetic resonance imaging (MRI) experiment. The measured values are transmitted via Bluetooth low energy (LE) and displayed in real time on a smartphone on the outside of the MRI room. During 7 MRI image acquisitions of at least 1 min and a total duration of 25 min no Bluetooth data packets were lost. The raw measurements of the light intensity for the photoplethysmogram based heart rate measurement shows an increased noise floor by 50LSB (least significant bit) during the MRI operation, whereas the temperature and humidity readings are unaffected. The device itself creates a magnetic resonance (MR) signal loss with a radius of 14 mm around the device surface and shows no significant increase in image noise of an acquired MRI image due to its radio frequency activity. This enables continuous and unobtrusive patient monitoring during MRI scans.

Printable thermoelectric devices and conductive patterns for medical applications

NASA Astrophysics Data System (ADS)

Lee, Jungmin; Kim, Hyunjung; Chen, Linfeng; Choi, Sang H.; Varadan, Vijay K.

2012-10-01

Remote point-of-care is expected to revolutionize the modern medical practice, and many efforts have been made for the development of wireless health monitoring systems for continuously detecting the physiological signals of patients. To make the remote point-of-care generally accepted and widely used, it is necessary to develop cost-effective and durable wireless health monitoring systems. Printing technique will be helpful for the fabrication of high-quality and low-cost medical devices and systems because it allows high-resolution and high-speed fabrication, low material consumption and nano-sized patterning on both flexible and rigid substrates. Furthermore, application of thermoelectric generators can replace conventional batteries as the power sources for wireless health monitoring systems because thermoelectric generators can convert the wasted heat or the heat from nature into electricity which is required for the operation of the wireless health monitoring systems. In this research, we propose the concept of printable thermoelectric devices and conductive patterns for the realization of more portable and cost-effective medical devices. To print thermoelectric generators and conductive patterns on substrates, printing inks with special characteristics should be developed. For the development of thermoelectric inks, nano-structured thermoelectric materials are synthesized and characterized; and for the development of conductive inks, two kinds of surface treated carbon nanotubes are used as active materials.

Impact of Remote Monitoring on Clinical Outcomes.

PubMed

Varma, Niraj; Ricci, Renato Pietro

2015-12-01

Follow-up of patients with cardiac implantable electronic devices is challenging due to both their increasing volume and technical complexity coupled to increasing clinical complexity of recipient patients. Remote monitoring (RM) offers an opportunity to resolve some of these difficulties by improving clinic efficiencies and providing a mechanism for device monitoring and patient management. Several recent randomized clinical trials and registries have demonstrated that RM may reduce in-hospital visit numbers, time required for patient follow-up, physician and nurse time, and hospital and social costs. Furthermore, patient retention and adherence to follow-up schedule are significantly improved by RM. Continuous wireless monitoring of data stored in the device memory with automatic alerts allows early detection of device malfunctions and of events, such as atrial fibrillation, ventricular arrhythmias, and heart failure suitable for clinical intervention. Early reaction may improve patient outcome. RM is easy to use and patients showed a high level of acceptance and satisfaction. Implementing RM in daily practice may require changes in clinic workflow. New organizational models promote significant efficiencies regarding physician and nursing time. Data management techniques are under development. Despite these demonstrable advantages of RM, adoption still remains modest, even in health care systems incentivized to use this follow-up method. © 2015 Wiley Periodicals, Inc.

Continuous glucose monitoring for patients with diabetes: an evidence-based analysis.

PubMed

2011-01-01

To determine the effectiveness and cost-effectiveness of continuous glucose monitoring combined with self-monitoring of blood glucose compared with self-monitoring of blood glucose alone in the management of diabetes. CONDITION AND TARGET POPULATION Diabetes is a chronic metabolic disorder that interferes with the body's ability to produce or effectively use insulin. In 2005, an estimated 816,000 Ontarians had diabetes representing 8.8% of the province's population. Type 1 or juvenile onset diabetes is a life-long disorder that commonly manifests in children and adolescents. It represents about 10% of the total diabetes population and involves immune-mediated destruction of insulin producing cells in the pancreas. The loss of these cells necessitates insulin therapy. Type 2 or "adult-onset" diabetes represents about 90% of the total diabetes population and is marked by a resistance to insulin or insufficient insulin secretion. The risk of developing type 2 diabetes increases with age, obesity and lack of physical activity. Approximately 30% of patients with type 2 diabetes eventually require insulin therapy. Continuous glucose monitors (CGM) measure glucose levels in the interstitial fluid surrounding skin cells. These measurements supplement conventional self monitoring of blood glucose (SMBG) by monitoring the glucose fluctuations continuously over a stipulated period of time, thereby identifying fluctuations that would not be identified with SMBG alone. To use a CGM, a sensor is inserted under the skin to measure glucose in the interstitial fluid. The sensor is wired to a transmitter. The device requires calibration using a capillary blood glucose measurement. Each sensor continuously measures glucose every 5-10 seconds averaging these values every 5 minutes and storing this data in the monitors memory. Depending on the device used, the algorithm in the device can measure glucose over a 3 or 6 day period using one sensor. After the 3 or 6 day period, a new sensor is required. The device is equipped with alarms which warn the patient of impending hypo-or hyperglycemia. Two types of CGM are available: Systems that is stored in a monitor and can be downloaded later.Real time systems that continuously provide the actual glucose concentration on a display. What is the effectiveness and cost-effectiveness of CGM combined with SMBG compared with SMBG alone in the management of diabetes? A literature search was performed on September 15, 2010 using OVID MEDLINE, MEDLINE In-Process and Other Non-Indexed Citations, EMBASE, the Cumulative Index to Nursing & Allied Health Literature (CINAHL), the Cochrane Library, and the International Agency for Health Technology Assessment (INAHTA) for studies published from January 1, 2002 until September 15, 2010. Abstracts were reviewed by a single reviewer and, for those studies meeting the eligibility criteria, full-text articles were obtained. Reference lists were also examined for any additional relevant studies not identified through the search. Articles with unknown eligibility were reviewed with a second clinical epidemiologist, then a group of epidemiologists until consensus was established. The quality of evidence was assessed as high, moderate, low or very low according to GRADE methodology. English languageRandomized controlled trials (N>30 patients)Adults or pediatric patients with insulin dependent diabetes (type 1 or 2 or gestational)Studies comparing CGM plus SMBG versus SMBG alone Case studiesStudies that did not compare CGM plus SMBG versus SMBG aloneStudies that did not report statistical analysis of outcomes or data was unextractable Change in glycosylated hemoglobin (HbA1c)Frequency or duration of hypo-or hyperglycemic episodes or euglycemiaAdverse effects Moderate quality evidence that CGM + SMBG: is not more effective than self monitoring of blood glucose (SMBG) alone in the reduction of HbA1c using insulin infusion pumps for Type 1 diabetes.is not more effective than SMBG alone in the reduction of hypoglycemic or severe hypoglycemic events using insulin infusion pumps for Type 1 diabetes.

Cardiopulmonary monitoring in Thai ICUs (ICU-rESOURCE I Study).

PubMed

Chittawatanarat, Kaweesak; Wattanathum, Anan; Chaiwat, Onuma

2014-01-01

Cardiopulmonary monitoring (CPM) is rapidly progressing but data regarding CPM in Thai ICUs was unavailable. The objective of this study was to describe the situation, and gaps of CPM in Thai ICUs. Data were retrieved from the ICU-RESOURCE I study database survey CPM was divided into two aspects of device and measurement methods. These were categorized by device availability grading (AG), device availability per bed (DPB) and numeric frequency grading scale (FGS). Device availability was compared between academic and non-academic ICUs. Gap analysis of DPB and FGS was performed. Statistical significant difference was defined as p-value < 0.05. One hundred and fifty-five ICUs across Thailand participated in this study. Academic ICUs had significantly more devices available in new equipment with p < 0.05 (Vigilio, PiCCO, NICOM, esophageal pressure monitoring, transcutaneous PO2, electrical impedance tomography of lung) as well as measurement methods (stroke volume variation [SVV], pulse pressure variation [PPC], central venous oxygen saturation [ScvO2], lung mechanics). Most of new and higher technological devices had low density and few were available in all of Thai ICUs. However, in gap analysis, although these new devices and measurement techniques were available in ICUs, they were not frequently utilized. New technology devices of CPM had more availability in ACAD than in non-ACAD ICUs. Formal continuous training in new measurement methods should be established for reducing the availability and utilization gap (Thai Clinical Trial Registry: TCTR-201200005).

Wearable Contact Lens Biosensors for Continuous Glucose Monitoring Using Smartphones.

PubMed

Elsherif, Mohamed; Hassan, Mohammed Umair; Yetisen, Ali K; Butt, Haider

2018-05-17

Low-cost, robust, and reusable continuous glucose monitoring systems that can provide quantitative measurements at point-of-care settings is an unmet medical need. Optical glucose sensors require complex and time-consuming fabrication processes, and their readouts are not practical for quantitative analyses. Here, a wearable contact lens optical sensor was created for the continuous quantification of glucose at physiological conditions, simplifying the fabrication process and facilitating smartphone readouts. A photonic microstructure having a periodicity of 1.6 μm was printed on a glucose-selective hydrogel film functionalized with phenylboronic acid. Upon binding with glucose, the microstructure volume swelled, which modulated the periodicity constant. The resulting change in the Bragg diffraction modulated the space between zero- and first-order spots. A correlation was established between the periodicity constant and glucose concentration within 0-50 mM. The sensitivity of the sensor was 12 nm mM -1 , and the saturation response time was less than 30 min. The sensor was integrated with commercial contact lenses and utilized for continuous glucose monitoring using smartphone camera readouts. The reflected power of the first-order diffraction was measured via a smartphone application and correlated to the glucose concentrations. A short response time of 3 s and a saturation time of 4 min was achieved in the continuous monitoring mode. Glucose-sensitive photonic microstructures may have applications in point-of-care continuous monitoring devices and diagnostics at home settings.

Network architecture for global biomedical monitoring service.

PubMed

Lopez-Casado, Carmen; Tejero-Calado, Juan; Bernal-Martin, Antonio; Lopez-Gomez, Miguel; Romero-Romero, Marco; Quesada, Guillermo; Lorca, Julio; Garcia, Eugenia

2005-01-01

Most of the patients who are in hospitals and, increasingly, patients controlled remotely from their homes, at-home monitoring, are continuously monitored in order to control their evolution. The medical devices used up to now, force the sanitary staff to go to the patients' room to control the biosignals that are being monitored, although in many cases, patients are in perfect conditions. If patient is at home, it is he or she who has to go to the hospital to take the record of the monitored signal. New wireless technologies, such as BlueTooth and WLAN, make possible the deployment of systems that allow the display and storage of those signals in any place where the hospital intranet is accessible. In that way, unnecessary displacements are avoided. This paper presents a network architecture that allows the identification of the biosignal acquisition device as IP network nodes. The system is based on a TCP/IP architecture which is scalable and avoids the deployment of a specific purpose network.